CN110914242B - 丙酸衍生物及其使用方法 - Google Patents
丙酸衍生物及其使用方法 Download PDFInfo
- Publication number
- CN110914242B CN110914242B CN201880042454.1A CN201880042454A CN110914242B CN 110914242 B CN110914242 B CN 110914242B CN 201880042454 A CN201880042454 A CN 201880042454A CN 110914242 B CN110914242 B CN 110914242B
- Authority
- CN
- China
- Prior art keywords
- oxo
- ureido
- dihydropyridin
- hydroxy
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract description 76
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 title description 4
- 150000005599 propionic acid derivatives Chemical class 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 47
- 108010044426 integrins Proteins 0.000 claims abstract description 21
- 102000006495 integrins Human genes 0.000 claims abstract description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16
- -1 3- (1-ethyl-4-hydroxy-5-methyl-2-oxo-1, 2-dihydropyridin-3-yl) ureido Chemical group 0.000 claims description 1347
- 229910052708 sodium Inorganic materials 0.000 claims description 582
- 239000011734 sodium Substances 0.000 claims description 582
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 573
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 362
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 42
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 40
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 35
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 claims description 27
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims description 21
- 125000005605 benzo group Chemical group 0.000 claims description 20
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 17
- 235000019260 propionic acid Nutrition 0.000 claims description 17
- 210000004027 cell Anatomy 0.000 claims description 14
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims description 14
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 201000011510 cancer Diseases 0.000 claims description 10
- SABDMSXAVDPYTF-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(4-methoxyphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC)=O SABDMSXAVDPYTF-IBGZPJMESA-N 0.000 claims description 6
- MBOVIUDKKKMDFG-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-imidazol-1-ylphenyl)propanoic acid Chemical compound N1(C=NC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O MBOVIUDKKKMDFG-AWEZNQCLSA-N 0.000 claims description 6
- AOVUQIXVSBYSLW-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC)=O AOVUQIXVSBYSLW-NRFANRHFSA-N 0.000 claims description 6
- MNPMYISYMKHYHB-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC(F)(F)F)=O MNPMYISYMKHYHB-KRWDZBQOSA-N 0.000 claims description 5
- FAXMAHSGFUTCMH-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-phenyl-5-(trifluoromethoxy)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)OC(F)(F)F)C1=CC=CC=C1)=O FAXMAHSGFUTCMH-KRWDZBQOSA-N 0.000 claims description 5
- DSMQXFGLHPTNOA-IBGZPJMESA-N (3S)-3-[3-(2,6-dimethylphenyl)-5-fluorophenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)C1=C(C=CC=C1C)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O DSMQXFGLHPTNOA-IBGZPJMESA-N 0.000 claims description 4
- RLRIJVDIZGDOLT-SFHVURJKSA-N (3S)-3-[4-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O RLRIJVDIZGDOLT-SFHVURJKSA-N 0.000 claims description 4
- 201000001320 Atherosclerosis Diseases 0.000 claims description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims description 4
- 206010013774 Dry eye Diseases 0.000 claims description 4
- 206010020751 Hypersensitivity Diseases 0.000 claims description 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 4
- 208000006011 Stroke Diseases 0.000 claims description 4
- 206010052779 Transplant rejections Diseases 0.000 claims description 4
- 230000007815 allergy Effects 0.000 claims description 4
- 208000006673 asthma Diseases 0.000 claims description 4
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 4
- 208000010247 contact dermatitis Diseases 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 claims description 4
- 206010025135 lupus erythematosus Diseases 0.000 claims description 4
- 201000006417 multiple sclerosis Diseases 0.000 claims description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 4
- 208000007056 sickle cell anemia Diseases 0.000 claims description 4
- SEBKLZRQJDEMEE-NRFANRHFSA-N tert-butyl (3S)-3-[4-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoate Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OC(C)(C)C)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O SEBKLZRQJDEMEE-NRFANRHFSA-N 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- ZQDIDGCBHCAUBU-KRWDZBQOSA-N (3S)-3-(2-fluoro-3-phenylphenyl)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC=C1[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O)C1=CC=CC=C1 ZQDIDGCBHCAUBU-KRWDZBQOSA-N 0.000 claims description 3
- CCQWXHOOFLAYHS-SFHVURJKSA-N (3S)-3-(2-fluoro-5-phenylphenyl)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O CCQWXHOOFLAYHS-SFHVURJKSA-N 0.000 claims description 3
- MKYLSIYESHFIAX-KRWDZBQOSA-N (3S)-3-(2-fluoro-5-phenylphenyl)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O MKYLSIYESHFIAX-KRWDZBQOSA-N 0.000 claims description 3
- UBPYCWOKNSAQCM-SFHVURJKSA-N (3S)-3-(3,4-dimethoxy-5-phenylphenyl)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound COC=1C=C(C=C(C=1OC)C1=CC=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O UBPYCWOKNSAQCM-SFHVURJKSA-N 0.000 claims description 3
- COBODZKHAWYOPF-SFHVURJKSA-N (3S)-3-(4-fluoro-3-phenylphenyl)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1C1=CC=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O COBODZKHAWYOPF-SFHVURJKSA-N 0.000 claims description 3
- YYCPDGBIJJQJFU-IBGZPJMESA-N (3S)-3-[(1-ethyl-4-hydroxy-5-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-phenylphenyl)propanoic acid Chemical compound C1(=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)CC)=O)C1=CC=CC=C1 YYCPDGBIJJQJFU-IBGZPJMESA-N 0.000 claims description 3
- SCUNNGRMZZQKGX-FQEVSTJZSA-N (3S)-3-[(1-ethyl-4-hydroxy-5-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-methylphenyl)phenyl]propanoic acid Chemical compound C(C)N1C(C(=C(C(=C1)C)O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O)=O SCUNNGRMZZQKGX-FQEVSTJZSA-N 0.000 claims description 3
- LVJYCTGAIBMDOH-FQEVSTJZSA-N (3S)-3-[(1-ethyl-4-hydroxy-5-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(4-methylphenyl)phenyl]propanoic acid Chemical compound C(C)N1C(C(=C(C(=C1)C)O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC=C(C=C1)C)=O)=O LVJYCTGAIBMDOH-FQEVSTJZSA-N 0.000 claims description 3
- UNTVGWUJVHDGQN-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(1-phenylpyrrol-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1N(C=CC=1)C1=CC=CC=C1)=O UNTVGWUJVHDGQN-HNNXBMFYSA-N 0.000 claims description 3
- NLXZCTXHEMFPBP-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(2-methyl-3-phenylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C(=C(C=CC=1)C1=CC=CC=C1)C)=O NLXZCTXHEMFPBP-IBGZPJMESA-N 0.000 claims description 3
- LYDXDENFHXIZLH-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-phenylphenyl)propanoic acid Chemical compound C1(=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C1=CC=CC=C1 LYDXDENFHXIZLH-SFHVURJKSA-N 0.000 claims description 3
- RTPNLKLXKMLSJJ-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyridin-3-ylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1C=NC=CC=1)=O RTPNLKLXKMLSJJ-KRWDZBQOSA-N 0.000 claims description 3
- GHMRMQLXCJZMAR-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(4-methoxy-3-phenylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1)=O GHMRMQLXCJZMAR-SFHVURJKSA-N 0.000 claims description 3
- QKCCXMVGNHBIEU-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(4-methyl-3-phenylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)C)C1=CC=CC=C1)=O QKCCXMVGNHBIEU-IBGZPJMESA-N 0.000 claims description 3
- MYURRGHCDLHXEB-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(4-phenylthiophen-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1SC=C(C=1)C1=CC=CC=C1)=O MYURRGHCDLHXEB-HNNXBMFYSA-N 0.000 claims description 3
- YWBMSZLTLXZCJM-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(5-phenylfuran-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1OC(=CC=1)C1=CC=CC=C1)=O YWBMSZLTLXZCJM-AWEZNQCLSA-N 0.000 claims description 3
- YAAINPCJFFMWIM-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(5-phenylthiophen-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1SC(=CC=1)C1=CC=CC=C1)=O YAAINPCJFFMWIM-AWEZNQCLSA-N 0.000 claims description 3
- QABSYBRQUHJDEQ-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-methoxyphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC)=O QABSYBRQUHJDEQ-SFHVURJKSA-N 0.000 claims description 3
- KBMRSMSUYPIWCA-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O KBMRSMSUYPIWCA-IBGZPJMESA-N 0.000 claims description 3
- ZFYMTJSFDLBOGF-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxy-2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C)=O ZFYMTJSFDLBOGF-IBGZPJMESA-N 0.000 claims description 3
- VKQBZOXGVCGLNY-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O VKQBZOXGVCGLNY-IBGZPJMESA-N 0.000 claims description 3
- WCIYWHPIGJYRHL-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC(=CC=C1)C)=O WCIYWHPIGJYRHL-IBGZPJMESA-N 0.000 claims description 3
- UGENKCAIIOIGFO-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(4-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC=C(C=C1)C)=O UGENKCAIIOIGFO-IBGZPJMESA-N 0.000 claims description 3
- USQGCINCSBBIHG-FQEVSTJZSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(5-methoxy-2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)C)=O USQGCINCSBBIHG-FQEVSTJZSA-N 0.000 claims description 3
- IWMGGATVLQIXHP-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(6-methoxypyridin-3-yl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC)=O IWMGGATVLQIXHP-KRWDZBQOSA-N 0.000 claims description 3
- VCUCAFVJZAWUOJ-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[2-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC(F)(F)F)=O VCUCAFVJZAWUOJ-KRWDZBQOSA-N 0.000 claims description 3
- HEPJEYRSHUQHIJ-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[2-(trifluoromethyl)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)C(F)(F)F)=O HEPJEYRSHUQHIJ-SFHVURJKSA-N 0.000 claims description 3
- PCCQZTXHDBODSN-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC(F)(F)F)=O PCCQZTXHDBODSN-SFHVURJKSA-N 0.000 claims description 3
- GEOUBCBUSJBWCS-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[4-(trifluoromethyl)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC=C(C=C1)C(F)(F)F)=O GEOUBCBUSJBWCS-SFHVURJKSA-N 0.000 claims description 3
- OGKFZAPZKFXMPW-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methoxy-3-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC=C1OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O OGKFZAPZKFXMPW-IBGZPJMESA-N 0.000 claims description 3
- VMNJQLKQSPBPPZ-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O VMNJQLKQSPBPPZ-IBGZPJMESA-N 0.000 claims description 3
- FTOHOHDASHEWCO-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)-4-(trifluoromethoxy)phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC)=O FTOHOHDASHEWCO-SFHVURJKSA-N 0.000 claims description 3
- VYMLUDFPJAXKNP-FQEVSTJZSA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)-4-methylphenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)=O VYMLUDFPJAXKNP-FQEVSTJZSA-N 0.000 claims description 3
- ZCVBODJGRWBGNE-FQEVSTJZSA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)-5-methylphenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)=O ZCVBODJGRWBGNE-FQEVSTJZSA-N 0.000 claims description 3
- BKNXAXRKYPBZFJ-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O BKNXAXRKYPBZFJ-IBGZPJMESA-N 0.000 claims description 3
- QWDLHIFGVVRXCZ-FQEVSTJZSA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-methoxy-5-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC(=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O QWDLHIFGVVRXCZ-FQEVSTJZSA-N 0.000 claims description 3
- WSJWHKQQOIBCHE-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-methoxy-5-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O WSJWHKQQOIBCHE-IBGZPJMESA-N 0.000 claims description 3
- HBSKFNRMRCHGIP-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-methyl-5-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O HBSKFNRMRCHGIP-IBGZPJMESA-N 0.000 claims description 3
- XLZHUAHODHGIIT-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-(2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C1=CC=C(C=C1)C1=C(C=CC=C1)C)=O XLZHUAHODHGIIT-IBGZPJMESA-N 0.000 claims description 3
- CBORISCANFSHRF-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methoxy-3-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O CBORISCANFSHRF-SFHVURJKSA-N 0.000 claims description 3
- MZKHQILYNKXNPZ-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methyl-3-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O MZKHQILYNKXNPZ-IBGZPJMESA-N 0.000 claims description 3
- ZHRQOQJMMGKFGU-ZDUSSCGKSA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[5-(4-methylthiophen-3-yl)thiophen-2-yl]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C1=CC=C(S1)C1=CSC=C1C)=O ZHRQOQJMMGKFGU-ZDUSSCGKSA-N 0.000 claims description 3
- JGGPRBCUQFLTCG-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(2-methoxy-5-phenylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1OC)C1=CC=CC=C1)=O JGGPRBCUQFLTCG-KRWDZBQOSA-N 0.000 claims description 3
- CKDVKJBUEXZYEG-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-indazol-1-ylphenyl)propanoic acid Chemical compound N1(N=CC2=CC=CC=C12)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O CKDVKJBUEXZYEG-KRWDZBQOSA-N 0.000 claims description 3
- XFSULGWNTSOFDG-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-methoxy-5-phenylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1)=O XFSULGWNTSOFDG-SFHVURJKSA-N 0.000 claims description 3
- KPDXLKSFCOQGTE-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-phenylphenyl)propanoic acid Chemical compound C1(=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O)C1=CC=CC=C1 KPDXLKSFCOQGTE-KRWDZBQOSA-N 0.000 claims description 3
- KRNKULQEUJREPZ-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyrazin-2-ylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C1=NC=CN=C1)=O KRNKULQEUJREPZ-AWEZNQCLSA-N 0.000 claims description 3
- WUXOKPCUAONXOC-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyrazol-1-ylphenyl)propanoic acid Chemical compound N1(N=CC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O WUXOKPCUAONXOC-AWEZNQCLSA-N 0.000 claims description 3
- MOEBBEOPOMENJA-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyridin-2-ylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C1=NC=CC=C1)=O MOEBBEOPOMENJA-INIZCTEOSA-N 0.000 claims description 3
- QYPXLJXLPMHHLX-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyrrol-1-ylphenyl)propanoic acid Chemical compound N1(C=CC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O QYPXLJXLPMHHLX-HNNXBMFYSA-N 0.000 claims description 3
- VLAREZPOVUCWCG-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-thiophen-2-ylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1SC=CC=1)=O VLAREZPOVUCWCG-AWEZNQCLSA-N 0.000 claims description 3
- MKYAOMHVLRJQRU-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(4-methoxy-3-phenylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1)=O MKYAOMHVLRJQRU-KRWDZBQOSA-N 0.000 claims description 3
- HKWIDMAJRFNYEC-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(4-phenylthiophen-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1SC=C(C=1)C1=CC=CC=C1)=O HKWIDMAJRFNYEC-AWEZNQCLSA-N 0.000 claims description 3
- KVOALMWTPCLMRR-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(5-phenylpyridin-3-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=NC=C(C=1)C1=CC=CC=C1)=O KVOALMWTPCLMRR-INIZCTEOSA-N 0.000 claims description 3
- GXHUSEIDZSOYCT-ZDUSSCGKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(5-phenylthiophen-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1SC(=CC=1)C1=CC=CC=C1)=O GXHUSEIDZSOYCT-ZDUSSCGKSA-N 0.000 claims description 3
- XMRGKSFCDDWNEX-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-(6-phenylpyridin-2-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=NC(=CC=C1)C1=CC=CC=C1)=O XMRGKSFCDDWNEX-INIZCTEOSA-N 0.000 claims description 3
- AKTUQDFCZSTCEA-ZDUSSCGKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(1,3-thiazol-2-yl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1SC=CN=1)=O AKTUQDFCZSTCEA-ZDUSSCGKSA-N 0.000 claims description 3
- CQHGRUZYJAVLND-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(1-methylpyrazol-4-yl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1C=NN(C=1)C)=O CQHGRUZYJAVLND-HNNXBMFYSA-N 0.000 claims description 3
- BRPFHPLJOZTCEF-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(1H-pyrrol-3-yl)phenyl]propanoic acid Chemical compound N1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O BRPFHPLJOZTCEF-HNNXBMFYSA-N 0.000 claims description 3
- FLIIQEXFADNBQG-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-methylphenyl)-4-(trifluoromethoxy)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC(F)(F)F)C1=C(C=CC=C1)C)=O FLIIQEXFADNBQG-KRWDZBQOSA-N 0.000 claims description 3
- GQZQMULDROBBOE-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O GQZQMULDROBBOE-SFHVURJKSA-N 0.000 claims description 3
- YTHVEFIOLUMJEF-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)-4-(trifluoromethoxy)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC)=O YTHVEFIOLUMJEF-KRWDZBQOSA-N 0.000 claims description 3
- MESZKOPGXIZBIL-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)-4-methylphenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)=O MESZKOPGXIZBIL-IBGZPJMESA-N 0.000 claims description 3
- DNDPRJRXNVRUNN-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)-5-methylphenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)=O DNDPRJRXNVRUNN-IBGZPJMESA-N 0.000 claims description 3
- JMXADKLPSNTYBN-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O JMXADKLPSNTYBN-SFHVURJKSA-N 0.000 claims description 3
- FYPZKTLSTFUNJR-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(4-methylthiophen-3-yl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C1=CSC=C1C)=O FYPZKTLSTFUNJR-INIZCTEOSA-N 0.000 claims description 3
- GQNWSLGJQBSRHF-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(6-methoxypyridazin-3-yl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1N=NC(=CC=1)OC)=O GQNWSLGJQBSRHF-HNNXBMFYSA-N 0.000 claims description 3
- BDSDJHXKYMKXGG-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(6-methoxypyridin-3-yl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC)=O BDSDJHXKYMKXGG-INIZCTEOSA-N 0.000 claims description 3
- BKDRLUZBJINWBJ-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[2-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC(F)(F)F)=O BKDRLUZBJINWBJ-INIZCTEOSA-N 0.000 claims description 3
- GQKNHXPOIVNCES-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-[4-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC(F)(F)F)=O GQKNHXPOIVNCES-KRWDZBQOSA-N 0.000 claims description 3
- DZGPNIJLADWLDE-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-methoxy-5-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC(=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O DZGPNIJLADWLDE-IBGZPJMESA-N 0.000 claims description 3
- VDYWWSDIWZAPCB-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-methoxy-5-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O VDYWWSDIWZAPCB-SFHVURJKSA-N 0.000 claims description 3
- NBGNNJVKUIOZEF-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-methyl-5-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O NBGNNJVKUIOZEF-SFHVURJKSA-N 0.000 claims description 3
- OVOFHAAZLKLUBV-INIZCTEOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-phenyl-4-(trifluoromethoxy)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC=CC=C1)=O OVOFHAAZLKLUBV-INIZCTEOSA-N 0.000 claims description 3
- ZTAVGTNPHBCHOS-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-phenyl-5-(trifluoromethyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C(F)(F)F)C1=CC=CC=C1)=O ZTAVGTNPHBCHOS-KRWDZBQOSA-N 0.000 claims description 3
- XKDXGCMWZYCQIN-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-(2-methylphenyl)phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC=C(C=C1)C1=C(C=CC=C1)C)=O XKDXGCMWZYCQIN-SFHVURJKSA-N 0.000 claims description 3
- ZDKMTKYORWLSSL-HNNXBMFYSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-(3-methoxyphenyl)thiophen-2-yl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1SC=C(C=1)C1=CC(=CC=C1)OC)=O ZDKMTKYORWLSSL-HNNXBMFYSA-N 0.000 claims description 3
- PCOIDFSEIBWQFN-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methoxy-3-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC=C1OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O PCOIDFSEIBWQFN-SFHVURJKSA-N 0.000 claims description 3
- ZNSSSIHQVLGATD-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methoxy-3-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O ZNSSSIHQVLGATD-KRWDZBQOSA-N 0.000 claims description 3
- MOMVILPFPVRXQR-KRWDZBQOSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methoxy-3-[4-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC)C1=CC=C(C=C1)OC(F)(F)F)=O MOMVILPFPVRXQR-KRWDZBQOSA-N 0.000 claims description 3
- YYGQTLRKVSLLOF-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methyl-3-[3-(trifluoromethoxy)phenyl]phenyl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O YYGQTLRKVSLLOF-SFHVURJKSA-N 0.000 claims description 3
- NTYAGHQISNWPAR-AWEZNQCLSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[5-(3-methoxyphenyl)thiophen-2-yl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1SC(=CC=1)C1=CC(=CC=C1)OC)=O NTYAGHQISNWPAR-AWEZNQCLSA-N 0.000 claims description 3
- NJVUNDLOSWZRDG-LBPRGKRZSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[5-(4-methylthiophen-3-yl)thiophen-2-yl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C1=CC=C(S1)C1=CSC=C1C)=O NJVUNDLOSWZRDG-LBPRGKRZSA-N 0.000 claims description 3
- SPUGSOSOWOLOLI-ZDUSSCGKSA-N (3S)-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1SC(=CC=1)C1=CC(=CC=C1)OC(F)(F)F)=O SPUGSOSOWOLOLI-ZDUSSCGKSA-N 0.000 claims description 3
- GKOAFAWMRBAKHI-IBGZPJMESA-N (3S)-3-[2-fluoro-5-(3-methoxyphenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O GKOAFAWMRBAKHI-IBGZPJMESA-N 0.000 claims description 3
- DRVVPGUEILDQRJ-SFHVURJKSA-N (3S)-3-[2-fluoro-5-(3-methoxyphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O DRVVPGUEILDQRJ-SFHVURJKSA-N 0.000 claims description 3
- CUBILOILZRTJKV-SFHVURJKSA-N (3S)-3-[2-fluoro-5-[3-(trifluoromethoxy)phenyl]phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O CUBILOILZRTJKV-SFHVURJKSA-N 0.000 claims description 3
- QPYAHJHHPPHFBL-KRWDZBQOSA-N (3S)-3-[2-fluoro-5-[3-(trifluoromethoxy)phenyl]phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O QPYAHJHHPPHFBL-KRWDZBQOSA-N 0.000 claims description 3
- PGXBJULSFKQUEW-FQEVSTJZSA-N (3S)-3-[3-(1-ethylindol-6-yl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound C(C)N1C=CC2=CC=C(C=C12)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O PGXBJULSFKQUEW-FQEVSTJZSA-N 0.000 claims description 3
- MHVOZZFWOHIFRV-KRWDZBQOSA-N (3S)-3-[3-(2,3-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC=C1F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O MHVOZZFWOHIFRV-KRWDZBQOSA-N 0.000 claims description 3
- QPMJTKSLXDJYKX-SFHVURJKSA-N (3S)-3-[3-(2,3-dimethoxyphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound COC1=C(C=CC=C1OC)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O QPMJTKSLXDJYKX-SFHVURJKSA-N 0.000 claims description 3
- AWGQWTWCJGUDRX-FQEVSTJZSA-N (3S)-3-[3-(2,3-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C=CC=C1C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O AWGQWTWCJGUDRX-FQEVSTJZSA-N 0.000 claims description 3
- BNJXEQMPVJYXKG-KRWDZBQOSA-N (3S)-3-[3-(2,4-difluorophenyl)-4-methoxyphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O BNJXEQMPVJYXKG-KRWDZBQOSA-N 0.000 claims description 3
- QYQOAPUGVBVKAK-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)-4-methylphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O QYQOAPUGVBVKAK-SFHVURJKSA-N 0.000 claims description 3
- YTPATNNWBKUFGF-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)-5-fluorophenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F)=O YTPATNNWBKUFGF-SFHVURJKSA-N 0.000 claims description 3
- PYSMVHHULAQIDU-KRWDZBQOSA-N (3S)-3-[3-(2,4-difluorophenyl)-5-fluorophenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F)=O PYSMVHHULAQIDU-KRWDZBQOSA-N 0.000 claims description 3
- IGALGIQHWOVHKS-IBGZPJMESA-N (3S)-3-[3-(2,4-difluorophenyl)-5-methoxyphenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O IGALGIQHWOVHKS-IBGZPJMESA-N 0.000 claims description 3
- LUMTZPIZMLVBPK-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)-5-methoxyphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O LUMTZPIZMLVBPK-SFHVURJKSA-N 0.000 claims description 3
- SIZGRZODNATVJU-IBGZPJMESA-N (3S)-3-[3-(2,4-difluorophenyl)-5-methylphenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O SIZGRZODNATVJU-IBGZPJMESA-N 0.000 claims description 3
- MJIXZAMKFNFTDU-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)-5-methylphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O MJIXZAMKFNFTDU-SFHVURJKSA-N 0.000 claims description 3
- ATZLJLPSPMRZJU-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(1-ethyl-4-hydroxy-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)CC)=O ATZLJLPSPMRZJU-SFHVURJKSA-N 0.000 claims description 3
- JKUBBYJAYGFBSR-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O JKUBBYJAYGFBSR-SFHVURJKSA-N 0.000 claims description 3
- TWLZUVDXWCUUCA-SFHVURJKSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O TWLZUVDXWCUUCA-SFHVURJKSA-N 0.000 claims description 3
- UWDQFCZXGCHLSF-IBGZPJMESA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxo-1,8-naphthyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C2=NC=CC=C2C=1O)C)=O UWDQFCZXGCHLSF-IBGZPJMESA-N 0.000 claims description 3
- NWFKHDWMTCVBNA-IBGZPJMESA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxo-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC1=C(C2=C(N(C1=O)C)CCC2)O NWFKHDWMTCVBNA-IBGZPJMESA-N 0.000 claims description 3
- NTEHBGUGQXJWDP-KRWDZBQOSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O NTEHBGUGQXJWDP-KRWDZBQOSA-N 0.000 claims description 3
- KIQQOAUKXOEILQ-INIZCTEOSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-2-oxo-1H-pyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(NC=CC=1O)=O KIQQOAUKXOEILQ-INIZCTEOSA-N 0.000 claims description 3
- LYPXBFDIJQIILV-KRWDZBQOSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-6-methyl-2-oxo-1H-pyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(NC(=CC=1O)C)=O LYPXBFDIJQIILV-KRWDZBQOSA-N 0.000 claims description 3
- RNQYNPSFQGTGIL-INIZCTEOSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(5-hydroxy-2-methyl-3-oxopyridazin-4-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(N=CC=1O)C)=O RNQYNPSFQGTGIL-INIZCTEOSA-N 0.000 claims description 3
- NIWNVTDCQDNJCQ-KRWDZBQOSA-N (3S)-3-[3-(2,4-difluorophenyl)phenyl]-3-[(7-hydroxy-4-methyl-5-oxothieno[3,2-b]pyridin-6-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC1=C(C2=C(N(C1=O)C)C=CS2)O NIWNVTDCQDNJCQ-KRWDZBQOSA-N 0.000 claims description 3
- OXGHXWNVRMTUQT-IBGZPJMESA-N (3S)-3-[3-(2,4-dimethoxyphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound COC1=C(C=CC(=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O OXGHXWNVRMTUQT-IBGZPJMESA-N 0.000 claims description 3
- WHCPRRKRVVVJGK-IBGZPJMESA-N (3S)-3-[3-(2,5-dimethoxyphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound COC1=C(C=C(C=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O WHCPRRKRVVVJGK-IBGZPJMESA-N 0.000 claims description 3
- POJJTYGSRIHMAS-FQEVSTJZSA-N (3S)-3-[3-(2,5-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C=C(C=C1)C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O POJJTYGSRIHMAS-FQEVSTJZSA-N 0.000 claims description 3
- AUZRRDNRPMCZOD-SFHVURJKSA-N (3S)-3-[3-(2,5-dimethylpyrrol-1-yl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC=1N(C(=CC=1)C)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O AUZRRDNRPMCZOD-SFHVURJKSA-N 0.000 claims description 3
- POVRMPJNQYXORN-KRWDZBQOSA-N (3S)-3-[3-(2,6-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O POVRMPJNQYXORN-KRWDZBQOSA-N 0.000 claims description 3
- NDVVUPUIZSQLNM-KRWDZBQOSA-N (3S)-3-[3-(2,6-dimethoxyphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound COC1=C(C(=CC=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O NDVVUPUIZSQLNM-KRWDZBQOSA-N 0.000 claims description 3
- RUFPREZEBHLLDN-IBGZPJMESA-N (3S)-3-[3-(2,6-dimethylphenyl)-4-fluorophenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1C1=C(C=CC=C1C)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O RUFPREZEBHLLDN-IBGZPJMESA-N 0.000 claims description 3
- HUWZISKZHRAUKQ-SFHVURJKSA-N (3S)-3-[3-(2,6-dimethylphenyl)-4-fluorophenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1C1=C(C=CC=C1C)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O HUWZISKZHRAUKQ-SFHVURJKSA-N 0.000 claims description 3
- HRVZIWALCYUFDR-SFHVURJKSA-N (3S)-3-[3-(2,6-dimethylphenyl)-4-methoxyphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C)=O HRVZIWALCYUFDR-SFHVURJKSA-N 0.000 claims description 3
- RWAONFBWLDIXRF-SFHVURJKSA-N (3S)-3-[3-(2,6-dimethylphenyl)-5-fluorophenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)C1=C(C=CC=C1C)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O RWAONFBWLDIXRF-SFHVURJKSA-N 0.000 claims description 3
- UKIYLWKCUGADID-FQEVSTJZSA-N (3S)-3-[3-(2,6-dimethylphenyl)-5-methoxyphenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)=O UKIYLWKCUGADID-FQEVSTJZSA-N 0.000 claims description 3
- ATXRJNRWVYSCKS-IBGZPJMESA-N (3S)-3-[3-(2,6-dimethylphenyl)-5-methoxyphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)=O ATXRJNRWVYSCKS-IBGZPJMESA-N 0.000 claims description 3
- LBWGAKKSOVWIPW-FQEVSTJZSA-N (3S)-3-[3-(2,6-dimethylphenyl)-5-methylphenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C)=O LBWGAKKSOVWIPW-FQEVSTJZSA-N 0.000 claims description 3
- WBPYUQOXDSFOSH-IBGZPJMESA-N (3S)-3-[3-(2,6-dimethylphenyl)-5-methylphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C)=O WBPYUQOXDSFOSH-IBGZPJMESA-N 0.000 claims description 3
- MVWHQVHMJPMWAG-IBGZPJMESA-N (3S)-3-[3-(2,6-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O MVWHQVHMJPMWAG-IBGZPJMESA-N 0.000 claims description 3
- SBHRLAPHBRFAGT-IBGZPJMESA-N (3S)-3-[3-(2,6-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O SBHRLAPHBRFAGT-IBGZPJMESA-N 0.000 claims description 3
- OLKXJICDRALPJC-SFHVURJKSA-N (3S)-3-[3-(2,6-dimethylphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O OLKXJICDRALPJC-SFHVURJKSA-N 0.000 claims description 3
- BHOVMTJNVVKQEB-FQEVSTJZSA-N (3S)-3-[3-(2-ethylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound C(C)C1=C(C=CC=C1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O BHOVMTJNVVKQEB-FQEVSTJZSA-N 0.000 claims description 3
- HIAKDVUTBPUIBE-INIZCTEOSA-N (3S)-3-[3-(2-fluoro-3-methoxyphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC=C1OC)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O HIAKDVUTBPUIBE-INIZCTEOSA-N 0.000 claims description 3
- AWAKCUZSSAATFN-SFHVURJKSA-N (3S)-3-[3-(2-fluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC=C1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O AWAKCUZSSAATFN-SFHVURJKSA-N 0.000 claims description 3
- DWUPGUWCEKTBKG-SFHVURJKSA-N (3S)-3-[3-(3,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=CC=1F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O DWUPGUWCEKTBKG-SFHVURJKSA-N 0.000 claims description 3
- UIOYBMJUKOSGCJ-SFHVURJKSA-N (3S)-3-[3-(3,4-dimethoxyphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound COC=1C=C(C=CC=1OC)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O UIOYBMJUKOSGCJ-SFHVURJKSA-N 0.000 claims description 3
- XXXUCVLIWHLOGH-FQEVSTJZSA-N (3S)-3-[3-(3,4-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC=1C=C(C=CC=1C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O XXXUCVLIWHLOGH-FQEVSTJZSA-N 0.000 claims description 3
- YAHRXKODKBMGOS-SFHVURJKSA-N (3S)-3-[3-(3,5-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O YAHRXKODKBMGOS-SFHVURJKSA-N 0.000 claims description 3
- NFYNYOCZUYARFT-FQEVSTJZSA-N (3S)-3-[3-(3,5-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC=1C=C(C=C(C=1)C)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O NFYNYOCZUYARFT-FQEVSTJZSA-N 0.000 claims description 3
- UQYLWPOEDTUUPI-KRWDZBQOSA-N (3S)-3-[3-(3-chlorophenyl)-4-methoxyphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O UQYLWPOEDTUUPI-KRWDZBQOSA-N 0.000 claims description 3
- SUGXFVIPXFKMSO-SFHVURJKSA-N (3S)-3-[3-(3-chlorophenyl)-4-methylphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O SUGXFVIPXFKMSO-SFHVURJKSA-N 0.000 claims description 3
- AOJNOBXXFJUFOB-SFHVURJKSA-N (3S)-3-[3-(3-chlorophenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O AOJNOBXXFJUFOB-SFHVURJKSA-N 0.000 claims description 3
- ZWEUHEXGEXZPHS-KRWDZBQOSA-N (3S)-3-[3-(3-chlorophenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O ZWEUHEXGEXZPHS-KRWDZBQOSA-N 0.000 claims description 3
- ZHYKUOUZCZPVRO-SFHVURJKSA-N (3S)-3-[3-(3-fluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=CC=1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O ZHYKUOUZCZPVRO-SFHVURJKSA-N 0.000 claims description 3
- WFGJZMPMKNSQFP-IBGZPJMESA-N (3S)-3-[3-(4-fluoro-3-methylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C WFGJZMPMKNSQFP-IBGZPJMESA-N 0.000 claims description 3
- TVPMAFXMRBGSCY-SFHVURJKSA-N (3S)-3-[3-(4-fluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O TVPMAFXMRBGSCY-SFHVURJKSA-N 0.000 claims description 3
- ZTXWUDGGNGHYNA-ZDUSSCGKSA-N (3S)-3-[3-(5-chlorothiophen-2-yl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC1=CC=C(S1)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O ZTXWUDGGNGHYNA-ZDUSSCGKSA-N 0.000 claims description 3
- RZAXXJFCNQERHL-HNNXBMFYSA-N (3S)-3-[3-(furan-3-yl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound O1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O RZAXXJFCNQERHL-HNNXBMFYSA-N 0.000 claims description 3
- KIBGGAIGNOVFPU-IBGZPJMESA-N (3S)-3-[3-fluoro-5-(3-methoxyphenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O KIBGGAIGNOVFPU-IBGZPJMESA-N 0.000 claims description 3
- OBQOIMWWIJMELJ-SFHVURJKSA-N (3S)-3-[3-fluoro-5-(3-methoxyphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O OBQOIMWWIJMELJ-SFHVURJKSA-N 0.000 claims description 3
- XXTZCPTWTORFNE-SFHVURJKSA-N (3S)-3-[3-fluoro-5-[3-(trifluoromethoxy)phenyl]phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O XXTZCPTWTORFNE-SFHVURJKSA-N 0.000 claims description 3
- ZTOQZZVZPWCDEI-KRWDZBQOSA-N (3S)-3-[3-fluoro-5-[3-(trifluoromethoxy)phenyl]phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O ZTOQZZVZPWCDEI-KRWDZBQOSA-N 0.000 claims description 3
- HJWHZHBWSQKBGA-SFHVURJKSA-N (3S)-3-[4-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O HJWHZHBWSQKBGA-SFHVURJKSA-N 0.000 claims description 3
- XGASFTRKNFNBEP-KRWDZBQOSA-N (3S)-3-[4-(2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O XGASFTRKNFNBEP-KRWDZBQOSA-N 0.000 claims description 3
- ZGBRILUHNMANLK-HNNXBMFYSA-N (3S)-3-[4-(2,4-difluorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C=1C=C(SC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O ZGBRILUHNMANLK-HNNXBMFYSA-N 0.000 claims description 3
- WVCRTRZWOOJSJC-AWEZNQCLSA-N (3S)-3-[4-(2,4-difluorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C=1C=C(SC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O WVCRTRZWOOJSJC-AWEZNQCLSA-N 0.000 claims description 3
- VVEACDKWGDKKDH-IBGZPJMESA-N (3S)-3-[4-(2,6-dimethylphenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC=C(C=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O VVEACDKWGDKKDH-IBGZPJMESA-N 0.000 claims description 3
- YOMRPAOAPWEHHI-SFHVURJKSA-N (3S)-3-[4-(2,6-dimethylphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC=C(C=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O YOMRPAOAPWEHHI-SFHVURJKSA-N 0.000 claims description 3
- ZTNHYBDCHOAIAY-HNNXBMFYSA-N (3S)-3-[4-(2,6-dimethylphenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C=1C=C(SC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O ZTNHYBDCHOAIAY-HNNXBMFYSA-N 0.000 claims description 3
- WIYCEYYVFYQQSE-AWEZNQCLSA-N (3S)-3-[4-(3-chlorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C=1C=C(SC=1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O WIYCEYYVFYQQSE-AWEZNQCLSA-N 0.000 claims description 3
- PJCAOZSRQYCKNC-IBGZPJMESA-N (3S)-3-[4-fluoro-3-(2-methylphenyl)phenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1C1=C(C=CC=C1)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O PJCAOZSRQYCKNC-IBGZPJMESA-N 0.000 claims description 3
- BLVOKLDRHHMKGS-SFHVURJKSA-N (3S)-3-[4-fluoro-3-(2-methylphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1C1=C(C=CC=C1)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O BLVOKLDRHHMKGS-SFHVURJKSA-N 0.000 claims description 3
- KIYLOQYCZGVJLK-SFHVURJKSA-N (3S)-3-[4-fluoro-3-(3-methoxyphenyl)phenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=CC=C(C=C1C1=CC(=CC=C1)OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O KIYLOQYCZGVJLK-SFHVURJKSA-N 0.000 claims description 3
- YGSSYZAGHQQGMH-ZDUSSCGKSA-N (3S)-3-[5-(2,4-difluorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O YGSSYZAGHQQGMH-ZDUSSCGKSA-N 0.000 claims description 3
- TYUZHKQSDAPHAS-ZDUSSCGKSA-N (3S)-3-[5-(2,5-difluorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)F)C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O TYUZHKQSDAPHAS-ZDUSSCGKSA-N 0.000 claims description 3
- PQZCQNAZHBDSNL-IBGZPJMESA-N (3S)-3-[5-(2,6-dimethylphenyl)-2-fluorophenyl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=C(C=CC=C1C)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O PQZCQNAZHBDSNL-IBGZPJMESA-N 0.000 claims description 3
- ZECYVZUZDZMQKH-SFHVURJKSA-N (3S)-3-[5-(2,6-dimethylphenyl)-2-fluorophenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)C1=C(C=CC=C1C)C)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O ZECYVZUZDZMQKH-SFHVURJKSA-N 0.000 claims description 3
- IUWATEXHABYOGQ-HNNXBMFYSA-N (3S)-3-[5-(2,6-dimethylphenyl)thiophen-2-yl]-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O IUWATEXHABYOGQ-HNNXBMFYSA-N 0.000 claims description 3
- VMDHYMNIBKXVSF-AWEZNQCLSA-N (3S)-3-[5-(2,6-dimethylphenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=C(C(=CC=C1)C)C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O VMDHYMNIBKXVSF-AWEZNQCLSA-N 0.000 claims description 3
- FWUCFVWBDRNIJP-NSHDSACASA-N (3S)-3-[5-(3,5-dimethyl-1,2-oxazol-4-yl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound CC1=NOC(=C1C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O)C FWUCFVWBDRNIJP-NSHDSACASA-N 0.000 claims description 3
- YKFFSLQIOWLOKV-ZDUSSCGKSA-N (3S)-3-[5-(3-chlorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O YKFFSLQIOWLOKV-ZDUSSCGKSA-N 0.000 claims description 3
- ACNSBHLIDANAGH-ZDUSSCGKSA-N (3S)-3-[5-(3-fluorophenyl)thiophen-2-yl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC=1C=C(C=CC=1)C1=CC=C(S1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=CC=1O)C)=O ACNSBHLIDANAGH-ZDUSSCGKSA-N 0.000 claims description 3
- ATSHGSAOYAHQHI-UHFFFAOYSA-N 3-(3-bromophenyl)-3-[(1-ethyl-4-hydroxy-5-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound BrC=1C=C(C=CC=1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)CC)=O ATSHGSAOYAHQHI-UHFFFAOYSA-N 0.000 claims description 3
- BBMACTRHPCPCFX-UHFFFAOYSA-N 3-(3-bromophenyl)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound BrC=1C=C(C=CC=1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O BBMACTRHPCPCFX-UHFFFAOYSA-N 0.000 claims description 3
- ZIGCJHXNNYHCBZ-UHFFFAOYSA-N 3-[(1-ethyl-4-hydroxy-5-methyl-2-oxopyridin-3-yl)carbamoylamino]-3-[3-(2-oxo-3-phenylpyridin-1-yl)phenyl]propanoic acid Chemical compound C(C)N1C(C(=C(C(=C1)C)O)NC(NC(CC(=O)O)C1=CC(=CC=C1)N1C(C(=CC=C1)C1=CC=CC=C1)=O)=O)=O ZIGCJHXNNYHCBZ-UHFFFAOYSA-N 0.000 claims description 3
- OJDVATKCMUCPQL-UHFFFAOYSA-N 3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyrimidin-5-ylphenyl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(NC(CC(=O)O)C1=CC(=CC=C1)C=1C=NC=NC=1)=O OJDVATKCMUCPQL-UHFFFAOYSA-N 0.000 claims description 3
- ZJUUDBVYRWUNON-UHFFFAOYSA-N 3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(3-pyrrol-1-ylphenyl)propanoic acid Chemical compound N1(C=CC=C1)C=1C=C(C=CC=1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O ZJUUDBVYRWUNON-UHFFFAOYSA-N 0.000 claims description 3
- JQONTYKPYHILAP-UHFFFAOYSA-N 3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(6-oxo-1-phenylpyridin-3-yl)propanoic acid Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(NC(CC(=O)O)C1=CN(C(C=C1)=O)C1=CC=CC=C1)=O JQONTYKPYHILAP-UHFFFAOYSA-N 0.000 claims description 3
- SJYSHPUAXWEREY-UHFFFAOYSA-N 3-[3-(3-acetylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound C(C)(=O)C=1C=C(C=CC=1)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O SJYSHPUAXWEREY-UHFFFAOYSA-N 0.000 claims description 3
- JCCPPESQXKVSKP-UHFFFAOYSA-N 3-[3-(3-chloro-4-fluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1F)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O JCCPPESQXKVSKP-UHFFFAOYSA-N 0.000 claims description 3
- DHQJAXKGVRAJTH-UHFFFAOYSA-N 3-[3-(3-chlorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O DHQJAXKGVRAJTH-UHFFFAOYSA-N 0.000 claims description 3
- QNRMADKWVPVVSZ-UHFFFAOYSA-N 3-[3-(4-acetylphenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound C(C)(=O)C1=CC=C(C=C1)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O QNRMADKWVPVVSZ-UHFFFAOYSA-N 0.000 claims description 3
- LKENVOCAHDKOPE-UHFFFAOYSA-N 3-[3-(4-chlorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC1=CC=C(C=C1)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O LKENVOCAHDKOPE-UHFFFAOYSA-N 0.000 claims description 3
- BVALOKCUEAHACO-UHFFFAOYSA-N 3-[3-(5-chloro-2,4-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C(=CC(=C(C=1)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)F)F BVALOKCUEAHACO-UHFFFAOYSA-N 0.000 claims description 3
- AZSJISMOYSUFDF-QFIPXVFZSA-N C(C)N1C(C(=C(C(=C1)C)O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O)=O Chemical compound C(C)N1C(C(=C(C(=C1)C)O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O)=O AZSJISMOYSUFDF-QFIPXVFZSA-N 0.000 claims description 3
- PNXBSYQYYQYKEA-NRFANRHFSA-N FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OC(C)(C)C)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OC(C)(C)C)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O PNXBSYQYYQYKEA-NRFANRHFSA-N 0.000 claims description 3
- QABHMEXWCUJZHK-FQEVSTJZSA-N FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OC(C)(C)C)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OC(C)(C)C)NC(=O)NC=1C(N(C=CC=1O)C)=O QABHMEXWCUJZHK-FQEVSTJZSA-N 0.000 claims description 3
- XVKNXNDKUFEULR-NRFANRHFSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1)C)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1)C)=O XVKNXNDKUFEULR-NRFANRHFSA-N 0.000 claims description 3
- VKEJYSCTTQUBSD-QFIPXVFZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)=O VKEJYSCTTQUBSD-QFIPXVFZSA-N 0.000 claims description 3
- CBTFFNMLLWISAH-QFIPXVFZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C)=O CBTFFNMLLWISAH-QFIPXVFZSA-N 0.000 claims description 3
- NELMBYDKHNUBTL-QFIPXVFZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)=O NELMBYDKHNUBTL-QFIPXVFZSA-N 0.000 claims description 3
- JFRZVUPNBWYYIJ-NRFANRHFSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O JFRZVUPNBWYYIJ-NRFANRHFSA-N 0.000 claims description 3
- NYKRNMGJBFVQMU-NRFANRHFSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O NYKRNMGJBFVQMU-NRFANRHFSA-N 0.000 claims description 3
- XINBKHUODHZDPA-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=NC(=CC=C1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=NC(=CC=C1)C1=CC=CC=C1)=O XINBKHUODHZDPA-SFHVURJKSA-N 0.000 claims description 3
- KCGCRIZTOYDWSI-NRFANRHFSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)=O KCGCRIZTOYDWSI-NRFANRHFSA-N 0.000 claims description 3
- JXQUQHSYLRQZBO-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1)=O JXQUQHSYLRQZBO-IBGZPJMESA-N 0.000 claims description 3
- GVWHRTYNKLCBFR-NRFANRHFSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C)=O GVWHRTYNKLCBFR-NRFANRHFSA-N 0.000 claims description 3
- YTAFXKSCWBWLAV-NRFANRHFSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)=O YTAFXKSCWBWLAV-NRFANRHFSA-N 0.000 claims description 3
- DDFZAXUOHIHXGT-NRFANRHFSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)=O DDFZAXUOHIHXGT-NRFANRHFSA-N 0.000 claims description 3
- XHUMXDHIPKOPQR-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1)=O XHUMXDHIPKOPQR-FQEVSTJZSA-N 0.000 claims description 3
- SDMUBNMDWWESRT-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O SDMUBNMDWWESRT-FQEVSTJZSA-N 0.000 claims description 3
- CJTCVNDQYSJHGL-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C)=O CJTCVNDQYSJHGL-FQEVSTJZSA-N 0.000 claims description 3
- YKHQFPLBJYUSJV-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=CC=CC=C1)=O YKHQFPLBJYUSJV-IBGZPJMESA-N 0.000 claims description 3
- LLDLETXUDDLQND-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=NC=C(C=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=NC=C(C=1)C1=CC=CC=C1)=O LLDLETXUDDLQND-SFHVURJKSA-N 0.000 claims description 3
- JFJNWMNDTRFMKX-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)C)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)C)=O JFJNWMNDTRFMKX-NRFANRHFSA-N 0.000 claims description 3
- OWDGPKXIHCMUMT-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC=CC=C1)=O OWDGPKXIHCMUMT-NRFANRHFSA-N 0.000 claims description 3
- AVRNATZJOKJVOK-FQEVSTJZSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1)=O AVRNATZJOKJVOK-FQEVSTJZSA-N 0.000 claims description 3
- PQTGHZSFCUJMNG-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C)=O PQTGHZSFCUJMNG-NRFANRHFSA-N 0.000 claims description 3
- FGGAIFRBNXMMHO-QFIPXVFZSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)C)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)C)=O FGGAIFRBNXMMHO-QFIPXVFZSA-N 0.000 claims description 3
- BXPWBOKRRSSCMU-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C)=O BXPWBOKRRSSCMU-NRFANRHFSA-N 0.000 claims description 3
- OKMFIIHQMDAOSS-FQEVSTJZSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC)=O OKMFIIHQMDAOSS-FQEVSTJZSA-N 0.000 claims description 3
- COMRLNUNKXBECB-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)C)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)C)=O COMRLNUNKXBECB-NRFANRHFSA-N 0.000 claims description 3
- FSTWDCFULKOCIV-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC)=O FSTWDCFULKOCIV-NRFANRHFSA-N 0.000 claims description 3
- FVCYGRRDIDISJI-NRFANRHFSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)C)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)C)=O FVCYGRRDIDISJI-NRFANRHFSA-N 0.000 claims description 3
- OZGLDECTXRXBSZ-KRWDZBQOSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1N(C=CC=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1N(C=CC=1)C1=CC=CC=C1)=O OZGLDECTXRXBSZ-KRWDZBQOSA-N 0.000 claims description 3
- HFUBHMSNDBNLFG-INIZCTEOSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1OC(=CC=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1OC(=CC=1)C1=CC=CC=C1)=O HFUBHMSNDBNLFG-INIZCTEOSA-N 0.000 claims description 3
- HFBJSPKKBIFPAO-INIZCTEOSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC=CC=C1)=O HFBJSPKKBIFPAO-INIZCTEOSA-N 0.000 claims description 3
- KFQTXGAOGHEBKL-KRWDZBQOSA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1)=O KFQTXGAOGHEBKL-KRWDZBQOSA-N 0.000 claims description 3
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 208000026935 allergic disease Diseases 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- IEBHJQKSTFDIFD-FQEVSTJZSA-N FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O IEBHJQKSTFDIFD-FQEVSTJZSA-N 0.000 claims 1
- YKJROPUQUZIZFU-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C)=O YKJROPUQUZIZFU-FQEVSTJZSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract description 17
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 230000004963 pathophysiological condition Effects 0.000 abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 243
- 238000005259 measurement Methods 0.000 description 209
- 239000000203 mixture Substances 0.000 description 164
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 101
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 80
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 76
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 74
- 239000000243 solution Substances 0.000 description 73
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 58
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 53
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 50
- 239000012044 organic layer Substances 0.000 description 47
- 239000007787 solid Substances 0.000 description 47
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- 229910052739 hydrogen Inorganic materials 0.000 description 41
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 40
- 235000019341 magnesium sulphate Nutrition 0.000 description 40
- 229910052757 nitrogen Inorganic materials 0.000 description 38
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 38
- 239000012267 brine Substances 0.000 description 37
- 239000001257 hydrogen Substances 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- 125000000217 alkyl group Chemical group 0.000 description 31
- 125000003118 aryl group Chemical group 0.000 description 31
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 31
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 30
- 239000000706 filtrate Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 24
- 229920006395 saturated elastomer Polymers 0.000 description 24
- 238000010898 silica gel chromatography Methods 0.000 description 24
- 238000003786 synthesis reaction Methods 0.000 description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 23
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 150000002367 halogens Chemical class 0.000 description 18
- 150000002431 hydrogen Chemical class 0.000 description 18
- 239000000725 suspension Substances 0.000 description 18
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 17
- 229910052736 halogen Inorganic materials 0.000 description 17
- 238000010992 reflux Methods 0.000 description 17
- 230000004048 modification Effects 0.000 description 16
- 238000012986 modification Methods 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 239000010410 layer Substances 0.000 description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- 125000001188 haloalkyl group Chemical group 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 125000003545 alkoxy group Chemical group 0.000 description 12
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 12
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 11
- 125000000623 heterocyclic group Chemical group 0.000 description 11
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 11
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 125000004663 dialkyl amino group Chemical group 0.000 description 10
- 125000004043 oxo group Chemical group O=* 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 125000005309 thioalkoxy group Chemical group 0.000 description 10
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 235000019270 ammonium chloride Nutrition 0.000 description 9
- 229910052786 argon Inorganic materials 0.000 description 9
- 125000003710 aryl alkyl group Chemical group 0.000 description 9
- 125000004104 aryloxy group Chemical group 0.000 description 9
- 239000012362 glacial acetic acid Substances 0.000 description 9
- 125000004438 haloalkoxy group Chemical group 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 8
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 239000002480 mineral oil Substances 0.000 description 7
- 235000010446 mineral oil Nutrition 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- HJBGZJMKTOMQRR-UHFFFAOYSA-N (3-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C=O)=C1 HJBGZJMKTOMQRR-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 239000012298 atmosphere Substances 0.000 description 6
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 6
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 6
- 230000001991 pathophysiological effect Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 108010041012 Integrin alpha4 Proteins 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 125000000304 alkynyl group Chemical group 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- HHVUFPUWPWOWOA-UHFFFAOYSA-N 3-bromo-2-methylbenzaldehyde Chemical compound CC1=C(Br)C=CC=C1C=O HHVUFPUWPWOWOA-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 4
- 230000021164 cell adhesion Effects 0.000 description 4
- 239000006184 cosolvent Substances 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 4
- 239000011698 potassium fluoride Substances 0.000 description 4
- 235000003270 potassium fluoride Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- LFILDSDQMSCNBV-LURJTMIESA-N propane-2-sulfinamide Chemical compound CC(C)[S@@](N)=O LFILDSDQMSCNBV-LURJTMIESA-N 0.000 description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 4
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- PMDGXZZKMUOICT-UHFFFAOYSA-N 3-(1-ethylindol-6-yl)benzaldehyde Chemical compound C(C)N1C=CC2=CC=C(C=C12)C=1C=C(C=O)C=CC=1 PMDGXZZKMUOICT-UHFFFAOYSA-N 0.000 description 3
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 3
- SUISZCALMBHJQX-UHFFFAOYSA-N 3-bromobenzaldehyde Chemical compound BrC1=CC=CC(C=O)=C1 SUISZCALMBHJQX-UHFFFAOYSA-N 0.000 description 3
- NCJWPSOBHRFXEU-UHFFFAOYSA-N 3-iodo-4-(trifluoromethoxy)benzaldehyde Chemical compound FC(F)(F)OC1=CC=C(C=O)C=C1I NCJWPSOBHRFXEU-UHFFFAOYSA-N 0.000 description 3
- XYNBXICQKGHDID-UHFFFAOYSA-N 3-phenyl-5-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC(C=O)=CC(C=2C=CC=CC=2)=C1 XYNBXICQKGHDID-UHFFFAOYSA-N 0.000 description 3
- NTHCVKPOWDMRGY-UHFFFAOYSA-N 3-thiophen-2-ylbenzaldehyde Chemical compound O=CC1=CC=CC(C=2SC=CC=2)=C1 NTHCVKPOWDMRGY-UHFFFAOYSA-N 0.000 description 3
- CSMMEAYSMCAJPJ-UHFFFAOYSA-N 3h-pyridin-6-one Chemical compound O=C1C=CCC=N1 CSMMEAYSMCAJPJ-UHFFFAOYSA-N 0.000 description 3
- QARWCILSUIUECG-UHFFFAOYSA-N 3h-pyridine-4,6-dione Chemical compound O=C1CC=NC(=O)C1 QARWCILSUIUECG-UHFFFAOYSA-N 0.000 description 3
- GFBVUFQNHLUCPX-UHFFFAOYSA-N 5-bromothiophene-2-carbaldehyde Chemical compound BrC1=CC=C(C=O)S1 GFBVUFQNHLUCPX-UHFFFAOYSA-N 0.000 description 3
- JTEWEGJCDPOJFI-UHFFFAOYSA-N 5-hydroxy-2-methylpyridazin-3-one Chemical compound CN1N=CC(O)=CC1=O JTEWEGJCDPOJFI-UHFFFAOYSA-N 0.000 description 3
- KTKVAYJIQSQSLT-UHFFFAOYSA-N 5-methyl-3H-[1,3]oxazolo[4,5-c]pyridine-2,4-dione Chemical compound CN1C(C2=C(C=C1)OC(N2)=O)=O KTKVAYJIQSQSLT-UHFFFAOYSA-N 0.000 description 3
- GFQPTVGPUTXTBG-UHFFFAOYSA-N 6-bromo-1-ethylindole Chemical compound C1=C(Br)C=C2N(CC)C=CC2=C1 GFQPTVGPUTXTBG-UHFFFAOYSA-N 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical group [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 3
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 239000004324 sodium propionate Substances 0.000 description 3
- 235000010334 sodium propionate Nutrition 0.000 description 3
- 229960003212 sodium propionate Drugs 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- REHVCPNQQBDOJJ-UHFFFAOYSA-N (3-ethoxycarbonylphenyl)boronic acid Chemical compound CCOC(=O)C1=CC=CC(B(O)O)=C1 REHVCPNQQBDOJJ-UHFFFAOYSA-N 0.000 description 2
- ICRMNLKUOTVCPN-IBGZPJMESA-N (3S)-3-[(4-hydroxy-1,6-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-[4-methoxy-3-(3-methoxyphenyl)phenyl]propanoic acid Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC=C1OC)[C@H](CC(=O)O)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O ICRMNLKUOTVCPN-IBGZPJMESA-N 0.000 description 2
- FSHRVGNBIACANN-SFHVURJKSA-N (3S)-3-[3-(2,5-difluorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound FC1=C(C=C(C=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O FSHRVGNBIACANN-SFHVURJKSA-N 0.000 description 2
- DHQJAXKGVRAJTH-SFHVURJKSA-N (3S)-3-[3-(3-chlorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O DHQJAXKGVRAJTH-SFHVURJKSA-N 0.000 description 2
- ATXATYDBIXCNOD-SFHVURJKSA-N (3S)-3-[5-(2,6-dimethylphenyl)-2-methoxyphenyl]-3-[(4-hydroxy-1-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)O)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C)=O ATXATYDBIXCNOD-SFHVURJKSA-N 0.000 description 2
- HVRUGFJYCAFAAN-UHFFFAOYSA-N 1-bromo-2-ethylbenzene Chemical compound CCC1=CC=CC=C1Br HVRUGFJYCAFAAN-UHFFFAOYSA-N 0.000 description 2
- LXEQKKWJDGVPRW-UHFFFAOYSA-N 1-phenylpyrrole-2-carbaldehyde Chemical compound O=CC1=CC=CN1C1=CC=CC=C1 LXEQKKWJDGVPRW-UHFFFAOYSA-N 0.000 description 2
- OJVAMHKKJGICOG-UHFFFAOYSA-N 2,5-hexanedione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- XJXVEYLKVSDPHZ-UHFFFAOYSA-N 3-(3,5-dimethyl-1,2-oxazol-4-yl)benzaldehyde Chemical compound CC1=NOC(C)=C1C1=CC=CC(C=O)=C1 XJXVEYLKVSDPHZ-UHFFFAOYSA-N 0.000 description 2
- NLNYLGFBQPYQOC-UHFFFAOYSA-N 3-[3-(2-chlorophenyl)phenyl]-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]propanoic acid Chemical compound ClC1=C(C=CC=C1)C1=CC(=CC=C1)C(CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O NLNYLGFBQPYQOC-UHFFFAOYSA-N 0.000 description 2
- QMPNFQLVIGPNEI-UHFFFAOYSA-N 3-bromo-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1Br QMPNFQLVIGPNEI-UHFFFAOYSA-N 0.000 description 2
- WTXXUAHMTVAQHW-UHFFFAOYSA-N 3-bromo-4-methylbenzaldehyde Chemical compound CC1=CC=C(C=O)C=C1Br WTXXUAHMTVAQHW-UHFFFAOYSA-N 0.000 description 2
- XBJLKXOOHLLTPG-UHFFFAOYSA-N 3-chloro-6-methoxypyridazine Chemical compound COC1=CC=C(Cl)N=N1 XBJLKXOOHLLTPG-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- CTAIEPPAOULMFY-UHFFFAOYSA-N 6-methoxypyridine-3-carbaldehyde Chemical compound COC1=CC=C(C=O)C=N1 CTAIEPPAOULMFY-UHFFFAOYSA-N 0.000 description 2
- PVZMGWZOXQPFLS-UHFFFAOYSA-N 6-phenylpyridine-2-carbaldehyde Chemical compound O=CC1=CC=CC(C=2C=CC=CC=2)=N1 PVZMGWZOXQPFLS-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- HXUCJOIABYXMCF-QFIPXVFZSA-N C(C)N1C(C(=C(C(=C1)C)O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)C)=O)=O Chemical compound C(C)N1C(C(=C(C(=C1)C)O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)C)=O)=O HXUCJOIABYXMCF-QFIPXVFZSA-N 0.000 description 2
- VKJCSGBTHMVDCI-QFIPXVFZSA-N C(C)N1C=CC2=CC=C(C=C12)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound C(C)N1C=CC2=CC=C(C=C12)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O VKJCSGBTHMVDCI-QFIPXVFZSA-N 0.000 description 2
- DGXUQIUDUPUWFS-XJFCNFDWSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 DGXUQIUDUPUWFS-XJFCNFDWSA-N 0.000 description 2
- IKXRSPOAFZPMAU-IBGZPJMESA-N C1(=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O)C1=CC=CC=C1 Chemical compound C1(=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O)C1=CC=CC=C1 IKXRSPOAFZPMAU-IBGZPJMESA-N 0.000 description 2
- YHUXVABBPKAAJD-NRFANRHFSA-N CC1=C(C(=CC=C1)C)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound CC1=C(C(=CC=C1)C)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O YHUXVABBPKAAJD-NRFANRHFSA-N 0.000 description 2
- WPQNBLSHHDVTHU-KRWDZBQOSA-N CC1=C(C(=CC=C1)C)C1=CC=C(S1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound CC1=C(C(=CC=C1)C)C1=CC=C(S1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O WPQNBLSHHDVTHU-KRWDZBQOSA-N 0.000 description 2
- UJVACVWJGICICZ-KRWDZBQOSA-N CC1=C(C(=CC=C1)C)C=1C=C(SC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound CC1=C(C(=CC=C1)C)C=1C=C(SC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O UJVACVWJGICICZ-KRWDZBQOSA-N 0.000 description 2
- DPXXMMPAGJLEQL-ZDUSSCGKSA-N CC1=NOC(=C1C1=CC=C(S1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O)C Chemical compound CC1=NOC(=C1C1=CC=C(S1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O)C DPXXMMPAGJLEQL-ZDUSSCGKSA-N 0.000 description 2
- QEZBGWZUDADFOT-QFIPXVFZSA-N CC=1C=C(C=C(C=1)C)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound CC=1C=C(C=C(C=1)C)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O QEZBGWZUDADFOT-QFIPXVFZSA-N 0.000 description 2
- BAHOMPYOXLRGFB-QFIPXVFZSA-N CC=1C=C(C=CC=1C)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound CC=1C=C(C=CC=1C)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O BAHOMPYOXLRGFB-QFIPXVFZSA-N 0.000 description 2
- DIUFZSIBBYRJFB-FQEVSTJZSA-N CC=1N(C(=CC=1)C)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound CC=1N(C(=CC=1)C)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O DIUFZSIBBYRJFB-FQEVSTJZSA-N 0.000 description 2
- DMQPXCMUKCVNPT-IBGZPJMESA-N COC1=C(C(=CC=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound COC1=C(C(=CC=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O DMQPXCMUKCVNPT-IBGZPJMESA-N 0.000 description 2
- GUVYNVQVTUILBV-NRFANRHFSA-N COC1=C(C=C(C=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound COC1=C(C=C(C=C1)OC)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O GUVYNVQVTUILBV-NRFANRHFSA-N 0.000 description 2
- XBGCKAULLNUIGO-QFIPXVFZSA-N COC=1C=C(C=CC=1)C1=CC(=CC(=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC(=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O XBGCKAULLNUIGO-QFIPXVFZSA-N 0.000 description 2
- DXILGQYTPHVOJG-NRFANRHFSA-N COC=1C=C(C=CC=1)C1=CC(=CC(=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound COC=1C=C(C=CC=1)C1=CC(=CC(=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O DXILGQYTPHVOJG-NRFANRHFSA-N 0.000 description 2
- HZVCXQUCOBBOES-FQEVSTJZSA-N COC=1C=C(C=CC=1OC)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound COC=1C=C(C=CC=1OC)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O HZVCXQUCOBBOES-FQEVSTJZSA-N 0.000 description 2
- GAJRSAIQUMJNDF-FQEVSTJZSA-N ClC=1C=C(C=CC=1)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound ClC=1C=C(C=CC=1)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O GAJRSAIQUMJNDF-FQEVSTJZSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- MWCWATLUIAYKBL-IBGZPJMESA-N FC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound FC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O MWCWATLUIAYKBL-IBGZPJMESA-N 0.000 description 2
- FNLHHRBNLQIHFI-FQEVSTJZSA-N FC1=C(C=C(C=C1)C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=C(C=C1)C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O FNLHHRBNLQIHFI-FQEVSTJZSA-N 0.000 description 2
- SVKGCDKACUYDEU-IBGZPJMESA-N FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O SVKGCDKACUYDEU-IBGZPJMESA-N 0.000 description 2
- PKHWUIHVASIBBA-NRFANRHFSA-N FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O PKHWUIHVASIBBA-NRFANRHFSA-N 0.000 description 2
- TZOCDQUDRBBQQF-NRFANRHFSA-N FC1=C(C=C(C=C1)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C Chemical compound FC1=C(C=C(C=C1)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C TZOCDQUDRBBQQF-NRFANRHFSA-N 0.000 description 2
- JRDRUPDWCVJQBW-IBGZPJMESA-N FC1=C(C=C(C=C1)C1=CC=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=C(C=C1)C1=CC=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O JRDRUPDWCVJQBW-IBGZPJMESA-N 0.000 description 2
- UABNTFPEPATRMN-FQEVSTJZSA-N FC1=C(C=C(C=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound FC1=C(C=C(C=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O UABNTFPEPATRMN-FQEVSTJZSA-N 0.000 description 2
- RKLNJASGJUAXMB-NRFANRHFSA-N FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O RKLNJASGJUAXMB-NRFANRHFSA-N 0.000 description 2
- NNEPRBNCHNMHCW-FQEVSTJZSA-N FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC(=C1)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O NNEPRBNCHNMHCW-FQEVSTJZSA-N 0.000 description 2
- DANNRDHRYCLNRG-FQEVSTJZSA-N FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O DANNRDHRYCLNRG-FQEVSTJZSA-N 0.000 description 2
- QKLQTBKBSHWJNG-NRFANRHFSA-N FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C2=NC=CC=C2C=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C2=NC=CC=C2C=1O)C)=O QKLQTBKBSHWJNG-NRFANRHFSA-N 0.000 description 2
- RUOYCXJSUVCPRT-FQEVSTJZSA-N FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O RUOYCXJSUVCPRT-FQEVSTJZSA-N 0.000 description 2
- RFRJUJQTDJBDTF-SFHVURJKSA-N FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(N=CC=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(N=CC=1O)C)=O RFRJUJQTDJBDTF-SFHVURJKSA-N 0.000 description 2
- RWBJRLNQNAGWNV-IBGZPJMESA-N FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(NC(=CC=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(NC(=CC=1O)C)=O RWBJRLNQNAGWNV-IBGZPJMESA-N 0.000 description 2
- BITOGBIYVIJWNL-IBGZPJMESA-N FC1=C(C=CC(=C1)F)C1=CC(=CC=C1OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC(=CC=C1OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O BITOGBIYVIJWNL-IBGZPJMESA-N 0.000 description 2
- YEHZACWTFIALFI-IBGZPJMESA-N FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(C=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O YEHZACWTFIALFI-IBGZPJMESA-N 0.000 description 2
- KDOLJCPBHCGTSQ-FQEVSTJZSA-N FC1=C(C=CC=C1)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O Chemical compound FC1=C(C=CC=C1)C1=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O KDOLJCPBHCGTSQ-FQEVSTJZSA-N 0.000 description 2
- KWYWRMITLPGCFW-IBGZPJMESA-N FC1=C(C=CC=C1[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O)C1=CC=CC=C1 Chemical compound FC1=C(C=CC=C1[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O)C1=CC=CC=C1 KWYWRMITLPGCFW-IBGZPJMESA-N 0.000 description 2
- FNCCKQULYVCRGU-NRFANRHFSA-N FC1=CC=C(C=C1C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC1=CC=C(C=C1C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O FNCCKQULYVCRGU-NRFANRHFSA-N 0.000 description 2
- MGYABPMJGDRPEF-FQEVSTJZSA-N FC1=CC=C(C=C1C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC1=CC=C(C=C1C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O MGYABPMJGDRPEF-FQEVSTJZSA-N 0.000 description 2
- YCODMJDGSRMJDR-FQEVSTJZSA-N FC=1C=C(C=C(C=1)C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC=1C=C(C=C(C=1)C1=C(C=CC=C1C)C)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O YCODMJDGSRMJDR-FQEVSTJZSA-N 0.000 description 2
- KZBCQTVMORNSJM-FQEVSTJZSA-N FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O KZBCQTVMORNSJM-FQEVSTJZSA-N 0.000 description 2
- RDPFWFFXMBFAJO-IBGZPJMESA-N FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC(F)(F)F)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O RDPFWFFXMBFAJO-IBGZPJMESA-N 0.000 description 2
- KZLZMZBSVNGFEY-NRFANRHFSA-N FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O Chemical compound FC=1C=C(C=C(C=1)C1=CC(=CC=C1)OC)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C(=CC=1O)C)C)=O KZLZMZBSVNGFEY-NRFANRHFSA-N 0.000 description 2
- 108010008212 Integrin alpha4beta1 Proteins 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JSJWCHRYRHKBBW-UHFFFAOYSA-N N-carbamoyl-beta-alanine Chemical compound NC(=O)NCCC(O)=O JSJWCHRYRHKBBW-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- KEEYFVPYNOWZBW-INIZCTEOSA-N N1(N=CC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound N1(N=CC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O KEEYFVPYNOWZBW-INIZCTEOSA-N 0.000 description 2
- KKYGWSJUSRIKOZ-KRWDZBQOSA-N N1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound N1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O KKYGWSJUSRIKOZ-KRWDZBQOSA-N 0.000 description 2
- UKJWQQIYKCIARD-KRWDZBQOSA-N O1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O Chemical compound O1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=CC=1O)C)=O UKJWQQIYKCIARD-KRWDZBQOSA-N 0.000 description 2
- FBIZEOHKBMSIID-HNNXBMFYSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(S1)C1=CSC=C1C)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(S1)C1=CSC=C1C)=O FBIZEOHKBMSIID-HNNXBMFYSA-N 0.000 description 2
- AENYNBDOOVOVJO-NRFANRHFSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O AENYNBDOOVOVJO-NRFANRHFSA-N 0.000 description 2
- AMAVDTOXSSFZOT-FQEVSTJZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC)=O AMAVDTOXSSFZOT-FQEVSTJZSA-N 0.000 description 2
- PAOQNVREGQUSHM-FQEVSTJZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O PAOQNVREGQUSHM-FQEVSTJZSA-N 0.000 description 2
- IKJDLPHYYHJQIF-NRFANRHFSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O IKJDLPHYYHJQIF-NRFANRHFSA-N 0.000 description 2
- MPWOPXLMLBCIEV-QFIPXVFZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)=O MPWOPXLMLBCIEV-QFIPXVFZSA-N 0.000 description 2
- WHNJVCCZUXQXIV-FQEVSTJZSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F)=O WHNJVCCZUXQXIV-FQEVSTJZSA-N 0.000 description 2
- CDOHMKXGCNDUSA-NRFANRHFSA-N OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C(=C1)C)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O CDOHMKXGCNDUSA-NRFANRHFSA-N 0.000 description 2
- PNBLFBMFGSIKIW-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CSC=C1C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CSC=C1C)=O PNBLFBMFGSIKIW-SFHVURJKSA-N 0.000 description 2
- BYFTXKABELGRPQ-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC=CC=C1)=O BYFTXKABELGRPQ-SFHVURJKSA-N 0.000 description 2
- POKRZZACVUWJIC-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC)=O POKRZZACVUWJIC-SFHVURJKSA-N 0.000 description 2
- PMMROKQUIPLJMG-KRWDZBQOSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NN(C=1)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NN(C=1)C)=O PMMROKQUIPLJMG-KRWDZBQOSA-N 0.000 description 2
- SFRZICBXJJSIHA-KRWDZBQOSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1N=NC(=CC=1)OC)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1N=NC(=CC=1)OC)=O SFRZICBXJJSIHA-KRWDZBQOSA-N 0.000 description 2
- OWHGOBSASPIVOV-INIZCTEOSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CC=1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CC=1)=O OWHGOBSASPIVOV-INIZCTEOSA-N 0.000 description 2
- XGDMTPLHYNCGQR-HNNXBMFYSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CN=1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CN=1)=O XGDMTPLHYNCGQR-HNNXBMFYSA-N 0.000 description 2
- VRHQXOHUPZAGCR-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1)C)=O VRHQXOHUPZAGCR-FQEVSTJZSA-N 0.000 description 2
- TWJLUVQITQNIRY-AWEZNQCLSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(S1)C1=CSC=C1C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC=C(S1)C1=CSC=C1C)=O TWJLUVQITQNIRY-AWEZNQCLSA-N 0.000 description 2
- LYSTWTAIMBGIAT-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=C(C=CC=C1)C)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=C(C=CC=C1)C)=O LYSTWTAIMBGIAT-IBGZPJMESA-N 0.000 description 2
- HEQPHVWEOSTVST-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC)=O HEQPHVWEOSTVST-IBGZPJMESA-N 0.000 description 2
- OPVPFUSNADKKPE-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC=CC=C1)=O OPVPFUSNADKKPE-SFHVURJKSA-N 0.000 description 2
- XEKNHRGUERQUNF-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O XEKNHRGUERQUNF-IBGZPJMESA-N 0.000 description 2
- VLGHLTLMWNVDCH-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C(F)(F)F)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C(F)(F)F)C1=CC=CC=C1)=O VLGHLTLMWNVDCH-IBGZPJMESA-N 0.000 description 2
- HKSRSTYFVGDOGX-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F)=O HKSRSTYFVGDOGX-FQEVSTJZSA-N 0.000 description 2
- OAXFXTVTNQUFPB-FQEVSTJZSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F)=O OAXFXTVTNQUFPB-FQEVSTJZSA-N 0.000 description 2
- TYLSXIUKNRAOEF-SFHVURJKSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC(F)(F)F)=O TYLSXIUKNRAOEF-SFHVURJKSA-N 0.000 description 2
- RAXIPIUDKFGHFB-IBGZPJMESA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC(F)(F)F)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC(F)(F)F)=O RAXIPIUDKFGHFB-IBGZPJMESA-N 0.000 description 2
- APCXUYTVYYKZPB-HNNXBMFYSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC=CC=C1)=O APCXUYTVYYKZPB-HNNXBMFYSA-N 0.000 description 2
- ODODAKDHFQQLOK-INIZCTEOSA-N OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1)=O Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1)=O ODODAKDHFQQLOK-INIZCTEOSA-N 0.000 description 2
- MYRFAMKXYKNLDQ-IBGZPJMESA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC)=O MYRFAMKXYKNLDQ-IBGZPJMESA-N 0.000 description 2
- YLOWIBSGZYCKHG-IBGZPJMESA-N OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC=CC=1)=O Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC=CC=1)=O YLOWIBSGZYCKHG-IBGZPJMESA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000005703 Trimethylamine hydrochloride Substances 0.000 description 2
- QQIRAVWVGBTHMJ-UHFFFAOYSA-N [dimethyl-(trimethylsilylamino)silyl]methane;lithium Chemical compound [Li].C[Si](C)(C)N[Si](C)(C)C QQIRAVWVGBTHMJ-UHFFFAOYSA-N 0.000 description 2
- 125000005011 alkyl ether group Chemical group 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 238000010936 aqueous wash Methods 0.000 description 2
- 125000005125 aryl alkyl amino carbonyl group Chemical group 0.000 description 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 2
- 125000003828 azulenyl group Chemical group 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- 239000002027 dichloromethane extract Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 150000002148 esters Chemical group 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- AEJMLFIKIYQESK-UHFFFAOYSA-N ethyl 3-(3-bromophenyl)-3-[(1-ethyl-4-hydroxy-5-methyl-2-oxopyridin-3-yl)carbamoylamino]propanoate Chemical compound BrC=1C=C(C=CC=1)C(CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)CC)=O AEJMLFIKIYQESK-UHFFFAOYSA-N 0.000 description 2
- AQFOXRGUKFKZAE-UHFFFAOYSA-N ethyl 3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(6-oxo-1-phenylpyridin-3-yl)propanoate Chemical compound OC1=C(C(N(C=C1C)C)=O)NC(NC(CC(=O)OCC)C1=CN(C(C=C1)=O)C1=CC=CC=C1)=O AQFOXRGUKFKZAE-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- JMXKSZRRTHPKDL-UHFFFAOYSA-N titanium ethoxide Chemical compound [Ti+4].CC[O-].CC[O-].CC[O-].CC[O-] JMXKSZRRTHPKDL-UHFFFAOYSA-N 0.000 description 2
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- SZYJELPVAFJOGJ-UHFFFAOYSA-N trimethylamine hydrochloride Chemical compound Cl.CN(C)C SZYJELPVAFJOGJ-UHFFFAOYSA-N 0.000 description 2
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 2
- 235000019798 tripotassium phosphate Nutrition 0.000 description 2
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- ZYZHMSJNPCYUTB-CYBMUJFWSA-N (1r)-n-benzyl-1-phenylethanamine Chemical compound N([C@H](C)C=1C=CC=CC=1)CC1=CC=CC=C1 ZYZHMSJNPCYUTB-CYBMUJFWSA-N 0.000 description 1
- JRHPOFJADXHYBR-HTQZYQBOSA-N (1r,2r)-1-n,2-n-dimethylcyclohexane-1,2-diamine Chemical compound CN[C@@H]1CCCC[C@H]1NC JRHPOFJADXHYBR-HTQZYQBOSA-N 0.000 description 1
- XYDXDWXAAQXHLK-UHFFFAOYSA-N (3-bromo-2-methylphenyl)methanol Chemical compound CC1=C(Br)C=CC=C1CO XYDXDWXAAQXHLK-UHFFFAOYSA-N 0.000 description 1
- FISOIOAMTHXGEL-UHFFFAOYSA-N (3-methoxy-2-methylphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1C FISOIOAMTHXGEL-UHFFFAOYSA-N 0.000 description 1
- GMONVWLXRKOKFQ-SFHVURJKSA-N (3S)-3-[(4-hydroxy-1,5-dimethyl-2-oxopyridin-3-yl)carbamoylamino]-3-(4-phenylphenyl)propanoic acid Chemical compound C1(=CC=C(C=C1)[C@H](CC(=O)O)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C1=CC=CC=C1 GMONVWLXRKOKFQ-SFHVURJKSA-N 0.000 description 1
- DEQOVKFWRPOPQP-UHFFFAOYSA-N (5-formylthiophen-2-yl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)S1 DEQOVKFWRPOPQP-UHFFFAOYSA-N 0.000 description 1
- QUQJFILPCCJEGB-UHFFFAOYSA-N (5-methoxy-2-methylphenyl)boronic acid Chemical compound COC1=CC=C(C)C(B(O)O)=C1 QUQJFILPCCJEGB-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- ODGBPPAGLWQVOD-OTJDAXFFSA-N (NE,R)-N-[[3-(5-chlorothiophen-2-yl)phenyl]methylidene]-2-methylpropane-2-sulfinamide Chemical compound ClC1=CC=C(S1)C=1C=C(\C=N\[S@](=O)C(C)(C)C)C=CC=1 ODGBPPAGLWQVOD-OTJDAXFFSA-N 0.000 description 1
- QARGMVVIEAEADD-JRVGGCGHSA-N (NE,R)-N-[[3-(6-methoxypyridazin-3-yl)phenyl]methylidene]-2-methylpropane-2-sulfinamide Chemical compound COC1=CC=C(N=N1)C=1C=C(\C=N\[S@](=O)C(C)(C)C)C=CC=1 QARGMVVIEAEADD-JRVGGCGHSA-N 0.000 description 1
- KEQHUZBEASYPKK-OUQXZNHLSA-N (NE,R)-N-[[3-(furan-3-yl)phenyl]methylidene]-2-methylpropane-2-sulfinamide Chemical compound O1C=C(C=C1)C=1C=C(\C=N\[S@](=O)C(C)(C)C)C=CC=1 KEQHUZBEASYPKK-OUQXZNHLSA-N 0.000 description 1
- CCLUGZGCENMFNV-MZPCATCRSA-N (NE,R)-N-[[5-(2,4-difluorophenyl)thiophen-2-yl]methylidene]-2-methylpropane-2-sulfinamide Chemical compound FC1=C(C=CC(=C1)F)C1=CC=C(S1)\C=N\[S@](=O)C(C)(C)C CCLUGZGCENMFNV-MZPCATCRSA-N 0.000 description 1
- MKCZAEPOOHKPAL-KDHISYJLSA-N (NE,R)-N-[[5-(3-methoxyphenyl)thiophen-2-yl]methylidene]-2-methylpropane-2-sulfinamide Chemical compound COC=1C=C(C=CC=1)C1=CC=C(S1)\C=N\[S@](=O)C(C)(C)C MKCZAEPOOHKPAL-KDHISYJLSA-N 0.000 description 1
- YEMUSDCFQUBPAL-SNAWJCMRSA-N (e)-3-(3-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=CC(Br)=C1 YEMUSDCFQUBPAL-SNAWJCMRSA-N 0.000 description 1
- CPDDDTNAMBSPRN-ZZXKWVIFSA-N (e)-3-(4-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Br)C=C1 CPDDDTNAMBSPRN-ZZXKWVIFSA-N 0.000 description 1
- WFJQPZFHZNOMJB-MRHLJLSQSA-N (ne)-n-[(5-bromopyridin-3-yl)methylidene]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)\N=C\C1=CN=CC(Br)=C1 WFJQPZFHZNOMJB-MRHLJLSQSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 description 1
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
- ASWYHZXKFSLNLN-UHFFFAOYSA-N 1,3-dibromo-5-fluorobenzene Chemical compound FC1=CC(Br)=CC(Br)=C1 ASWYHZXKFSLNLN-UHFFFAOYSA-N 0.000 description 1
- OQZAQBGJENJMHT-UHFFFAOYSA-N 1,3-dibromo-5-methoxybenzene Chemical compound COC1=CC(Br)=CC(Br)=C1 OQZAQBGJENJMHT-UHFFFAOYSA-N 0.000 description 1
- NOTHTKKUQYVXRA-UHFFFAOYSA-N 1-bromo-3-(2,4-difluorophenyl)-5-fluorobenzene Chemical group BrC=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F NOTHTKKUQYVXRA-UHFFFAOYSA-N 0.000 description 1
- KDHRJLQXMOBXRV-UHFFFAOYSA-N 1-bromo-3-(diethoxymethyl)benzene Chemical compound CCOC(OCC)C1=CC=CC(Br)=C1 KDHRJLQXMOBXRV-UHFFFAOYSA-N 0.000 description 1
- SWGNVJXIRJIOFQ-UHFFFAOYSA-N 1-bromo-3-fluoro-5-(3-methoxyphenyl)benzene Chemical group BrC=1C=C(C=C(C=1)F)C1=CC(=CC=C1)OC SWGNVJXIRJIOFQ-UHFFFAOYSA-N 0.000 description 1
- AHAAGRATPHZHSW-UHFFFAOYSA-N 1-bromo-3-fluoro-5-[3-(trifluoromethoxy)phenyl]benzene Chemical group BrC=1C=C(C=C(C=1)F)C1=CC(=CC=C1)OC(F)(F)F AHAAGRATPHZHSW-UHFFFAOYSA-N 0.000 description 1
- SBMVNLFBEJAXFY-UHFFFAOYSA-N 1-bromo-3-methoxy-2-methylbenzene Chemical compound COC1=CC=CC(Br)=C1C SBMVNLFBEJAXFY-UHFFFAOYSA-N 0.000 description 1
- YUEFXSTZJQMTKW-UHFFFAOYSA-N 1-ethyl-4-hydroxy-3-nitropyridin-2-one Chemical compound CCN1C=CC(O)=C([N+]([O-])=O)C1=O YUEFXSTZJQMTKW-UHFFFAOYSA-N 0.000 description 1
- OQAPOANOWDXKBB-UHFFFAOYSA-N 1-ethyl-4-hydroxy-5-methyl-3-nitropyridin-2-one Chemical compound C(C)N1C(C(=C(C(=C1)C)O)[N+](=O)[O-])=O OQAPOANOWDXKBB-UHFFFAOYSA-N 0.000 description 1
- ACMOALYKJSFWTC-UHFFFAOYSA-N 1-ethyl-4-hydroxy-5-methylpyridin-2-one Chemical compound C(C)N1C(C=C(C(=C1)C)O)=O ACMOALYKJSFWTC-UHFFFAOYSA-N 0.000 description 1
- GEZGAZKEOUKLBR-UHFFFAOYSA-N 1-phenylpyrrole Chemical compound C1=CC=CN1C1=CC=CC=C1 GEZGAZKEOUKLBR-UHFFFAOYSA-N 0.000 description 1
- 125000005955 1H-indazolyl group Chemical group 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-Tetramethylpiperidine Substances CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 description 1
- GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical compound COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 1
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical compound BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 description 1
- XGGKVEUXSGPBDA-UHFFFAOYSA-N 2-[3-(diethoxymethyl)phenyl]thiophene Chemical compound C(C)OC(C=1C=C(C=CC=1)C=1SC=CC=1)OCC XGGKVEUXSGPBDA-UHFFFAOYSA-N 0.000 description 1
- RXNZFHIEDZEUQM-UHFFFAOYSA-N 2-bromo-1,3-thiazole Chemical compound BrC1=NC=CS1 RXNZFHIEDZEUQM-UHFFFAOYSA-N 0.000 description 1
- MGRYVEDNIGXKQE-UHFFFAOYSA-N 2-bromo-4-methoxy-1-methylbenzene Chemical compound COC1=CC=C(C)C(Br)=C1 MGRYVEDNIGXKQE-UHFFFAOYSA-N 0.000 description 1
- KMODISUYWZPVGV-UHFFFAOYSA-N 2-bromo-6-methoxypyridine Chemical compound COC1=CC=CC(Br)=N1 KMODISUYWZPVGV-UHFFFAOYSA-N 0.000 description 1
- XIYPPJVLAAXYAB-UHFFFAOYSA-N 2-bromo-6-phenylpyridine Chemical compound BrC1=CC=CC(C=2C=CC=CC=2)=N1 XIYPPJVLAAXYAB-UHFFFAOYSA-N 0.000 description 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 1
- UUOLETYDNTVQDY-UHFFFAOYSA-N 2-chloro-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1Cl UUOLETYDNTVQDY-UHFFFAOYSA-N 0.000 description 1
- OYWPFIUVDKHHGQ-UHFFFAOYSA-N 2-iodopyrazine Chemical compound IC1=CN=CC=N1 OYWPFIUVDKHHGQ-UHFFFAOYSA-N 0.000 description 1
- NXQVPFXJWOSNOU-UHFFFAOYSA-N 2-methoxy-3-phenylpyridine Chemical compound COC1=NC=CC=C1C1=CC=CC=C1 NXQVPFXJWOSNOU-UHFFFAOYSA-N 0.000 description 1
- YXFAOWYMDGUFIQ-UHFFFAOYSA-N 2-methoxypyridin-3-amine Chemical compound COC1=NC=CC=C1N YXFAOWYMDGUFIQ-UHFFFAOYSA-N 0.000 description 1
- IFMFMTSKMLYKOB-UHFFFAOYSA-N 2-methyl-3-phenylbenzaldehyde Chemical compound CC1=C(C=O)C=CC=C1C1=CC=CC=C1 IFMFMTSKMLYKOB-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- COQVYUXWSXLODW-UHFFFAOYSA-N 3,4-dimethoxy-5-phenylbenzaldehyde Chemical compound COC1=CC(C=O)=CC(C=2C=CC=CC=2)=C1OC COQVYUXWSXLODW-UHFFFAOYSA-N 0.000 description 1
- OGVSVJLQFRZSPX-UHFFFAOYSA-N 3,5-dihydro-[1,3]oxazolo[4,5-c]pyridine-2,4-dione Chemical compound O=c1[nH]c2c(cc[nH]c2=O)o1 OGVSVJLQFRZSPX-UHFFFAOYSA-N 0.000 description 1
- RDQWUQDBPCCHEQ-UHFFFAOYSA-N 3,6,7,8-tetrahydro-[1,3]oxazolo[4,5-f]indolizine-2,4-dione Chemical compound O1C(NC=2C(N3CCCC3=CC=21)=O)=O RDQWUQDBPCCHEQ-UHFFFAOYSA-N 0.000 description 1
- GUSWJGOYDXFJSI-UHFFFAOYSA-N 3,6-dichloropyridazine Chemical compound ClC1=CC=C(Cl)N=N1 GUSWJGOYDXFJSI-UHFFFAOYSA-N 0.000 description 1
- YJMGIEKCDQXKKZ-UHFFFAOYSA-N 3-(1,3-thiazol-2-yl)benzaldehyde Chemical compound O=CC1=CC=CC(C=2SC=CN=2)=C1 YJMGIEKCDQXKKZ-UHFFFAOYSA-N 0.000 description 1
- JMMVYZMDDGBVAW-UHFFFAOYSA-N 3-(1-methylpyrazol-4-yl)benzaldehyde Chemical compound C1=NN(C)C=C1C1=CC=CC(C=O)=C1 JMMVYZMDDGBVAW-UHFFFAOYSA-N 0.000 description 1
- XVYKUVSBTSTVCB-UHFFFAOYSA-N 3-(2,6-dimethylphenyl)-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1C1=C(C)C=CC=C1C XVYKUVSBTSTVCB-UHFFFAOYSA-N 0.000 description 1
- QJUNMUKAZLOMHH-UHFFFAOYSA-N 3-(2-methylphenyl)-4-(trifluoromethoxy)benzaldehyde Chemical compound CC1=C(C=CC=C1)C1=CC(=CC=C1OC(F)(F)F)C=O QJUNMUKAZLOMHH-UHFFFAOYSA-N 0.000 description 1
- TXXJUGKQQAFZKH-UHFFFAOYSA-N 3-(2-phenylphenyl)propanoic acid Chemical class OC(=O)CCC1=CC=CC=C1C1=CC=CC=C1 TXXJUGKQQAFZKH-UHFFFAOYSA-N 0.000 description 1
- VHCZVFXXIVKQHN-UHFFFAOYSA-N 3-(3-chlorophenyl)-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1C1=CC=CC(Cl)=C1 VHCZVFXXIVKQHN-UHFFFAOYSA-N 0.000 description 1
- MNUNBJABIAVVCT-UHFFFAOYSA-N 3-(3-chlorophenyl)-4-methylbenzaldehyde Chemical compound Cc1ccc(C=O)cc1-c1cccc(Cl)c1 MNUNBJABIAVVCT-UHFFFAOYSA-N 0.000 description 1
- FKGMIIOMKXEURF-UHFFFAOYSA-N 3-(5-chlorothiophen-2-yl)benzaldehyde Chemical compound S1C(Cl)=CC=C1C1=CC=CC(C=O)=C1 FKGMIIOMKXEURF-UHFFFAOYSA-N 0.000 description 1
- KGIJSCHQXFZBSY-UHFFFAOYSA-N 3-(6-methoxypyridazin-3-yl)benzaldehyde Chemical compound COc1ccc(nn1)-c1cccc(C=O)c1 KGIJSCHQXFZBSY-UHFFFAOYSA-N 0.000 description 1
- IFTQDOZCEQMAOS-UHFFFAOYSA-N 3-(6-methoxypyridin-2-yl)benzaldehyde Chemical compound COc1cccc(n1)-c1cccc(C=O)c1 IFTQDOZCEQMAOS-UHFFFAOYSA-N 0.000 description 1
- RLYAXKJHJUXZOT-UHFFFAOYSA-N 3-amino-3-(3-bromophenyl)propanoic acid Chemical compound OC(=O)CC(N)C1=CC=CC(Br)=C1 RLYAXKJHJUXZOT-UHFFFAOYSA-N 0.000 description 1
- XMMIAPDTLRFLED-UHFFFAOYSA-N 3-amino-3-(6-oxo-1h-pyridin-3-yl)propanoic acid Chemical compound OC(=O)CC(N)C=1C=CC(=O)NC=1 XMMIAPDTLRFLED-UHFFFAOYSA-N 0.000 description 1
- WBTHOSZMTIPJLR-UHFFFAOYSA-N 3-amino-5-(trifluoromethyl)benzoic acid Chemical compound NC1=CC(C(O)=O)=CC(C(F)(F)F)=C1 WBTHOSZMTIPJLR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZBOWULRIADNEHR-UHFFFAOYSA-N 3-azaniumyl-3-(3-iodophenyl)propanoate Chemical compound OC(=O)CC(N)C1=CC=CC(I)=C1 ZBOWULRIADNEHR-UHFFFAOYSA-N 0.000 description 1
- IILVSKMKMOJHMA-UHFFFAOYSA-N 3-bromo-2-methylaniline Chemical compound CC1=C(N)C=CC=C1Br IILVSKMKMOJHMA-UHFFFAOYSA-N 0.000 description 1
- BJGKVCKGUBYULR-UHFFFAOYSA-N 3-bromo-2-methylbenzoic acid Chemical compound CC1=C(Br)C=CC=C1C(O)=O BJGKVCKGUBYULR-UHFFFAOYSA-N 0.000 description 1
- WPDXAMRGYMDTOV-UHFFFAOYSA-N 3-bromo-2-methylphenol Chemical compound CC1=C(O)C=CC=C1Br WPDXAMRGYMDTOV-UHFFFAOYSA-N 0.000 description 1
- GMZKNRDHSHYMHG-UHFFFAOYSA-N 3-bromo-4-methylphenol Chemical compound CC1=CC=C(O)C=C1Br GMZKNRDHSHYMHG-UHFFFAOYSA-N 0.000 description 1
- MBUSOPVRLCFJCS-UHFFFAOYSA-N 3-bromo-4-methylthiophene Chemical compound CC1=CSC=C1Br MBUSOPVRLCFJCS-UHFFFAOYSA-N 0.000 description 1
- MEFQRXHVMJPOKZ-UHFFFAOYSA-N 3-bromo-5-fluorobenzaldehyde Chemical compound FC1=CC(Br)=CC(C=O)=C1 MEFQRXHVMJPOKZ-UHFFFAOYSA-N 0.000 description 1
- BJUOAPFXYPEEMK-UHFFFAOYSA-N 3-hydroxy-5-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC(O)=CC(C(F)(F)F)=C1 BJUOAPFXYPEEMK-UHFFFAOYSA-N 0.000 description 1
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 1
- ODCLHXGXGFBBTA-UHFFFAOYSA-N 3-nitro-5-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC(C(F)(F)F)=C1 ODCLHXGXGFBBTA-UHFFFAOYSA-N 0.000 description 1
- BDCLDNALSPBWPQ-UHFFFAOYSA-M 3-oxohexanoate Chemical compound CCCC(=O)CC([O-])=O BDCLDNALSPBWPQ-UHFFFAOYSA-M 0.000 description 1
- FLYJEBSUJDZJDE-UHFFFAOYSA-N 3-phenyl-1h-pyridin-2-one Chemical compound O=C1NC=CC=C1C1=CC=CC=C1 FLYJEBSUJDZJDE-UHFFFAOYSA-N 0.000 description 1
- QZTDFWZRFJHOJO-UHFFFAOYSA-N 3-phenyl-4-(trifluoromethoxy)benzaldehyde Chemical compound FC(OC1=CC=C(C=C1C1=CC=CC=C1)C=O)(F)F QZTDFWZRFJHOJO-UHFFFAOYSA-N 0.000 description 1
- CLHDOSZCXSKSSD-UHFFFAOYSA-N 3-pyrazin-2-ylbenzaldehyde Chemical compound O=CC1=CC=CC(C=2N=CC=NC=2)=C1 CLHDOSZCXSKSSD-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- UVNJRXLXTZABSL-UHFFFAOYSA-N 4-(2,4-difluorophenyl)thiophene-2-carbaldehyde Chemical compound FC1=C(C=CC(=C1)F)C=1C=C(SC=1)C=O UVNJRXLXTZABSL-UHFFFAOYSA-N 0.000 description 1
- LOHKKAFXRKSYTH-UHFFFAOYSA-N 4-(2,6-dimethylphenyl)thiophene-2-carbaldehyde Chemical compound CC1=CC=CC(C)=C1C1=CSC(C=O)=C1 LOHKKAFXRKSYTH-UHFFFAOYSA-N 0.000 description 1
- YOWHPHLMKMGQFV-UHFFFAOYSA-N 4-(3-methoxyphenyl)thiophene-2-carbaldehyde Chemical compound COC1=CC=CC(C=2C=C(C=O)SC=2)=C1 YOWHPHLMKMGQFV-UHFFFAOYSA-N 0.000 description 1
- XQNVDQZWOBPLQZ-UHFFFAOYSA-N 4-(trifluoromethoxy)benzaldehyde Chemical compound FC(F)(F)OC1=CC=C(C=O)C=C1 XQNVDQZWOBPLQZ-UHFFFAOYSA-N 0.000 description 1
- PDONIKHDXYHTLS-UHFFFAOYSA-N 4-bromothiophene-2-carbaldehyde Chemical compound BrC1=CSC(C=O)=C1 PDONIKHDXYHTLS-UHFFFAOYSA-N 0.000 description 1
- OGHGGBMXRUJBAF-UHFFFAOYSA-N 4-chloro-5-methoxy-2-methylpyridazin-3-one Chemical compound COC=1C=NN(C)C(=O)C=1Cl OGHGGBMXRUJBAF-UHFFFAOYSA-N 0.000 description 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- MVBVLALZUUMWFS-UHFFFAOYSA-N 4-hydroxy-1,5-dimethyl-3-nitropyridin-2-one Chemical compound OC1=C(C(N(C=C1C)C)=O)[N+](=O)[O-] MVBVLALZUUMWFS-UHFFFAOYSA-N 0.000 description 1
- MEJPJSXICHNLPD-UHFFFAOYSA-N 4-hydroxy-1,5-dimethylpyridin-2-one Chemical compound CC1=CN(C)C(=O)C=C1O MEJPJSXICHNLPD-UHFFFAOYSA-N 0.000 description 1
- KVSGLQJHGFHBTA-UHFFFAOYSA-N 4-hydroxy-1,6-dimethyl-3-nitropyridin-2-one Chemical compound CC1=CC(O)=C([N+]([O-])=O)C(=O)N1C KVSGLQJHGFHBTA-UHFFFAOYSA-N 0.000 description 1
- OECKSWZIGOPSOO-UHFFFAOYSA-N 4-hydroxy-1-methyl-1,8-naphthyridin-2-one Chemical compound C1=CC=C2C(O)=CC(=O)N(C)C2=N1 OECKSWZIGOPSOO-UHFFFAOYSA-N 0.000 description 1
- QHKFZZRBKMFSAY-UHFFFAOYSA-N 4-hydroxy-1-methyl-3-nitro-1,8-naphthyridin-2-one Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C(=O)N(C)C2=N1 QHKFZZRBKMFSAY-UHFFFAOYSA-N 0.000 description 1
- XHXWKKQOCZYQPQ-UHFFFAOYSA-N 4-hydroxy-1-methyl-3-nitro-6,7-dihydro-5H-cyclopenta[b]pyridin-2-one Chemical compound OC=1C2=C(N(C(C=1[N+](=O)[O-])=O)C)CCC2 XHXWKKQOCZYQPQ-UHFFFAOYSA-N 0.000 description 1
- RRJVFCWRAGAYAJ-UHFFFAOYSA-N 4-hydroxy-1-methyl-3-nitropyridin-2-one Chemical compound [N+](=O)([O-])C=1C(N(C=CC1O)C)=O RRJVFCWRAGAYAJ-UHFFFAOYSA-N 0.000 description 1
- LXENIDSZFZDKCA-UHFFFAOYSA-N 4-hydroxy-1-methyl-6,7-dihydro-5H-cyclopenta[b]pyridin-2-one Chemical compound OC=1C2=C(N(C(C=1)=O)C)CCC2 LXENIDSZFZDKCA-UHFFFAOYSA-N 0.000 description 1
- QIKWTNPFTOEELW-UHFFFAOYSA-N 4-hydroxy-6-methyl-3-nitro-1h-pyridin-2-one Chemical compound CC1=CC(=O)C([N+]([O-])=O)=C(O)N1 QIKWTNPFTOEELW-UHFFFAOYSA-N 0.000 description 1
- RSDRDHPLXWMTRJ-UHFFFAOYSA-N 4-iodo-1-methylpyrazole Chemical compound CN1C=C(I)C=N1 RSDRDHPLXWMTRJ-UHFFFAOYSA-N 0.000 description 1
- LLNQWPTUJJYTTE-UHFFFAOYSA-N 4-iodopyrazole Chemical compound IC=1C=NNC=1 LLNQWPTUJJYTTE-UHFFFAOYSA-N 0.000 description 1
- 125000002471 4H-quinolizinyl group Chemical group C=1(C=CCN2C=CC=CC12)* 0.000 description 1
- ADEKJVNFIQUGRR-UHFFFAOYSA-N 4h-pyridin-3-one Chemical compound O=C1CC=CN=C1 ADEKJVNFIQUGRR-UHFFFAOYSA-N 0.000 description 1
- BCDIDLMEHCLQQQ-UHFFFAOYSA-N 5,6-dimethyl-3H-[1,3]oxazolo[4,5-c]pyridine-2,4-dione Chemical compound CN1C(C2=C(C=C1C)OC(N2)=O)=O BCDIDLMEHCLQQQ-UHFFFAOYSA-N 0.000 description 1
- LKDLFEHMJBHFOK-UHFFFAOYSA-N 5,7-dimethyl-3H-[1,3]oxazolo[4,5-c]pyridine-2,4-dione Chemical compound CN1C(C2=C(C(=C1)C)OC(N2)=O)=O LKDLFEHMJBHFOK-UHFFFAOYSA-N 0.000 description 1
- RRQFTJHKFUDHJR-UHFFFAOYSA-N 5-(2,4-difluorophenyl)thiophene-2-carbaldehyde Chemical compound FC1=CC(F)=CC=C1C1=CC=C(C=O)S1 RRQFTJHKFUDHJR-UHFFFAOYSA-N 0.000 description 1
- MRCMBYYPXMBGPK-UHFFFAOYSA-N 5-(2,5-difluorophenyl)thiophene-2-carbaldehyde Chemical compound FC1=CC=C(F)C(C=2SC(C=O)=CC=2)=C1 MRCMBYYPXMBGPK-UHFFFAOYSA-N 0.000 description 1
- JVHQPBDJHLUILP-UHFFFAOYSA-N 5-(2,6-dimethylphenyl)thiophene-2-carbaldehyde Chemical compound CC1=CC=CC(C)=C1C1=CC=C(C=O)S1 JVHQPBDJHLUILP-UHFFFAOYSA-N 0.000 description 1
- HEFBVBAPRGIBJU-UHFFFAOYSA-N 5-(3,5-dimethyl-1,2-oxazol-4-yl)thiophene-2-carbaldehyde Chemical compound CC1=NOC(=C1C1=CC=C(S1)C=O)C HEFBVBAPRGIBJU-UHFFFAOYSA-N 0.000 description 1
- DNIBJTALGPZHEB-UHFFFAOYSA-N 5-(3-chlorophenyl)thiophene-2-carbaldehyde Chemical compound ClC1=CC=CC(C=2SC(C=O)=CC=2)=C1 DNIBJTALGPZHEB-UHFFFAOYSA-N 0.000 description 1
- AMTYNYZDGZBISY-UHFFFAOYSA-N 5-(3-fluorophenyl)thiophene-2-carbaldehyde Chemical compound FC1=CC=CC(C=2SC(C=O)=CC=2)=C1 AMTYNYZDGZBISY-UHFFFAOYSA-N 0.000 description 1
- DLXLICDIIBNILO-UHFFFAOYSA-N 5-(3-methoxyphenyl)thiophene-2-carbaldehyde Chemical compound COC1=CC=CC(C=2SC(C=O)=CC=2)=C1 DLXLICDIIBNILO-UHFFFAOYSA-N 0.000 description 1
- VLQFLLUUVJESIF-UHFFFAOYSA-N 5-(4-methylthiophen-3-yl)thiophene-2-carbaldehyde Chemical compound CC=1C(=CSC=1)C=1SC(=CC=1)C=O VLQFLLUUVJESIF-UHFFFAOYSA-N 0.000 description 1
- PEYVORVOTSTWGE-UHFFFAOYSA-N 5-[3-(trifluoromethoxy)phenyl]thiophene-2-carbaldehyde Chemical compound FC(F)(F)OC1=CC=CC(C=2SC(C=O)=CC=2)=C1 PEYVORVOTSTWGE-UHFFFAOYSA-N 0.000 description 1
- RVMWFOFQRYTRHZ-UHFFFAOYSA-N 5-bromo-2,3-dimethoxybenzaldehyde Chemical compound COC1=CC(Br)=CC(C=O)=C1OC RVMWFOFQRYTRHZ-UHFFFAOYSA-N 0.000 description 1
- NGUVGKAEOFPLDT-UHFFFAOYSA-N 5-bromopyridine-3-carbaldehyde Chemical compound BrC1=CN=CC(C=O)=C1 NGUVGKAEOFPLDT-UHFFFAOYSA-N 0.000 description 1
- SUZFURZANOKZBL-UHFFFAOYSA-N 5-chloro-4-methoxy-1h-pyridazin-6-one Chemical compound COC=1C=NNC(=O)C=1Cl SUZFURZANOKZBL-UHFFFAOYSA-N 0.000 description 1
- RPZNWOZQQUICJH-UHFFFAOYSA-N 5-ethyl-3H-[1,3]oxazolo[4,5-c]pyridine-2,4-dione Chemical compound C(C)N1C(C2=C(C=C1)OC(N2)=O)=O RPZNWOZQQUICJH-UHFFFAOYSA-N 0.000 description 1
- ZTSQLDOGBJJULZ-UHFFFAOYSA-N 5-ethyl-7-methyl-3H-[1,3]oxazolo[4,5-c]pyridine-2,4-dione Chemical compound C(C)N1C(C2=C(C(=C1)C)OC(N2)=O)=O ZTSQLDOGBJJULZ-UHFFFAOYSA-N 0.000 description 1
- RITIQEJWQQYYLH-UHFFFAOYSA-N 5-hydroxy-2-methyl-4-nitropyridazin-3-one Chemical compound OC1=C(C(N(N=C1)C)=O)[N+](=O)[O-] RITIQEJWQQYYLH-UHFFFAOYSA-N 0.000 description 1
- RRGAHPMHECROKI-UHFFFAOYSA-N 5-methoxy-2-methylpyridazin-3-one Chemical compound COC=1C=NN(C)C(=O)C=1 RRGAHPMHECROKI-UHFFFAOYSA-N 0.000 description 1
- QYGNDKJRRNVSEC-UHFFFAOYSA-N 5-methoxy-3,4-dihydro-2h-pyrrole Chemical compound COC1=NCCC1 QYGNDKJRRNVSEC-UHFFFAOYSA-N 0.000 description 1
- DUIFDKGPGKTAAV-UHFFFAOYSA-N 5-methyl-3H-[1,3]oxazolo[4,5-c][1,8]naphthyridine-2,4-dione Chemical compound CN1C(C2=C(C=3C=CC=NC1=3)OC(N2)=O)=O DUIFDKGPGKTAAV-UHFFFAOYSA-N 0.000 description 1
- BUMAFTGGYPBHHK-UHFFFAOYSA-N 6-oxo-1h-pyridine-3-carbaldehyde Chemical compound O=CC=1C=CC(=O)NC=1 BUMAFTGGYPBHHK-UHFFFAOYSA-N 0.000 description 1
- OVLDKZQYCKDJRN-UHFFFAOYSA-N 7-hydroxy-4-methyl-6-nitrothieno[3,2-b]pyridin-5-one Chemical compound OC1=C([N+]([O-])=O)C(=O)N(C)C2=C1SC=C2 OVLDKZQYCKDJRN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- JBVKIKFTEWSJCF-UHFFFAOYSA-N 8-methyl-3-oxa-12-thia-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),10-triene-4,7-dione Chemical compound CN1C2=C(C3=C(C1=O)NC(O3)=O)SC=C2 JBVKIKFTEWSJCF-UHFFFAOYSA-N 0.000 description 1
- NXBBROUVEQNTFI-UHFFFAOYSA-N 8-methyl-3-oxa-5,8-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6)-diene-4,7-dione Chemical compound CN1C2=C(C3=C(C1=O)NC(O3)=O)CCC2 NXBBROUVEQNTFI-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- LMQXCGOSSYBNOB-LMOVPXPDSA-N C(C)(=O)O.N[C@@H](CC(=O)OC(C)(C)C)C1=CC=C(C=C1)C1=C(C=C(C=C1)F)F Chemical compound C(C)(=O)O.N[C@@H](CC(=O)OC(C)(C)C)C1=CC=C(C=C1)C1=C(C=C(C=C1)F)F LMQXCGOSSYBNOB-LMOVPXPDSA-N 0.000 description 1
- HWBNGYDWQCAPOH-UHFFFAOYSA-N C(C)(C)[Si](N1C=C(C=C1)C=1C=C(C=O)C=CC=1)(C(C)C)C(C)C Chemical compound C(C)(C)[Si](N1C=C(C=C1)C=1C=C(C=O)C=CC=1)(C(C)C)C(C)C HWBNGYDWQCAPOH-UHFFFAOYSA-N 0.000 description 1
- SULURZIJGHCQSS-QNLPTKCRSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OC(C)(C)C)C1=CC=C(C=C1)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OC(C)(C)C)C1=CC=C(C=C1)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 SULURZIJGHCQSS-QNLPTKCRSA-N 0.000 description 1
- HPVYYVKBOICURE-DICHSLLOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OC(C)(C)C)C1=CC=C(C=C1)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OC(C)(C)C)C1=CC=C(C=C1)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 HPVYYVKBOICURE-DICHSLLOSA-N 0.000 description 1
- QBAWRSRCEIUGLW-DVECYGJZSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=C(C(=CC=C1)I)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=C(C(=CC=C1)I)F)[C@H](C)C1=CC=CC=C1 QBAWRSRCEIUGLW-DVECYGJZSA-N 0.000 description 1
- XKVRGSXWTHAZPL-CLOONOSVSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=C(C=CC(=C1)Br)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=C(C=CC(=C1)Br)F)[C@H](C)C1=CC=CC=C1 XKVRGSXWTHAZPL-CLOONOSVSA-N 0.000 description 1
- RGZRQHUKQPJAEJ-NLFFAJNJSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=C(C=CC(=C1)Br)OC)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=C(C=CC(=C1)Br)OC)[C@H](C)C1=CC=CC=C1 RGZRQHUKQPJAEJ-NLFFAJNJSA-N 0.000 description 1
- AQYTZTIVDSUPIB-RLWLMLJZSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=C(C=C1)C)Br)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=C(C=C1)C)Br)[C@H](C)C1=CC=CC=C1 AQYTZTIVDSUPIB-RLWLMLJZSA-N 0.000 description 1
- VUXRJFSQJAYFGC-CLOONOSVSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=C(C=C1)F)Br)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=C(C=C1)F)Br)[C@H](C)C1=CC=CC=C1 VUXRJFSQJAYFGC-CLOONOSVSA-N 0.000 description 1
- KSRVHALKNIFWJY-NLFFAJNJSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=C(C=C1)OC)Br)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=C(C=C1)OC)Br)[C@H](C)C1=CC=CC=C1 KSRVHALKNIFWJY-NLFFAJNJSA-N 0.000 description 1
- RMOLGYMJDRVHAF-RLWLMLJZSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=CC(=C1)C)Br)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=CC(=C1)C)Br)[C@H](C)C1=CC=CC=C1 RMOLGYMJDRVHAF-RLWLMLJZSA-N 0.000 description 1
- BSICTIJFLUSBLP-CLOONOSVSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=CC(=C1)F)Br)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=CC(=C1)F)Br)[C@H](C)C1=CC=CC=C1 BSICTIJFLUSBLP-CLOONOSVSA-N 0.000 description 1
- CKCPQGCAZVVYOG-IBVKSMDESA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=CC(=C1)OC)Br)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C1=CC(=CC(=C1)OC)Br)[C@H](C)C1=CC=CC=C1 CKCPQGCAZVVYOG-IBVKSMDESA-N 0.000 description 1
- PHKXCWOAPMNKRR-DICHSLLOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)C)[C@H](C)C1=CC=CC=C1 PHKXCWOAPMNKRR-DICHSLLOSA-N 0.000 description 1
- CKQCGAOJTATGAJ-HLADLETHSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)F)[C@H](C)C1=CC=CC=C1 CKQCGAOJTATGAJ-HLADLETHSA-N 0.000 description 1
- SGMDSQRPQMQEBP-QNLPTKCRSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 SGMDSQRPQMQEBP-QNLPTKCRSA-N 0.000 description 1
- QQWRWENOYNGMRO-NYFMKLKXSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC)[C@H](C)C1=CC=CC=C1 QQWRWENOYNGMRO-NYFMKLKXSA-N 0.000 description 1
- RIVQGVRWRQUFDV-DICHSLLOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 RIVQGVRWRQUFDV-DICHSLLOSA-N 0.000 description 1
- JYACDLPUPBGNRI-IPBJYNAHSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 JYACDLPUPBGNRI-IPBJYNAHSA-N 0.000 description 1
- UENWHLXEMSWCGY-ZUKKLESISA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 UENWHLXEMSWCGY-ZUKKLESISA-N 0.000 description 1
- BVSBKCLWRPQARM-QNLPTKCRSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 BVSBKCLWRPQARM-QNLPTKCRSA-N 0.000 description 1
- IHCSRBMNFJLPFF-NYFMKLKXSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC)[C@H](C)C1=CC=CC=C1 IHCSRBMNFJLPFF-NYFMKLKXSA-N 0.000 description 1
- CRDOGCXGTUQKEL-DICHSLLOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 CRDOGCXGTUQKEL-DICHSLLOSA-N 0.000 description 1
- DPIAQFHMDADWTI-HEIROHQZSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=C(C=C1)F)F)[C@H](C)C1=CC=CC=C1 DPIAQFHMDADWTI-HEIROHQZSA-N 0.000 description 1
- LBDMFYPHECGXIL-SYBRLPANSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 LBDMFYPHECGXIL-SYBRLPANSA-N 0.000 description 1
- YKEUILXUOLTKTL-GOXGLGGOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 YKEUILXUOLTKTL-GOXGLGGOSA-N 0.000 description 1
- GVIDJEJHFAEKMC-NLFFAJNJSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1)B(O)O)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1)B(O)O)[C@H](C)C1=CC=CC=C1 GVIDJEJHFAEKMC-NLFFAJNJSA-N 0.000 description 1
- QJKPKSDJLZLCHI-DICHSLLOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C)[C@H](C)C1=CC=CC=C1 QJKPKSDJLZLCHI-DICHSLLOSA-N 0.000 description 1
- NOSJSZJPUDQJKR-DICHSLLOSA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 NOSJSZJPUDQJKR-DICHSLLOSA-N 0.000 description 1
- VXQJBMCZAVBUPP-ZUKKLESISA-N C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C)[C@H](C)C1=CC=CC=C1 VXQJBMCZAVBUPP-ZUKKLESISA-N 0.000 description 1
- TVGJEJZYOAZARO-FQEVSTJZSA-N C1(=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C1=CC=CC=C1 Chemical compound C1(=CC(=CC=C1)[C@H](CC(=O)OCC)NC(=O)NC=1C(N(C=C(C=1O)C)C)=O)C1=CC=CC=C1 TVGJEJZYOAZARO-FQEVSTJZSA-N 0.000 description 1
- KGURZXMSXMQMSB-HFJWLAOPSA-N CC(C)([S@@](=O)N[C@@H](CC(=O)OCC)C=1C=NC=C(C=1)C1=CC=CC=C1)C Chemical compound CC(C)([S@@](=O)N[C@@H](CC(=O)OCC)C=1C=NC=C(C=1)C1=CC=CC=C1)C KGURZXMSXMQMSB-HFJWLAOPSA-N 0.000 description 1
- AWNOQOOXKXLEDW-SDZGCHGRSA-N CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CN(C=C1)[Si](C(C)C)(C(C)C)C(C)C Chemical compound CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CN(C=C1)[Si](C(C)C)(C(C)C)C(C)C AWNOQOOXKXLEDW-SDZGCHGRSA-N 0.000 description 1
- YQGBVNCKCDXMJP-AFJIDDCJSA-N CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC=CN=C1 Chemical compound CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC=CN=C1 YQGBVNCKCDXMJP-AFJIDDCJSA-N 0.000 description 1
- GQOJPUGCKSVNAN-HMILPKGGSA-N CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CN=1 Chemical compound CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CN=1 GQOJPUGCKSVNAN-HMILPKGGSA-N 0.000 description 1
- QXXQMSQVLBACJO-DUTUXMCTSA-N CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC(=CC=C1)OC(F)(F)F Chemical compound CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC(=CC=C1)OC(F)(F)F QXXQMSQVLBACJO-DUTUXMCTSA-N 0.000 description 1
- FKIRDOATRMIHBR-WTYVLRPYSA-N CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1 Chemical compound CC1=CC=C(C=C1)[S@@](=O)N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1 FKIRDOATRMIHBR-WTYVLRPYSA-N 0.000 description 1
- UPRVOEHSZATTNP-WTYVLRPYSA-N CC=1C=CC=C(C=1)[S@@](=O)N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1 Chemical compound CC=1C=CC=C(C=1)[S@@](=O)N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1 UPRVOEHSZATTNP-WTYVLRPYSA-N 0.000 description 1
- YDYWBMOZTSCZGQ-UHFFFAOYSA-N CN1N=CC2=C(C1=O)NC(O2)=O Chemical compound CN1N=CC2=C(C1=O)NC(O2)=O YDYWBMOZTSCZGQ-UHFFFAOYSA-N 0.000 description 1
- LUNKZWWQGCGBID-OUKQBFOZSA-N COC1=NC=CC=C1/N=N/N1CCOCC1 Chemical compound COC1=NC=CC=C1/N=N/N1CCOCC1 LUNKZWWQGCGBID-OUKQBFOZSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
- 102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- JJFMQPIROJPBHX-GAISBVLPSA-N FC=1C=C(C=CC=1)C1=CC=C(S1)\C=N\[S@](=O)C1=CC=C(C=C1)C Chemical compound FC=1C=C(C=CC=1)C1=CC=C(S1)\C=N\[S@](=O)C1=CC=C(C=C1)C JJFMQPIROJPBHX-GAISBVLPSA-N 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- HGINADPHJQTSKN-UHFFFAOYSA-N Monoethyl malonic acid Chemical compound CCOC(=O)CC(O)=O HGINADPHJQTSKN-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- SZPPFMBEFPAWQF-ZDUSSCGKSA-N N1(C=NC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N Chemical compound N1(C=NC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N SZPPFMBEFPAWQF-ZDUSSCGKSA-N 0.000 description 1
- RLUYUFUYMDYNKJ-INIZCTEOSA-N N1(N=CC2=CC=CC=C12)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N Chemical compound N1(N=CC2=CC=CC=C12)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N RLUYUFUYMDYNKJ-INIZCTEOSA-N 0.000 description 1
- HSXSZFPPNQAVOC-ZDUSSCGKSA-N N1(N=CC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N Chemical compound N1(N=CC=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N HSXSZFPPNQAVOC-ZDUSSCGKSA-N 0.000 description 1
- JFKLKMCDUQAYMR-AWEZNQCLSA-N N1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N Chemical compound N1C=C(C=C1)C=1C=C(C=CC=1)[C@H](CC(=O)OCC)N JFKLKMCDUQAYMR-AWEZNQCLSA-N 0.000 description 1
- IJECGEJFWGAFHC-IBGZPJMESA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CC=C2C=CN(C2=C1)CC Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CC=C2C=CN(C2=C1)CC IJECGEJFWGAFHC-IBGZPJMESA-N 0.000 description 1
- ARPZUMCQDKSUHV-AWEZNQCLSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=COC=C1 Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=COC=C1 ARPZUMCQDKSUHV-AWEZNQCLSA-N 0.000 description 1
- MUXBIKVMHMSFGD-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CSC=C1C Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=CSC=C1C MUXBIKVMHMSFGD-HNNXBMFYSA-N 0.000 description 1
- BYGWJSXRBNEQCM-AWEZNQCLSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC(=CC=C1)OC BYGWJSXRBNEQCM-AWEZNQCLSA-N 0.000 description 1
- CQSKQTVEJRBRNV-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC=CN=C1 Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C1=NC=CN=C1 CQSKQTVEJRBRNV-ZDUSSCGKSA-N 0.000 description 1
- QFHCTTOMAWJFAZ-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC(=CC=1)OC QFHCTTOMAWJFAZ-HNNXBMFYSA-N 0.000 description 1
- MRRNAEKFFMEHJO-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC=CC=1 Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NC=CC=1 MRRNAEKFFMEHJO-HNNXBMFYSA-N 0.000 description 1
- NQCMXNJVPPAENH-AWEZNQCLSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NN(C=1)C Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1C=NN(C=1)C NQCMXNJVPPAENH-AWEZNQCLSA-N 0.000 description 1
- HFWFDOTZQYUNJX-LBPRGKRZSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC(=CC=1)Cl Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC(=CC=1)Cl HFWFDOTZQYUNJX-LBPRGKRZSA-N 0.000 description 1
- HTUVHCQNCHFZFF-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CC=1 Chemical compound N[C@@H](CC(=O)OCC)C1=CC(=CC=C1)C=1SC=CC=1 HTUVHCQNCHFZFF-ZDUSSCGKSA-N 0.000 description 1
- QYFXURWGGUPUNK-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1)C Chemical compound N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1)C QYFXURWGGUPUNK-KRWDZBQOSA-N 0.000 description 1
- VNIBJWHJOGNMNY-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C1=CC=C(C=C1)C1=C(C=CC=C1C)C VNIBJWHJOGNMNY-KRWDZBQOSA-N 0.000 description 1
- OWNZGXSXSIPPIU-NSHDSACASA-N N[C@@H](CC(=O)OCC)C1=CC=C(S1)C1=CSC=C1C Chemical compound N[C@@H](CC(=O)OCC)C1=CC=C(S1)C1=CSC=C1C OWNZGXSXSIPPIU-NSHDSACASA-N 0.000 description 1
- SGXKLMLZCHUZQV-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C1=NC(=CC=C1)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C1=NC(=CC=C1)C1=CC=CC=C1 SGXKLMLZCHUZQV-ZDUSSCGKSA-N 0.000 description 1
- WAOKLSIKYRAGMH-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)C Chemical compound N[C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)C WAOKLSIKYRAGMH-KRWDZBQOSA-N 0.000 description 1
- PPNWLAHUCFJPKD-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)F Chemical compound N[C@@H](CC(=O)OCC)C=1C(=C(C=CC=1)C1=CC=CC=C1)F PPNWLAHUCFJPKD-HNNXBMFYSA-N 0.000 description 1
- OFUADKOFYPKCGT-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=C(C=1)OC)OC)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=C(C=1)OC)OC)C1=CC=CC=C1 OFUADKOFYPKCGT-INIZCTEOSA-N 0.000 description 1
- QBYUMXYJLVXVPB-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=C(C=C(C=C1)F)F QBYUMXYJLVXVPB-KRWDZBQOSA-N 0.000 description 1
- HHXJLNKFKVILLH-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)Cl Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)Cl HHXJLNKFKVILLH-KRWDZBQOSA-N 0.000 description 1
- DDODZEOQOMEJJU-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC DDODZEOQOMEJJU-SFHVURJKSA-N 0.000 description 1
- UBASGGNNNJNHDU-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC(=CC=C1)OC(F)(F)F UBASGGNNNJNHDU-KRWDZBQOSA-N 0.000 description 1
- RQZWHEHFXVJAAK-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)C)C1=CC=CC=C1 RQZWHEHFXVJAAK-KRWDZBQOSA-N 0.000 description 1
- GRKHDCDRGKXGNP-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1)C GRKHDCDRGKXGNP-KRWDZBQOSA-N 0.000 description 1
- NBFTZSLMJLYVHO-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1C)C NBFTZSLMJLYVHO-KRWDZBQOSA-N 0.000 description 1
- PLTGUZGKKKBQTO-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=CC(=CC=C1)OC PLTGUZGKKKBQTO-KRWDZBQOSA-N 0.000 description 1
- SHBKTXWMYGKQQZ-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=CC=CC=C1 SHBKTXWMYGKQQZ-INIZCTEOSA-N 0.000 description 1
- GUTXFJIPZOASHX-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=C(C=CC=C1)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=C(C=CC=C1)C GUTXFJIPZOASHX-INIZCTEOSA-N 0.000 description 1
- BBCPVJPZINHGFY-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC(=CC=C1)OC BBCPVJPZINHGFY-INIZCTEOSA-N 0.000 description 1
- MZEYRTISICNBLI-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC(F)(F)F)C1=CC=CC=C1 MZEYRTISICNBLI-HNNXBMFYSA-N 0.000 description 1
- NMCQTNPIAZDHEP-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=C(C=C1)F)F NMCQTNPIAZDHEP-INIZCTEOSA-N 0.000 description 1
- GQHKIPZPIVGWGN-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=C(C=CC=C1C)C GQHKIPZPIVGWGN-KRWDZBQOSA-N 0.000 description 1
- KRNGQIYLSZJHPV-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)Cl Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)Cl KRNGQIYLSZJHPV-INIZCTEOSA-N 0.000 description 1
- OCEKYUFELMLVBE-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC OCEKYUFELMLVBE-KRWDZBQOSA-N 0.000 description 1
- BNQYUYSQYQYFDB-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC(=CC=C1)OC(F)(F)F BNQYUYSQYQYFDB-INIZCTEOSA-N 0.000 description 1
- KVJCLAWVTGJTHO-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=C(C=C1)OC(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=C(C=C1)OC(F)(F)F KVJCLAWVTGJTHO-INIZCTEOSA-N 0.000 description 1
- ZQGGIOVXONNYBI-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)OC)C1=CC=CC=C1 ZQGGIOVXONNYBI-INIZCTEOSA-N 0.000 description 1
- YIPQARUSMJAHFN-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C(F)(F)F)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C(F)(F)F)C1=CC=CC=C1 YIPQARUSMJAHFN-INIZCTEOSA-N 0.000 description 1
- VUVHIVOVMFTDKC-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=C(C=C1)F)F VUVHIVOVMFTDKC-KRWDZBQOSA-N 0.000 description 1
- ADOJAXKGEMPPCD-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=C(C=CC=C1C)C ADOJAXKGEMPPCD-SFHVURJKSA-N 0.000 description 1
- JCXWPHFRDRGYOB-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC JCXWPHFRDRGYOB-SFHVURJKSA-N 0.000 description 1
- OFDOJYVIVQCLOS-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)C)C1=CC(=CC=C1)OC(F)(F)F OFDOJYVIVQCLOS-KRWDZBQOSA-N 0.000 description 1
- YNJGVXVMFKQDPT-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=C(C=C(C=C1)F)F YNJGVXVMFKQDPT-INIZCTEOSA-N 0.000 description 1
- YFDQKRNUKOOVNF-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)F)C1=CC(=CC=C1)OC YFDQKRNUKOOVNF-KRWDZBQOSA-N 0.000 description 1
- DMIBELOPNQZFSU-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=C(C=C1)F)F DMIBELOPNQZFSU-KRWDZBQOSA-N 0.000 description 1
- LSBPDFFLMZWQLA-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=C(C=CC=C1C)C LSBPDFFLMZWQLA-SFHVURJKSA-N 0.000 description 1
- AKTKDPLVDUSBQF-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC AKTKDPLVDUSBQF-SFHVURJKSA-N 0.000 description 1
- VFYJDFRZTJDGNW-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC(=CC=C1)OC(F)(F)F VFYJDFRZTJDGNW-KRWDZBQOSA-N 0.000 description 1
- NUXUAORVEYAFPD-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=C(C=1)OC)C1=CC=CC=C1 NUXUAORVEYAFPD-KRWDZBQOSA-N 0.000 description 1
- NCVJDYPTRJMZMK-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)C)C NCVJDYPTRJMZMK-SFHVURJKSA-N 0.000 description 1
- VHPXGUAYWJIFEV-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)F)F VHPXGUAYWJIFEV-HNNXBMFYSA-N 0.000 description 1
- HXAVVXUHANDCGR-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)C HXAVVXUHANDCGR-KRWDZBQOSA-N 0.000 description 1
- BCWNQQPKJMXOAL-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)F BCWNQQPKJMXOAL-HNNXBMFYSA-N 0.000 description 1
- HAZKGZMVSPVACM-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C(=CC=C1)OC)OC HAZKGZMVSPVACM-INIZCTEOSA-N 0.000 description 1
- VXXFXQNUWJUGFA-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=C(C=C1)F)F VXXFXQNUWJUGFA-INIZCTEOSA-N 0.000 description 1
- RYQOXSMDEKGXTJ-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=C(C=C1)OC)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=C(C=C1)OC)OC RYQOXSMDEKGXTJ-KRWDZBQOSA-N 0.000 description 1
- MUUVCLUNUOBLIQ-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)C)C MUUVCLUNUOBLIQ-SFHVURJKSA-N 0.000 description 1
- FQNRVZVSOGWNBU-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)F)F FQNRVZVSOGWNBU-INIZCTEOSA-N 0.000 description 1
- BZYDBMHWCGXOEC-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)C BZYDBMHWCGXOEC-SFHVURJKSA-N 0.000 description 1
- BAUHFIOLUIDQPJ-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC(=C1)OC)OC BAUHFIOLUIDQPJ-KRWDZBQOSA-N 0.000 description 1
- ZZJUGNFTTCCPBU-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)C(F)(F)F ZZJUGNFTTCCPBU-INIZCTEOSA-N 0.000 description 1
- YHEOIXLMMQNVHP-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)CC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)CC YHEOIXLMMQNVHP-SFHVURJKSA-N 0.000 description 1
- NPISYQJTTXMGQZ-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)F NPISYQJTTXMGQZ-INIZCTEOSA-N 0.000 description 1
- NMYBNFMEZPTDPE-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC NMYBNFMEZPTDPE-INIZCTEOSA-N 0.000 description 1
- VAIWQDLYXXWNIS-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC(F)(F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1)OC(F)(F)F VAIWQDLYXXWNIS-HNNXBMFYSA-N 0.000 description 1
- DCMIPJUEFPXHTK-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1C)C DCMIPJUEFPXHTK-KRWDZBQOSA-N 0.000 description 1
- IBEHEFZQXARBNU-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1F)F IBEHEFZQXARBNU-HNNXBMFYSA-N 0.000 description 1
- SDTKXVHAMDVAFN-HNNXBMFYSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1OC)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=C(C=CC=C1OC)OC SDTKXVHAMDVAFN-HNNXBMFYSA-N 0.000 description 1
- RZXLRUANRBOJOI-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)C)C RZXLRUANRBOJOI-SFHVURJKSA-N 0.000 description 1
- FGBZCFLZYPJKLJ-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)F)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)F)C FGBZCFLZYPJKLJ-KRWDZBQOSA-N 0.000 description 1
- LSGNZGLPXDNEMU-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)F)F LSGNZGLPXDNEMU-INIZCTEOSA-N 0.000 description 1
- ZFNDJFZYKOPBPR-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)OC)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=C(C=C1)OC)OC ZFNDJFZYKOPBPR-INIZCTEOSA-N 0.000 description 1
- JTRBCSBPIVEJTG-SFHVURJKSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC(=C1)C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC(=C1)C)C JTRBCSBPIVEJTG-SFHVURJKSA-N 0.000 description 1
- GLUIHZUCGPSAFV-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC(=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC(=C1)F)F GLUIHZUCGPSAFV-INIZCTEOSA-N 0.000 description 1
- CXZAWDFIKTVZNH-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)C CXZAWDFIKTVZNH-KRWDZBQOSA-N 0.000 description 1
- XCVQXVHGVPCPMK-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)F XCVQXVHGVPCPMK-INIZCTEOSA-N 0.000 description 1
- AMDPMOLHWOLRRV-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC(=CC=C1)OC AMDPMOLHWOLRRV-KRWDZBQOSA-N 0.000 description 1
- NNNQSNJEEJOHRZ-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)C NNNQSNJEEJOHRZ-KRWDZBQOSA-N 0.000 description 1
- PGRRUUDTNUJDCZ-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)F Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)F PGRRUUDTNUJDCZ-INIZCTEOSA-N 0.000 description 1
- GXHYIVFHOWWONC-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1)C1=CC=C(C=C1)OC GXHYIVFHOWWONC-KRWDZBQOSA-N 0.000 description 1
- DLCIHXDXJIFWCJ-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=C(C=CC=C1C)C DLCIHXDXJIFWCJ-KRWDZBQOSA-N 0.000 description 1
- OOEDOGRWZPRRRQ-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=CC(=CC=C1)OC OOEDOGRWZPRRRQ-KRWDZBQOSA-N 0.000 description 1
- YNAFDJCKGMCMOJ-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1F)C1=CC=CC=C1 YNAFDJCKGMCMOJ-INIZCTEOSA-N 0.000 description 1
- ZFRUGLKURWOASR-KRWDZBQOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=C(C=CC=C1C)C ZFRUGLKURWOASR-KRWDZBQOSA-N 0.000 description 1
- BYSCTVPYQSCKBI-INIZCTEOSA-N N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=CC=CC=C1 BYSCTVPYQSCKBI-INIZCTEOSA-N 0.000 description 1
- NSSGMSYBRBWDJC-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C=1N(C=CC=1)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1N(C=CC=1)C1=CC=CC=C1 NSSGMSYBRBWDJC-ZDUSSCGKSA-N 0.000 description 1
- ZRSNBXYBJZYSHD-LBPRGKRZSA-N N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=C(C=C(C=C1)F)F ZRSNBXYBJZYSHD-LBPRGKRZSA-N 0.000 description 1
- KONZOSLBFHODII-LBPRGKRZSA-N N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=C(C=CC(=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=C(C=CC(=C1)F)F KONZOSLBFHODII-LBPRGKRZSA-N 0.000 description 1
- NQVWRLIRJMXAOJ-LBPRGKRZSA-N N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC(=CC=C1)Cl Chemical compound N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC(=CC=C1)Cl NQVWRLIRJMXAOJ-LBPRGKRZSA-N 0.000 description 1
- GTQCPTOTPGZGNG-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC(=CC=C1)OC GTQCPTOTPGZGNG-ZDUSSCGKSA-N 0.000 description 1
- HNAOGYZKQNKRCL-LBPRGKRZSA-N N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C1=CC=CC=C1 HNAOGYZKQNKRCL-LBPRGKRZSA-N 0.000 description 1
- CICDHPLGSOQGGN-JTQLQIEISA-N N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C=1C(=NOC=1C)C Chemical compound N[C@@H](CC(=O)OCC)C=1SC(=CC=1)C=1C(=NOC=1C)C CICDHPLGSOQGGN-JTQLQIEISA-N 0.000 description 1
- TZIBJOOQDNWEFA-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=C(C=C(C=C1)F)F Chemical compound N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=C(C=C(C=C1)F)F TZIBJOOQDNWEFA-ZDUSSCGKSA-N 0.000 description 1
- NSCUQEJRQHPSPO-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC(=CC=C1)Cl Chemical compound N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC(=CC=C1)Cl NSCUQEJRQHPSPO-ZDUSSCGKSA-N 0.000 description 1
- WSMIJFVGUNVBEV-AWEZNQCLSA-N N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC(=CC=C1)OC Chemical compound N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC(=CC=C1)OC WSMIJFVGUNVBEV-AWEZNQCLSA-N 0.000 description 1
- RYXIUJBRKZSWQC-ZDUSSCGKSA-N N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1 Chemical compound N[C@@H](CC(=O)OCC)C=1SC=C(C=1)C1=CC=CC=C1 RYXIUJBRKZSWQC-ZDUSSCGKSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- YCHJJDNGMPVWLP-UQKRIMTDSA-M OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)[O-])C1=CC(=CC=C1)C1=NC=CN=C1)=O.[Na+] Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)[O-])C1=CC(=CC=C1)C1=NC=CN=C1)=O.[Na+] YCHJJDNGMPVWLP-UQKRIMTDSA-M 0.000 description 1
- MUTUOIFTTJHKAX-UQKRIMTDSA-M OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)[O-])C=1SC=C(C=1)C1=CC=CC=C1)=O.[Na+] Chemical compound OC1=C(C(N(C=C1)C)=O)NC(N[C@@H](CC(=O)[O-])C=1SC=C(C=1)C1=CC=CC=C1)=O.[Na+] MUTUOIFTTJHKAX-UQKRIMTDSA-M 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical group [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- NQICGNSARVCSGJ-CYKOAPEFSA-N [(5s)-5-methyl-2-propan-2-ylcyclohexyl] 4-methylbenzenesulfinate Chemical compound CC(C)C1CC[C@H](C)CC1O[S@@](=O)C1=CC=C(C)C=C1 NQICGNSARVCSGJ-CYKOAPEFSA-N 0.000 description 1
- HUBVAOMVEMGRFA-UHFFFAOYSA-N [1-tri(propan-2-yl)silylpyrrol-3-yl]boronic acid Chemical compound CC(C)[Si](C(C)C)(C(C)C)N1C=CC(B(O)O)=C1 HUBVAOMVEMGRFA-UHFFFAOYSA-N 0.000 description 1
- RBDUNPHIWSUOSY-UHFFFAOYSA-N [3-(1-ethylindol-6-yl)phenyl]methanol Chemical compound C(C)N1C=CC2=CC=C(C=C12)C=1C=C(C=CC=1)CO RBDUNPHIWSUOSY-UHFFFAOYSA-N 0.000 description 1
- GVTWDKREOXKHIP-UHFFFAOYSA-N [3-phenyl-5-(trifluoromethyl)phenyl]methanol Chemical compound FC(F)(F)C1=CC(CO)=CC(C=2C=CC=CC=2)=C1 GVTWDKREOXKHIP-UHFFFAOYSA-N 0.000 description 1
- GOPYZMJAIPBUGX-UHFFFAOYSA-N [O-2].[O-2].[Mn+4] Chemical class [O-2].[O-2].[Mn+4] GOPYZMJAIPBUGX-UHFFFAOYSA-N 0.000 description 1
- NZHXEWZGTQSYJM-UHFFFAOYSA-N [bromo(diphenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Br)C1=CC=CC=C1 NZHXEWZGTQSYJM-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000005418 aryl aryl group Chemical group 0.000 description 1
- 125000005013 aryl ether group Chemical group 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 150000005347 biaryls Chemical group 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008619 cell matrix interaction Effects 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- ABSOMGPQFXJESQ-UHFFFAOYSA-M cesium;hydroxide;hydrate Chemical compound O.[OH-].[Cs+] ABSOMGPQFXJESQ-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical group C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- ZSANYRMTSBBUCA-UHFFFAOYSA-N diethyl 3-oxopentanedioate Chemical compound CCOC(=O)CC(=O)CC(=O)OCC ZSANYRMTSBBUCA-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- RJHIGTYYDAYKCK-NJHZRGNWSA-N ethyl (3S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-3-(2-methoxy-5-phenylphenyl)propanoate Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C=CC=1OC)C1=CC=CC=C1)[C@H](C)C1=CC=CC=C1 RJHIGTYYDAYKCK-NJHZRGNWSA-N 0.000 description 1
- WKOHBMLWDKZEFT-GOXGLGGOSA-N ethyl (3S)-3-[benzyl-[(1R)-1-phenylethyl]amino]-3-[4-fluoro-3-(2-methylphenyl)phenyl]propanoate Chemical compound C(C1=CC=CC=C1)N([C@@H](CC(=O)OCC)C=1C=C(C(=CC=1)F)C1=C(C=CC=C1)C)[C@H](C)C1=CC=CC=C1 WKOHBMLWDKZEFT-GOXGLGGOSA-N 0.000 description 1
- BJMVVQRZULUYAB-ONEGZZNKSA-N ethyl (E)-3-[3-bromo-5-(trifluoromethoxy)phenyl]prop-2-enoate Chemical compound BrC=1C=C(C=C(C=1)OC(F)(F)F)/C=C/C(=O)OCC BJMVVQRZULUYAB-ONEGZZNKSA-N 0.000 description 1
- BHVXYKORYGCMHC-FNORWQNLSA-N ethyl (e)-3-(3-bromo-4-methoxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(OC)C(Br)=C1 BHVXYKORYGCMHC-FNORWQNLSA-N 0.000 description 1
- JHZPNBKZPAWCJD-UHFFFAOYSA-N ethyl 2-oxocyclopentane-1-carboxylate Chemical compound CCOC(=O)C1CCCC1=O JHZPNBKZPAWCJD-UHFFFAOYSA-N 0.000 description 1
- PRJGJROFCIBRPJ-UHFFFAOYSA-N ethyl 3-(6-oxo-1H-pyridin-3-yl)-3-(tritylamino)propanoate Chemical compound O=C1C=CC(=CN1)C(CC(=O)OCC)NC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1 PRJGJROFCIBRPJ-UHFFFAOYSA-N 0.000 description 1
- QXRBTPQLSXLFNC-UHFFFAOYSA-N ethyl 3-[3-(3-acetylphenyl)phenyl]-3-aminopropanoate hydrochloride Chemical compound Cl.CCOC(=O)CC(N)c1cccc(c1)-c1cccc(c1)C(C)=O QXRBTPQLSXLFNC-UHFFFAOYSA-N 0.000 description 1
- WYFRQYICMZBJKP-UHFFFAOYSA-N ethyl 3-[3-(4-acetylphenyl)phenyl]-3-aminopropanoate hydrochloride Chemical compound Cl.CCOC(=O)CC(N)c1cccc(c1)-c1ccc(cc1)C(C)=O WYFRQYICMZBJKP-UHFFFAOYSA-N 0.000 description 1
- HPQVOJJALSLWRD-UHFFFAOYSA-N ethyl 3-amino-3-(3-pyrrol-1-ylphenyl)propanoate Chemical compound N1(C=CC=C1)C=1C=C(C=CC=1)C(CC(=O)OCC)N HPQVOJJALSLWRD-UHFFFAOYSA-N 0.000 description 1
- FGRKDWXFYGIVAA-UHFFFAOYSA-N ethyl 3-hydroxy-5-(trifluoromethyl)benzoate Chemical compound CCOC(=O)C1=CC(O)=CC(C(F)(F)F)=C1 FGRKDWXFYGIVAA-UHFFFAOYSA-N 0.000 description 1
- NWSKLPDPUFBJDU-UHFFFAOYSA-N ethyl 7-hydroxy-5-oxo-2,3-dihydro-1h-indolizine-8-carboxylate Chemical compound O=C1C=C(O)C(C(=O)OCC)=C2CCCN21 NWSKLPDPUFBJDU-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- AQQGSFJFMJVJSA-UHFFFAOYSA-N formaldehyde 2-phenylpyridine Chemical compound C=O.C1(=CC=CC=C1)C1=NC=CC=C1 AQQGSFJFMJVJSA-UHFFFAOYSA-N 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000006301 indolyl methyl group Chemical group 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- OEFLXQWFXFCBSV-UHFFFAOYSA-N methyl 2-(methylamino)pyridine-3-carboxylate Chemical compound CNC1=NC=CC=C1C(=O)OC OEFLXQWFXFCBSV-UHFFFAOYSA-N 0.000 description 1
- NZZDEODTCXHCRS-UHFFFAOYSA-N methyl 2-aminopyridine-3-carboxylate Chemical compound COC(=O)C1=CC=CN=C1N NZZDEODTCXHCRS-UHFFFAOYSA-N 0.000 description 1
- OSKPFMSGZDCERA-UHFFFAOYSA-N methyl 3-(methylamino)thiophene-2-carboxylate Chemical compound CNC=1C=CSC=1C(=O)OC OSKPFMSGZDCERA-UHFFFAOYSA-N 0.000 description 1
- TWEQNZZOOFKOER-UHFFFAOYSA-N methyl 3-aminothiophene-2-carboxylate Chemical compound COC(=O)C=1SC=CC=1N TWEQNZZOOFKOER-UHFFFAOYSA-N 0.000 description 1
- QCWGWMKTSBFJJD-UHFFFAOYSA-N methyl 5-hydroxy-4-methyl-3-oxopent-4-enoate Chemical compound COC(=O)CC(=O)C(C)=CO QCWGWMKTSBFJJD-UHFFFAOYSA-N 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- IKKMOLIJQSTKRS-OAHLLOKOSA-N n-[(3-bromophenyl)methylidene]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N=CC1=CC=CC(Br)=C1 IKKMOLIJQSTKRS-OAHLLOKOSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MHJUNMARMFAUBI-UHFFFAOYSA-N n-phenyliminobenzamide Chemical compound C=1C=CC=CC=1C(=O)N=NC1=CC=CC=C1 MHJUNMARMFAUBI-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 210000001986 peyer's patch Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- IPOVLZSJBYKHHU-UHFFFAOYSA-N piperidin-3-ylmethanamine Chemical compound NCC1CCCNC1 IPOVLZSJBYKHHU-UHFFFAOYSA-N 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- MVAOBGLRADEZSQ-UHFFFAOYSA-N propan-2-olate;titanium(4+) Chemical compound [Ti+4].CC(C)[O-].CC(C)[O-].CC(C)[O-] MVAOBGLRADEZSQ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000024155 regulation of cell adhesion Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 150000003457 sulfones Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229950009390 symclosene Drugs 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- CTADSHDVGQFFAV-KRWDZBQOSA-N tert-butyl (3S)-3-amino-3-(4-phenylphenyl)propanoate Chemical compound CC(C)(C)OC(=O)C[C@H](N)c1ccc(cc1)-c1ccccc1 CTADSHDVGQFFAV-KRWDZBQOSA-N 0.000 description 1
- KKHZPTKSPSPODS-RLWLMLJZSA-N tert-butyl (3s)-3-[benzyl-[(1r)-1-phenylethyl]amino]-3-(4-bromophenyl)propanoate Chemical compound N([C@H](C)C=1C=CC=CC=1)([C@@H](CC(=O)OC(C)(C)C)C=1C=CC(Br)=CC=1)CC1=CC=CC=C1 KKHZPTKSPSPODS-RLWLMLJZSA-N 0.000 description 1
- FFPDSVNJARXKCJ-UHFFFAOYSA-N tert-butyl 3-(4-bromophenyl)prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=CC1=CC=C(Br)C=C1 FFPDSVNJARXKCJ-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 1
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/48—Aldehydo radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
本文提供了式I的化合物和药物组合物,其中R1、R2、R3、R4、R5和R6如本文所述。还提供了这些化合物的药学上可接受的盐或立体异构体。另外,提供了用于抑制整合素的结合,以治疗各种病理生理学症状的方法。
Description
相关申请的交叉引用
本国际申请要求于2017年4月26日提交的待决非临时申请美国序列号15/497,414的优先权权益,该申请的全部内容通过引用并入本文。
技术领域
本发明大体上涉及医药化学和治疗性化合物的领域。更具体地说,本发明涉及作为整合素抑制剂的丙酸衍生物。
背景技术
整合素是细胞粘附蛋白质分子的大家族,其在许多细胞上表达,并且介导多种细胞-细胞和细胞-基质的相互作用。相应地,许多生理过程,诸如并且包括细胞粘附、迁移、信号传导、存活和分化的调节已知涉及这些分子。每种整合素均由非共价联结的α和β跨膜异二聚体亚基组成,迄今为止已鉴别出18种不同的α单元和8种不同的β单元。整合素充当发生在细胞内部与其外部环境之间的信号传导的导管。通过配体相互作用,整合素感知细胞外环境,活化,然后将该信息传递至细胞内部。这一过程对于细胞与各种组织的功能性相互作用来说很重要,其中各种组织诸如并且包括血管内皮、骨髓基质细胞、一些肿瘤细胞和胃肠粘膜。另外,由于整合素在白细胞、尤其是T细胞上广泛表达,因此是调节炎症和自身免疫性疾病的病理生理过程的关键因素。
迄今为止,已鉴别出大约24种不同的整合素分子。其中,源自α4亚基的整合素与当前未满足医疗需求的疾病状态相关。两种此类整合素是α4β1(也称为极迟抗原-4(VLA-4))和α4β7(也称为粘膜血管地址素细胞粘附分子1(MAdCAM-1))。这两种整合素是本专利申请的主要病原性靶标。
白细胞有三种主要类型:粒细胞、单核细胞(monocyte)和淋巴细胞。α4整合素在单核细胞、淋巴细胞和两个粒细胞亚类(嗜酸性粒细胞和嗜碱性粒细胞)的表面上表达。这些蛋白质通过它们识别其它如诸如血管细胞粘附分子1(VCAM-l)、纤连蛋白等蛋白质的细胞表面部分,或其它与衬于毛细血管内壁的内皮细胞相关的蛋白质的细胞表面部分,并与其结合的能力,而在细胞粘附中发挥关键作用。例如,在毛细血管周围的组织受到感染或损伤之后,内皮细胞表达一系列粘附分子,包括VCAM-1,这些粘附分子对于结合抗感染所必需的白细胞是至关重要的。以类似的方式,α4β7在派尔斑(Peyer’s patch)或肠系膜淋巴结中的T细胞活化期间被诱导,其中α4β7对于归巢至肠粘膜是至关重要的。
目前以及在将来可通过抑制α4整合素加以治疗的一些疾病症状包括,但不限于,造血干细胞移植疗法、镰状细胞病、干眼病、动脉粥样硬化、类风湿性关节炎、哮喘、变态反应、多发性硬化、狼疮、炎性肠病、移植排斥、接触性超敏反应、中风、肺动脉高压和糖尿病。已提出,涉及α4β1的细胞粘附可能参与某些癌细胞的转移和存活。因此,α4β1结合的抑制剂也可用于治疗某些形式的癌症。
美国专利号5,510,332中公开了抑制α4β1与蛋白质结合的肽的分离和纯化。WO95/15973、EP 0 341915、EP 0 422 938 A1、美国专利号5,192,746和WO 96/06108中公开了抑制结合的肽。WO 96/22966、WO 98/04247和US 2004/0234624 A1(WO 98/04913)、WO2005014534 A1、US 7,812,03、6,972,296、US 6,723,711、US 6,262,084中公开了可用于抑制和预防细胞粘附和细胞粘附介导的病理的新型小分子化合物。
本发明的目的是提供,作为α4β1和α4β7结合作用拮抗剂的新型小分子化合物和包含此类新型化合物的相应的药物组合物。
发明内容
本发明涉及具有以下化学结构的式I的化合物
在这些化合物中,R1可以是
R2和R3可独立地为氢或C1-4烷基;R4可以是H或C1-4烷基;R5可以是经以下基团中的一种或多种取代的苯基、芳基、杂环基或芳烷基:氢、C1-4烷基、烷氧基、芳氧基、氧代、卤素、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R6可以是经以下基团中的一种或多种取代的C1-4烷基、卤素、苯基、芳基或杂环基:氢、C1-4烷基、烷氧基、芳基、芳氧基、卤素、氧代、乙酰基、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、环烷基或卤代烷基;R7可以是H或C1-4烷基;R8、R9和R10可独立地为氢、卤素、C1-4烷基、C3-6环烷基或羟基。所述化合物涵盖其药学上可接受的盐或立体异构体。
本发明涉及具有以下化学结构的式I的相关化合物
在这些化合物中,R1可以是
R2和R3可独立地为氢或甲基;R4可以是氢、甲基、乙基或叔丁基;R5可以是经以下基团中的一种或多种取代的苯基、芳基、杂环基或芳烷基:氢、C1-4烷基、烷氧基、芳氧基、氧代、卤素、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R6可以是经以下基团中的一种或多种取代的C1-4烷基、卤素、苯基、芳基或杂环基:氢、C1-4烷基、烷氧基、芳基、芳氧基、卤素、氧代、乙酰基、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R7可以是H、甲基或乙基;R8和R9可独立地为氢或甲基;并且R10可以是羟基。所述化合物涵盖其药学上可接受的盐或立体异构体。
本发明还涉及药物组合物,其包含:至少一种如本文所述的化合物,和一种或多种药学上可接受的载体。
本发明进一步涉及用于治疗需要此类治疗的受试者的,由α4整合素(即α4β1、α4β7或混合α4β1和α4β7整合素)介导的病理生理学症状的方法。所述方法包括施用药理学有效量的如本文所述的药物组合物。
本发明还涉及用于抑制与病理生理学症状相关的细胞中整合素结合的方法。所述方法包括使所述细胞与一种或多种如本文所述的化合物接触。
从下文出于公开目的所给出的本发明当前优选实施方案的描述中,本发明的其它和另外方面、特征、益处和优点将是显而易见的。
具体实施方式
如本文说明书中所用,“一个/种(a)”或“一个/种(an)”可意指一个/种或多个/种。如本文权利要求书中所用,当结合词语“包含”使用时,词语“一个/种(a)”或“一个/种(an)”可意指一个/种或多于一个/种。
如本文所使用,“另一”或“其它”可意指至少第二个或更多个相同或不同的要求的元件或部件。类似地,除非上下文另外明确指出,否则词语“或”意在包括“和”。“包含”意指“包括”。
如本文所用,无论是否明确指出,术语“约”是指数值,包括例如整数、分数和百分比。术语“约”通常是指本领域普通技术人员会认为等同于列举值(例如,具有相同的功能或结果)的数值范围(例如,列举值的+/-5~10%)。在一些情况下,术语“约”可包括四舍五入至最接近的有效数字的数值。
术语“nd”意在意指尚未确定。
术语阿尔法(alpha)4整合素(又名α4-整合素)是指一类由α4亚基与通常称为贝塔(beta,b)亚基的另一亚基偶合构成的整合素二聚体分子。典型但非排他性的实例是α4β1和α4β7。
除非术语烷基前面有Cx-Cy指代,否则如本文单独或组合使用的术语“烷基”是指,通过去除一个氢原子,衍生自饱和烃的C1-C12直链或支链、经取代或未经取代的饱和链基团。烷基的代表性实例包括甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基和叔丁基等。
如本文单独或组合使用的术语“烯基”是指,含有2至10个碳原子的,经取代或未经取代的直链烯基,或经取代或未经取代的支链烯基。此类基团的实例包括但不限于乙烯基、E-戊烯基和Z-戊烯基、癸烯基等。
如本文单独或组合使用的术语“炔基”是指,含有2至10个碳原子的,经取代或未经取代的直链炔基,或经取代或未经取代的支链炔基。此类基团的实例包括但不限于乙炔基、丙炔基、炔丙基、丁炔基、己炔基、癸炔基等。
如本文所用的术语“环烷基”是指具有3至10个碳原子和1至3个环的脂族环系,包括但不限于环丙基、环戊基、环己基、降冰片基和金刚烷基等。环烷基可未经取代,或经一种、两种或三种独立地选自以下基团的取代基取代:低级烷基、卤代烷基、烷氧基、硫代烷氧基、氨基、烷基氨基、二烷基氨基、羟基、卤代、巯基、硝基、羧基醛(carboxaldehyde)、羧基、烷氧基羰基和羧酰胺。
“环烷基”包括顺式或反式形式。此外,在桥接二环体系中,取代基可处于内型-或外型-位置。
如本文所用的术语“卤代”或“卤素”是指I、Br、Cl或F。
如本文所用的术语“卤代烷基”是指附接有至少一个卤素取代基的C1-C4烷基,例如氯甲基、氟乙基、二氟甲基、三氟甲基和五氟乙基等。
如本文单独或组合使用的术语“烷氧基”是指烷基醚基团,其中术语“烷基”如上文所定义。适合的烷基醚基团的实例包括但不限于甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基、异丁氧基、仲丁氧基、叔丁氧基等。
如本文单独或组合使用的术语“卤代烷氧基”是指卤代烷基醚基团,其中术语“卤代烷基”如上文所定义。适合的卤代烷基醚基团的实例包括但不限于氯甲氧基、三氟甲氧基、二氟甲氧基、三氟乙氧基等。
术语“硫代烷氧基”是指化学式为烷基--S--的硫醚基,其中“烷基”如上文所定义。
如本文所用的术语“二烷基氨基”是指Rf Rg N--,其中Rf和Rg独立地选自C1-C4烷基,例如二乙基氨基和甲基丙基氨基等。
如本文单独或组合使用的术语“芳基(aryl)”或“芳族(aromatic)”是指具有约6至12个碳原子的,经取代或未经取代的碳环芳族基团,诸如苯基、萘基、茚基、茚满基、甘菊环基(azulenyl)、芴基和蒽基;或含有至少一个环内N、O或S原子的杂环芳族基团,诸如呋喃基、噻吩基、吡啶基、二氢吡啶基、吡咯基、噁唑基、噻唑基、咪唑基、吡唑基、2-吡唑啉基、吡唑烷基、异噁唑基、异噻唑基、1,2,3-噁二唑基、1,2,3-三唑基、1,3,4-噻二唑基、哒嗪基、嘧啶基、吡嗪基、1,3,5-三嗪基、1,3,5-三噻烷基、吲嗪基、吲哚基、异吲哚基、3H-吲哚基、二氢吲哚基、苯并[b]呋喃基、2,3-二氢苯并呋喃基、苯并[b]噻吩基、苯并二氧代基(benzodioxolyl)、1H-吲唑基、苯并咪唑基、苯并噻唑基、嘌呤基、4H-喹嗪基、异喹啉基、噌啉基、酞嗪基、喹唑啉基、喹喔啉基、1,8-二氮杂萘基(1,8-naphthridinyl)、蝶啶基、咔唑基、吖啶基、吩嗪基、吩噻嗪基、吩噁嗪基(phenoxyazinyl)、吡唑并[1,5-c]三嗪基等。“芳烷基”和“烷基芳基”采用如上文所定义的术语“烷基”。环可被多取代。
如本文单独或组合使用的术语“联芳基”是指结构式为芳基-芳基的基团,其中术语“芳基”如上文所定义。
如本文单独或组合使用的术语“芳烷基”是指芳基取代的烷基,其中术语“烷基”和“芳基”如上文所定义。适合的芳烷基的实例包括但不限于苯甲基、苯乙基、苯己基、二苯基甲基、吡啶基甲基、四唑基甲基、呋喃基甲基、咪唑基甲基、吲哚基甲基、噻吩基丙基等。
如本文单独或组合使用的术语“芳氧基”是指芳基醚基,其中术语“芳基”如上文所定义。
如本文所用的术语“苄基”是指C6H5CH2--。
如本文单独或组合使用的术语“杂环基”是指,含有至少一个内环N、O或S原子的非芳族3至10元环。杂环可任选地为芳基稠合的。杂环还可任选地经至少一个取代基取代,其中取代基独立地选自由以下基团组成的组:氢、卤素、羟基、氨基、硝基、三氟甲基、三氟甲氧基、三氟乙氧基、烷基、烷氧基、芳烷基、烯基、炔基、芳基、氰基、羧基、烷氧羰基、羧基烷基、氧代、乙酰基、芳基磺酰基和芳烷基氨基羰基等。
如本文所用的术语“杂芳基”是指芳族部分,其含有一个或多个作为环结构一部分的杂原子(例如,N、O、S等),并且在环结构(即,碳原子和杂原子)中具有5至最多14个范围内的总原子。“经取代的杂芳基”是指进一步带有一个或多个取代基的杂芳基。
如本文所用的术语“立体异构体”是指由相同原子通过相同键键合构成、但具有不可互换的不同三维结构的化合物。这样的三维结构被称为构型。
如本文所用的术语化合物的“药学上可接受的盐”意指,如本文所定义的药学上可接受的且具有母体化合物的期望药理作用的盐。此类盐包括药学上可接受的碱的加成盐,该药学上可接受的碱的加成盐是当母体化合物中所含的酸性质子被金属离子例如碱金属离子、碱土金属离子或铝离子替代,或者与药学上可接受的有机或无机碱配位时形成的。可接受的有机碱包括二乙醇胺、乙醇胺、N-甲基葡糖胺、三乙醇胺、氨丁三醇等。可接受的无机碱包括氢氧化铝、氢氧化钙、氢氧化钾、碳酸钠和氢氧化钠。特别地,钠是优选的,并且其可以是单钠或二钠形式或是其混合物。
如本文所用的术语“有效量”通常是指有效实现预期目的的量,例如药理上的有效量。但是,该量可小于要施用多种组合物时的量,即总有效量可以累积剂量单位来施用。当组合物持续释放药理活性剂时,活性剂的量也可大于有效量。待使用的药理活性剂的总量可通过本领域技术人员已知的方法来确定。然而,由于所述组合物可以比现有组合物更有效地递送药理活性剂,因此可向受试者施用比现有剂量单位形式或递送系统中使用的活性剂更少量的活性剂,同时仍然实现相同的血液水平和/或治疗效果。
如本文所用,术语“钠”意指所公开的化合物的钠盐,并且包括单钠盐、二钠盐和其混合物。
如本文所用,术语“接触”是指任何适合方法,使化合物或药物组合物在体内、体外或离体与细胞接触。对于体内应用,如本文所述,任何已知的施用方法均适合。
如本文所用,术语“受试者”是指本文所述的化合物和/或药物组合物的任何接受者,例如人或非人哺乳动物。
上述术语的使用意在涵盖经取代和未经取代的部分。取代可通过诸如醇、醚、酯、酰胺、砜、硫化物、羟基、硝基、氰基、羧基、胺、杂原子、低级烷基、低级烷氧基、低级烷氧基羰基、烷氧基烷氧基、酰氧基、卤素、三氟甲氧基、三氟甲基、烷基、芳烷基、烯基、炔基、芳基、氰基、羧基、烷氧羰基、羧基烷基、环烷基、环烷基烷基、杂环基、烷基杂环基、杂环基烷基、氧代、芳基磺酰基和芳烷基氨基羰基等基团的一种或多种来进行,或通过先前段落的任何取代基,或那些直接连接或经适合接头连接的任何取代基来进行。接头通常是1~3个原子的短链,含有--C--、--C(O)--、--NH--、--S--、--S(O)--、--O--、--C(O)O--或--S(O)O--的任何组合。环可被取代多次。
在本发明的一个实施方案中,提供了具有以下化学结构的式I化合物,或其药学上可接受的盐或立体异构体,
其中R1为
R2和R3独立地为氢或C1-4烷基;R4为H或C1-4烷基;R5为经以下基团中的一种或多种取代的苯基、芳基、杂环基或芳烷基:氢、C1-4烷基、烷氧基、芳氧基、氧代、卤素、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R6为经以下基团中的一种或多种取代的C1-4烷基、卤素、苯基、芳基或杂环基:氢、C1-4烷基、烷氧基、芳基、芳氧基、卤素、氧代、乙酰基、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R7为H或C1-4烷基;R8、R9和R10独立地为氢、卤素、C1-4烷基、C3-6环烷基或羟基。
在该实施方案中,R2和R3各自为氢,R4为氢、甲基、乙基或叔丁基。同样在该实施方案中,R7为氢、甲基或乙基。同样在该实施方案中,R8和R9独立地为氢或甲基。同样在该实施方案中,R10为羟基。同样在该实施方案和其如所述的所有方面,药学上可接受的盐为单钠盐或二钠盐,并且立体异构体具有(S)-构型。
在该实施方案的一个方面,所提供的式I化合物为具有以下化学结构的式IA化合物,或其药学上可接受的盐或立体异构体,
其中,R2、R3、R4、R5、R6、R7、R8、R9和R10如上文所述。
在该实施方案的另一方面,所提供的式I化合物为具有以下化学结构的式IB化合物,或其药学上可接受的盐或立体异构体,
其中,R2、R3、R4、R5、R6、R7、R9和R10如上文所述。
在该实施方案的再一方面,所提供的式I化合物为具有以下化学结构的式IC化合物,或其药学上可接受的盐或立体异构体,
其中,R2、R3、R4、R5、R6、R7和R10如上文所述。
在该实施方案的再一方面,所提供的式I化合物为具有以下化学结构的式ID化合物,或其药学上可接受的盐或立体异构体,
其中,R2、R3、R4、R5、R6、R7和R10如上文所述。
在该实施方案的再一方面,所提供的式I化合物为具有以下化学结构的式IE化合物,或其药学上可接受的盐或立体异构体,
其中,R2、R3、R4、R5、R6、R7和R10如上文所述。
在该实施方案的再一方面,所提供的式I化合物为具有以下化学结构的式IF化合物,或其药学上可接受的盐或立体异构体,
其中,R2、R3、R4、R5、R6、R9和R10如上文所述。
在本发明的另一实施方案中,提供了药物组合物,其包含至少一种如上文所述的化合物,和一种或多种药学上可接受的载体。
在本发明的再一实施方案中,提供了用于治疗需要此类治疗的受试者的由α4整合素(例如α4β1、α4β7或混合的α4β1和α4β7整合素)介导的病理生理学症状的方法,其包括向所述受试者施用药理有效量的如上文所述的药物组合物。在该实施方案中,病理生理学症状为造血干细胞移植疗法、镰状细胞病、干眼病、动脉粥样硬化、类风湿性关节炎、哮喘、变态反应、多发性硬化、狼疮、炎性肠病、移植排斥、接触性超敏反应、中风、肺动脉高压、糖尿病或癌症。
在本发明的再一实施方案中,提供了用于抑制与病理生理学症状相关的细胞中整合素结合的方法,其包括:使所述细胞与一种或多种如上文所述的化合物接触。在该实施方案中,整合素为α4β1和/或α4β7整合素。同样在该实施方案中,病理生理学症状为癌症。
在本发明的再一实施方案中,提供了具有以下化学结构的式II化合物,或其药学上可接受的盐或立体异构体,
其中R1为
R2和R3独立地为氢;R4为氢、甲基、乙基或叔丁基;R5为经以下基团中的一种或多种取代的苯基、芳基、杂环基或芳烷基:氢、C1-4烷基、烷氧基、芳氧基、氧代、卤素、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R6为经以下基团中的一种或多种取代的C1-4烷基、卤素、苯基、芳基、杂芳基:氢、C1-4烷基、烷氧基、芳基、芳氧基、卤素、氧代、乙酰基、卤代烷氧基、-CF3、羟基、-OCF3、芳基、-OCF2H、-OCF2CF2H、-O(C3-6环烷基)、-OCH2CF3、硫代烷氧基、二烷基氨基、C3-6环烷基或卤代烷基;R7为氢、甲基或乙基;R8和R9独立地为氢或甲基。
在本发明的再一实施方案中,提供了以下化合物:
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-9;
(S)-3-(联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-10;
3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸乙酯1-11;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯1-12;
(S)-3-(2'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-13;
(S)-3-(6-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-14;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸乙酯1-15;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-16;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-17;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-18;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸乙酯1-19;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸乙酯1-20;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸乙酯1-21;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸乙酯1-22;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸乙酯1-23;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-24;
(S)-3-(3',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-25;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯1-26;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'–甲氧基联苯-3-基)丙酸乙酯1-27;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸乙酯1-28,
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-29;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-30;
(S)-3-(2',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-31;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯1-32;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-33;
(S)-3-(2',3'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-34;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸乙酯1-35;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-36;
(S)-3-(3'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-37;
(S)-3-(4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-38;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-39;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-40;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-41;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-42;
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-43;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-44;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-45;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸乙酯1-46;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-47;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯1-48;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-49;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸乙酯1-50;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-51;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-52;
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-53;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸乙酯1-54;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-55;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-56;
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-57;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-58;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-59;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-60;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯1-61;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯1-62;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸乙酯1-63;
(S)-3-(2'-乙基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-64;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-65;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-66;
(S)-3-(3',4'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-67;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-68;
(S)-3-(4'-氟-3'-甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-69;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸乙酯1-70;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-71;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸乙酯1-72;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯1-73;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-74;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-75;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-76;
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-77;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-78;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-79;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯1-80;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-81;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-82;
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-83;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-84;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸乙酯1-85;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-86;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-4-甲基-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸乙酯1-87;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-88;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-89;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-90;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-91;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸乙酯1-92;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-93;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-94;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-95;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-96;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-97;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸乙酯1-98;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-99;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯1-100;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸乙酯1-101;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-102;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-103;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸乙酯1-104;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-105;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-106;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-107;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-108;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-109;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-110;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-111;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸乙酯1-112;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-113;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯1-114;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-115;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-116;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸乙酯1-117;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸乙酯1-118;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-119;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸乙酯1-120;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(5-羟基-2-甲基-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸乙酯1-121;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-122;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-123;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-124;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯1-125;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-126;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-127;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-128;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-129;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸乙酯1-130
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-131;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-132;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-133;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-134;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯1-135;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-136;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-137;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-138;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-139;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-140;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯1-141;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-142;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸乙酯1-143;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-144;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯1-145;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-146;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-147;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-148;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-149;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-150;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-151;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-152;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-153;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯1-154;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸乙酯1-155;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯1-156;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯1-157;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯1-158;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-159;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-160;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-161;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-162;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯1-163;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯1-164;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-165;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-166;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-167;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基联苯-3-基)丙酸乙酯1-168;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯1-169;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯1-170;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯1-171;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-172;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸乙酯1-173;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-174;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-175;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-176;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-177;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-178;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-179;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-180;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-181;
(S)-3-(2-氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-182;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-183;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-184;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸乙酯1-185;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-186;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸乙酯1-187;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸乙酯1-188;
(S)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸乙酯1-189;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸乙酯1-190;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-191;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-192;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-193;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-194;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-195;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-196;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-197;
3-(3'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-198;
3-(4'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-199;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸乙酯1-200;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸乙酯1-201;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸乙酯1-202;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸乙酯1-203;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-204;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯1-205;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯1-206;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-207;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-208;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-209;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸乙酯1-210;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-211;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸乙酯1-212;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸乙酯1-213;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸乙酯1-214;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-215;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-216;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸乙酯1-217;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯1-218;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-219;
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-220,
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-221
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-222,
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-223,
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-224,
(S)-3-(联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-225;
3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸1-226;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-227;
(S)-3-(2'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-228;
(S)-3-(6-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-229;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-230;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸1-231;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-232;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-233;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-234;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸1-235;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸1-236;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸1-237;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸1-238;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸1-239;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-240;
(S)-3-(3',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-241;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸1-242;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸1-243;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲基)联苯-3-基)丙酸1-244;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸1-245;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸1-246;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-247;
(S)-3-(2',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-248;
(S)-3-(2',3'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-249;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸1-250;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-251;
(S)-3-(3'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-252;
(S)-3-(4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-253;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸1-254;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-255;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-256;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-257;
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-258;
3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-259;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-260;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸1-261;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-262;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸1-263;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-264;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸1-265;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-266;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-267;
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-268;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸1-269;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-270;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-271;
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-272;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-273;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-274;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-275;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸1-276;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸1-277;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸1-278;
(S)-3-(2'-乙基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-279;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-280;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-281;
(S)-3-(3',4'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-282;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-283;
(S)-3-(4'-氟-3'-甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-284;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸1-285;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-286;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸1-287;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸1-288;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-289;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-290;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-291;
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-292;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-293;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-294;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸1-295;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-296;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸1-297;
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-298;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸1-299;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-2,5,6,7-四氢-1H-环戊[b]吡啶-3-基)脲基)丙酸1-300;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸1-301;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-4-甲基-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸1-302;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-303;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-304;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-305;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-306;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸1-307;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-308;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-309;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-310;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-311;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-312;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸1-313;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-314;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸1-315;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸1-316;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-317;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-318;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸1-319;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-320;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-321;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-322;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸1-323;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-324;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-325;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-326;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸1-327;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-328;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸1-329;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-330;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-331;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸1-332;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸1-333;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-334;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸1-335;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(5-羟基-2-甲基-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸1-336;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-337;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-338;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-339;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸1-340;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-341;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-342;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-343;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-344;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸1-345;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-346;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-347;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-348;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-349;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸1-350;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-351;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-352;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-353;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-354;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-355;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸1-356;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-357;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸1-358;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-359;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸1-360;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-361;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-362;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-363;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-364;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-365;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-366;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-367;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-368;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸1-369;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸1-370;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸1-371;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸1-372;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸1-373;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-374;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-375;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-376;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-377;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸1-378;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸1-379;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-380;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-381;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-382;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基联苯-3-基)丙酸1-383;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸1-384;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-385;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-386;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-387;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸1-388;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-389;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-390;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-391;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-392;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-393;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-394;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-395;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-396;
(S)-3-(2-氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-397;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-398;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-399;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸1-400;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-401;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸1-402;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸1-403;
(S)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸1-404;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸1-405;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-406;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-407;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-408;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-409;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-410;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸1-411;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸1-412;
3-(3'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-413;
3-(4'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-414;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸1-415;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸1-416;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸1-417;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸1-418;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-419;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸1-420;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸1-421;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸1-422;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸1-423;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-424;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸1-425;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-426;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸1-427;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸1-428;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸1-429;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-430;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸1-431;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸1-432;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-433;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸1-434,
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-435,
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-436,
(S)-3-(联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-437;
(S)-3-(联苯-3-基)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-438;
3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸钠1-439;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-440;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-氟联苯-3-基)丙酸钠1-441;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟联苯-3-基)丙酸钠1-442;
(S)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-443;
(S)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸钠1-444;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-445;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-446;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-447;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸钠1-448;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸钠1-449;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸钠1-450;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸钠1-451;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸钠1-452;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-453;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3',5'-二甲基联苯-3-基)丙酸钠1-454;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸钠1-455;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸钠1-456;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲基)联苯-3-基)丙酸钠1-457;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-458;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5'-二甲基联苯-3-基)丙酸钠1-459;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸钠1-460;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸钠1-461;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',3'-二甲基联苯-3-基)丙酸钠1-462;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸钠1-463;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-464;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-氟联苯-3-基)丙酸钠1-465;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-氟联苯-3-基)丙酸钠1-466;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸钠1-467;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-468;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-469;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-3-基)丙酸钠1-470;
3-(4'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-471;
3-(3'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-472;
3-(2'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-473;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸钠1-474;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-475;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸钠1-476;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-477;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸钠1-478;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-479;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-480;
3-(3',4'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-481;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸钠1-482;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-483;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-484;
3-(2',3'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-485;
3-(3',5'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-486;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-487;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-488;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸钠1-489;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸钠1-490;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸钠1-491;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-乙基联苯-3-基)丙酸钠1-492;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟联苯-3-基)丙酸钠1-493;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-494;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3',4'-二甲基联苯-3-基)丙酸钠1-495;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-496;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-氟-3'-甲基联苯-3-基)丙酸钠1-497;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸钠1-498;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-499;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸钠1-500;
(S)-3-(3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-501;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-502;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-503;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-504;
(S)-3-(联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-505;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-506;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-507;
(S)-3-(3-(6-甲氧基吡啶-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-508;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-509;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸钠1-510;
3-(2',4'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-511;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸钠1-512;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸钠1-513;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸钠1-514;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-甲基-7-氧桥-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸钠1-515;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-516;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-517;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-518;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-519;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸钠1-520;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-521;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-522;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-523;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-524;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-525;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸钠1-526;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-527;
(S)-3-(4-(3-甲氧基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-528;
(S)-3-(6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-529;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-530;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-531;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸钠1-532;
(S)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-533;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-534;
(S)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-535;
(S)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-536;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-537;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-538;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-539;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸钠1-540;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-541;
(S)-3-(3'-甲氧基-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-542;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(2,6-二甲基苯基)噻吩-2-基)丙酸钠1-543;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-544;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸钠1-545;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸钠1-546;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-547;
(S)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-548;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(2-甲基-5-氧桥-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸钠1-549;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-3-基)丙酸钠1-550;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-551;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-552;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸钠1-553;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-554;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-555;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-556;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(6-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-557;
(S)-3-(5-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-558;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-559;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-560;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-561;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-562;
(S)-3-(5-(3-甲氧基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-563;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-564;
(S)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-565;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-566;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-567;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-568;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸钠1-569;
(S)-3-(4-氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-570;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸钠1-571;
(S)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-572;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸钠1-573;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-574;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-575;
(S)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-576;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-577;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟-2',6'-二甲基联苯-3-基)丙酸钠1-578;
(S)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-579;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸钠1-580;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-581;
(S)-3-(3'-甲氧基-5-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-582;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠1-583;
(S)-3-(4'-甲基-2,3'-联噻吩-5-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-584;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-2,3'-联噻吩-5-基)丙酸钠1-585;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸钠1-586;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-587;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(2,6-二甲基苯基)噻吩-2-基)丙酸钠1-588;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-2',6'-二甲基联苯-3-基)丙酸钠1-589;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-590;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸钠1-591;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸钠1-592;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-593;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-594;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-595;
(S)-3-(4-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-596;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸钠1-597;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-598;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-599;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-600;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸钠1-601;
(S)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-602;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-3'-甲氧基联苯-3-基)丙酸钠1-603;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-604;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-605;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-3'-三氟甲氧基联苯-3-基)丙酸钠1-606;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-607;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-608;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)丙酸钠1-609;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-氟联苯-3-基)丙酸钠1-610;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟-2'-甲基联苯-3-基)丙酸钠1-611;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-612;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸钠1-613;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-614;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸钠1-615;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸钠1-616;
(S)-3-(5-甲氧基联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠1-617;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸钠1-618;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-619;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-620;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-621;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-622;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-623;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸钠1-624;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸钠1-625;
3-(3'-乙酰基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-626;
3-(4'-乙酰基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-627;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸钠1-627;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸钠1-628;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠1-629;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸钠1-630;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-631;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸钠1-632;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸钠1-633;
(S)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-634;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸钠1-635;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-636;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸钠1-637;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-4-基)丙酸钠1-638;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸钠1-639;
(S)-3-(3-(6-甲氧基哒嗪-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-640;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸钠1-641;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-2',6'-二甲基联苯-3-基)丙酸钠1-642;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-643;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸钠1-644;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸钠1-645;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-646。
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸钠1-647,
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-648,或
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-649。
本文提供了为丙酸衍生物的化合物及其药物组合物。特别地,这些化合物可包括联苯基丙酸酯和联芳基丙酸酯的衍生物,诸如但不限于实施例中所述的那些化合物。这些化合物涵盖它们的药学上可接受的盐和/或它们的立体异构体。
如本领域已知的,药物组合物可包含已知的载体、赋形剂、稀释剂等,例如盐水、缓冲剂、油或粉末。药物组合物可在媒介物中递送,所述媒介物诸如但不限于喷雾剂、脂质体、纳米粒子、微粒、微胶囊、纳米悬浮液、微悬浮液或水凝胶。
本文所公开的化合物和药物组合物可用作针对需要此类治疗的受试者的病理生理学症状的治疗剂和预防剂。所述化合物和药物组合物可施用一次或多次以实现治疗效果。所述化合物和药物组合物可与用于特定病理生理学症状的其它治疗剂一起施用。如本领域已知的,本领域技术人员完全能够根据待治疗的症状和需要治疗的受试者,来确定剂量、给药方案和施用途径。
例如,治疗可与抑制α4-整合素,诸如α4β1或α4β7的结合相关。可通过抑制α4β1和/或α4β7结合来治疗的病理生理学症状的代表性实例,包括但不限于造血干细胞移植疗法、镰状细胞病、干眼病、动脉粥样硬化、类风湿性关节炎、哮喘、变态反应、多发性硬化、狼疮、炎性肠病、移植排斥、接触性超敏反应、中风、肺动脉高压和糖尿病或癌症。除了在一些白细胞上发现α4β1外,α4β1还发生存在于各种癌细胞(包括白血病、黑色素瘤、淋巴瘤和肉瘤细胞)上。已提出,涉及α4β1的细胞粘附可能参与某些癌症的转移。因此,α4β1结合的抑制剂也可用于治疗一些形式的癌症。
以下实施例是为了说明本发明的各种实施方案的目的而给出的,并不意在以任何方式限制本发明。
实施例1
(S)-3-(联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠(1-11)的合成
步骤1:在干燥的氮气氛下,向氢化钠(6.4g 60%矿物油分散液,160mmol)的THF(400mL)悬浮液中,添加TMEDA(23.4mL,155mmol)和丙酰基乙酸甲酯(18.1mL,144mmol),将混合物冷却至-45℃。逐滴添加正丁基锂的溶液(90mL,1.6M在己烷中,274mmol),并将所得混合物在-45℃下搅拌1小时。然后快速添加甲酸甲酯(6.0mL,97mmol)并将混合物搅拌30分钟,然后用HCl(6N,250mL)淬灭。反应物用乙醚(150mL)稀释,并用水将有机层再洗涤两次。合并水性层,并添加氯化钠直至饱和。该混合物用乙酸乙酯萃取(3次)。用饱和碳酸氢钠溶液和水洗涤原始醚层。将合并的水性洗涤物用过量的HCl(2N)酸化,用氯化钠饱和,并用乙酸乙酯萃取(3次)。将所有乙酸乙酯萃取物合并,经MgSO4干燥。将所得混合物通过粗硅胶真空过滤,将滤液在减压下浓缩,得到呈浅黄色油状物的5-羟基-4-甲基-3-氧代戊-4-烯酸甲酯(1-1,13.49g)。该材料在不经进一步纯化的情况下使用。
步骤2:在室温下,向1-1(13.49g,85.3mmol)的无水甲醇(250mL)溶液中缓慢添加甲胺无水甲醇溶液(2.0M,46.9mL,93.8mmol)。将溶液在55℃加热2小时,然后回流过夜。将反应混合物冷却至室温,并浓缩至干燥。将残余物置于二氯甲烷中并过滤。收集固体,在真空下干燥,得到呈浅黄色固体的4-羟基-1,5-二甲基吡啶-2(1H)-酮(1-2,4.056g)。将滤液浓缩,置于丙酮中,过滤以得到额外的部分(1.636g)。
该程序还用于制备1-乙基-4-羟基-5-甲基吡啶-2(1H)-酮。
步骤3:在室温下,向1-2(1.636g,11.8mmol)的冰乙酸(40mL)悬浮液中,依序添加NaNO2(41mg,0.59mmol)、水(3.36mL)和HNO3(70%,2.27mL,35.3mmol)。将所得亮黄色溶液在室温下搅拌过夜,用水稀释,并用乙酸乙酯萃取三次。将有机层合并且用盐水洗涤,经MgSO4干燥,并过滤。对来自前一步骤的剩余材料(4.047g 1-2、97mL乙酸;100mg NaNO2、8.3mL水和5.6mL硝酸)重复将该反应。将来自两个反应的滤液合并,在减压下浓缩以得到呈黄橙色固体的4-羟基-1,5-二甲基-3-硝基吡啶-2(1H)-酮(1-3,6.47g)。
该程序还用于制备
1-乙基-4-羟基-5-甲基-3-硝基吡啶-2(1H)-酮;
4-羟基-1-甲基-3-硝基-6,7-二氢-1H-环戊并[b]吡啶-2(5H)-酮;
7-羟基-4-甲基-6-硝基噻吩并[3,2-b]吡啶-5(4H)-酮;
7-羟基-6-硝基-2,3-二氢吲嗪-5(1H)-酮;
4-羟基-1-甲基-3-硝基-1,8-萘啶-2(1H)-酮;
在5-羟基-2-甲基-4-硝基哒嗪-3(2H)-酮的制备中,该反应在0℃下开始并使其升温至室温。
步骤4:在室温下,于干燥氮气氛下向1-3(6.45g,35.0mmol)的DMF(117mL)溶液中,添加Zn粉(10.3g,158mmol)和盐酸三乙胺(26.5g,193mmol)。将所得混合物加热至70℃并保持1小时,然后冷却至室温。向所得混合物中,添加固体CDI(11.36g,70.1mmol)。在添加时,发生气体逸出。然后将混合物加热至85℃并保持2小时,然后冷却至室温,并通过布氏漏斗(Buchner funnel)过滤至HCl(2N)中。将悬浮液搅拌15分钟,并过滤。将固体再悬浮于HCl(1N)中,搅拌15分钟,并再次过滤,用水洗涤。将固体在真空下干燥,得到呈灰白色固体的5,7-二甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮(1-4,3.981g)。
该程序还用于制备5-乙基-7-甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮和7,8-二氢噁唑并[4,5-f]吲嗪-2,4(3H,6H)-二酮。对该程序进行了修改,在15℃下使用二噁烷(4.0M,5.5当量)中的氯化氢来代替盐酸三乙胺,在添加CDI后升温至室温,以制备5-甲基-5,6,7,8-四氢-2H-环戊并[b]噁唑并[5,4-d]吡啶-2,4(3H)-二酮,
5-甲基噁唑并[5,4-d]噻吩并[3,2-b]吡啶-2,4(3H,5H)-二酮;
5-甲基噁唑并[4,5-c][1,8]萘啶-2,4(3H,5H)-二酮;
和5-甲基噁唑并[4,5-d]哒嗪-2,4(3H,5H)-二酮。
步骤5:向3-溴肉桂酸(29.0g,127.7mmol)的乙醇(450mL)溶液中,添加催化浓缩硫(约10滴)。将反应物加热以回流过夜,在减压下浓缩(至大约0.1L),用热乙酸乙酯稀释,并用水(3次)和饱和盐水洗涤。有机层经硫酸镁干燥,过滤并在减压下浓缩,得到(E)-3-(3-溴苯基)丙烯酸乙酯(1-5,32.5g)。
该程序还用于制备(E)-3-(3-溴-4-氟苯基)丙烯酸乙酯和(E)-3-(3-硝基苯基)丙烯酸乙酯。
步骤6:在氮气氛下,向冷却至-78℃的(R)-(+)-N-苄基-α-甲基苄胺(20.3g,96mmol)的四氢呋喃(150mL)溶液中,经30分钟逐滴添加仲丁基锂(1.3M在环己烷中,77mL,100mmol)。将混合物搅拌30分钟,并且经30分钟逐滴添加1-5(20.4g,80mmol)的四氢呋喃(100mL)溶液。将所得溶液在-78℃下搅拌3小时,添加乙醇(8mL),并将混合物倾倒至饱和氯化铵水溶液中。用乙酸乙酯萃取所得混合物(3次),并且将有机层合并,用盐水洗涤,经硫酸镁(无水)干燥,过滤并在减压下浓缩。残余物通过硅胶柱层析(用增加至己烷:乙酸酯(9:1)的己烷洗脱)纯化,得到(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴苯基)丙酸乙酯(1-6,27.19g)。
在不影响结果的情况下,还使用己烷中的正丁基锂代替环己烷中的仲丁基锂来实现这个程序。该程序还用于制备
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-4-氟苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-4-甲基苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-4-甲氧基苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-溴苯基)丙酸叔丁酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5,6-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-硝基苯基)丙酸乙酯(7-1);
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-溴-2-氟苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-碘苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-5-甲氧基苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-5-甲基苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-5-氟苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-溴-2-甲氧基苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-碘-4-(三氟甲氧基)苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2-氟-3-碘苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-溴-5-(三氟甲氧基)苯基)丙酸乙酯;和
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯(来自(E)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙烯酸乙酯)。
步骤7:在室温下,于氮气下向1-6(6.96g,14.9mmol)和苯基硼酸(2.00g,16.4mmol)的二甲氧基乙烷(50mL)混合物中,添加磷酸三钾(7.91g,37.3mmol)和双(三苯基膦)二氯化钯(II)(523mg,0.75mmol)。将混合物脱氧(在真空与氮气之间切换5次),并加热至85℃过夜。将混合物冷却,用乙酸乙酯稀释,并用水和盐水洗涤。将有机层干燥,过滤并浓缩。残余物通过硅胶柱层析(用己烷和乙酸乙酯洗脱)纯化,得到(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(联苯-3-基)丙酸乙酯(1-7,5.49g)。
该程序还用于制备(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(来自3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯);
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-甲氧基联苯-3-基)丙酸乙酯;
3-(1-乙基-1H-吲哚-6-基)苯甲酸乙酯(28-1,来自6-溴-1-乙基-1H-吲哚和3-乙氧基羰基苯基硼酸)。
还可通过添加2~5倍过量当量的三乙胺来进行该反应。该修改形式用于制备
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(来自3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯);和
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯。
在该程序的另一修改形式中,添加水作为共溶剂。该修改形式用于制备5-(2,4-二氟苯基)噻吩-2-甲醛(来自5-溴噻吩-2-甲醛)和5-(3-甲氧基苯基)噻吩-2-甲醛。
可对该程序进一步进行修改,使用碳酸氢钠作为碱来代替磷酸钾,以DME和水作为溶剂。这一修改形式用于制备4'-甲基-[2,3'-联噻吩]-5-甲醛[来自3-溴-4-甲基噻吩和(5-甲酰基噻吩-2-基)硼酸];5-(3-(三氟甲氧基)苯基)噻吩-2-甲醛(来自5-溴噻吩-2-甲醛)和5-(2,6-二甲基苯基)噻吩-2-甲醛。
该程序还在DMF而非DME中,以水作为共溶剂,在80℃与90℃之间的温度下进行,以制备(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',5'-二氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',5'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4'-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',4'-二氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',6'-二氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4'-氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',4'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(联苯-4-基)丙酸叔丁酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',5'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',6'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',4'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',3'-二氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4'-氟-3'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',3'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(苄基((R)-1-苯基乙基)氨基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二氟-6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',6-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二氟-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',6,6'-三甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',6,6'-三氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-氟-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3',5-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二氟-5-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二氟-5-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-氟-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-氟-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2-氟联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(6-氟-2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',6'-二甲基联苯-4-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-甲基联苯-4-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(4-氟联苯-3-基)丙酸乙酯;
3-(3'-乙酰基联苯-3-基)-3-(三苯甲基氨基)丙酸乙酯(来自2-3);
3-(4'-乙酰基联苯-3-基)-3-(三苯甲基氨基)丙酸乙酯;
2'-甲基-6-(三氟甲氧基)联苯-3-甲醛(来自24-1);
6-(三氟甲氧基)联苯-3-甲醛(来自3-溴-2-甲基苯甲醛);
2-甲基联苯-3-甲醛(来自3-溴-4-甲氧基苯甲醛);
6-甲氧基-2',6'-二甲基联苯-3-甲醛(来自3-溴-4-甲氧基苯甲醛);
3'-氯-6-甲氧基联苯-3-甲醛;
3'-氯-6-甲基联苯-3-甲醛(来自3-溴-4-甲基苯甲醛);
5,6-二甲氧基联苯-3-甲醛(来自3-溴-5,6-二甲氧基苯甲醛);
3-(1-(三异丙基硅基)-1H-吡咯-3-基)苯甲醛(来自3-溴苯甲醛和1-(三异丙基硅基)-1H-吡咯-3-硼酸);
3-(吡嗪-2-基)苯甲醛(来自3-甲酰基苯基硼酸和碘吡嗪);
3-(6-甲氧基吡啶-2-基)苯甲醛(来自3-甲酰基苯基硼酸和2-溴-6-甲氧基吡啶);
3-(1-甲基-1H-吡唑-4-基)苯甲醛(来自3-甲酰基苯基硼酸和16-1);
3-(噻唑-2-基)苯甲醛(来自3-甲酰基苯基硼酸和2-溴噻唑);
3-(3,5-二甲基异噁唑-4-基)苯甲醛(来自3-甲酰基苯基硼酸和3,5-二甲基-4-碘异噁唑);
4-(2,4-二氟苯基)噻吩-2-甲醛(来自4-溴噻吩-2-甲醛);
4-(3-甲氧基苯基)噻吩-2-甲醛;
4-(2,6-二甲基苯基)噻吩-2-甲醛;
5-(2,5-二氟苯基)噻吩-2-甲醛(来自5-溴噻吩-2-甲醛);
5-(3-氯苯基)噻吩-2-甲醛;
5-(3-氟苯基)噻吩-2-甲醛;
5-(3,5-二甲基异噁唑-4-基)噻吩-2-甲醛(来自5-甲酰基-2-噻吩硼酸和3,5-二甲基-4-碘异噁唑);
3-(6-(2,2,2-三氟乙氧基)联苯-3-基)-3-(三苯甲基氨基)丙酸乙酯(来自3-(3-溴-4-(2,2,2-三氟乙氧基)苯基)-3-(三苯甲基氨基)丙酸乙酯);
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(来自3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯);
3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸乙酯;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;和3-(5'-氯-2',4'-二氟联苯-3-基)-3-(三苯甲基氨基)丙酸乙酯(来自3-1)。
碳酸钾也可用作碱来代替磷酸三钾,以DMF和水作为溶剂。该修改形式用于制备(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-氟-3'-甲氧基联苯-3-基)丙酸乙酯;和
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(来自3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯)。
最后,上述程序使用甲苯和水的非均匀混合物作为共溶剂来完成,以制备(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二氟联苯-3-基)丙酸乙酯;(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',5'-二氟联苯-3-基)丙酸乙酯;和(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-(吡啶-3-基)苯基)丙酸乙酯(来自1-6和3-吡啶硼酸1,3-丙二醇酯)。
步骤8:向1-7(5.49g,11.3mmol)的乙醇(75mL)溶液中,添加冰乙酸(0.4mL),碳载钯金属(Degussa E101 NE/W型,50%H2O,10%Pd,以干重计,1.8g,0.83mmol Pd)。将气氛替代成氢气(在真空与来自气球的氢气之间切换数次),并将反应物搅拌过夜。将混合物通过过滤并将滤液在减压下浓缩。将残余物置于乙酸乙酯中,用饱和碳酸钠水溶液洗涤,并且有机层经硫酸镁干燥,过滤并在减压下浓缩。残余物通过硅胶柱层析(用己烷中的15%、然后40%的乙酸乙酯洗脱,之后用氯仿中的10%甲醇洗脱)纯化,得到(S)-3-氨基-3-(联苯-3-基)丙酸乙酯(1-8,1.89g)。
该程序还用于制备(S)-3-氨基-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',4'-二氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',5'-二氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3-(吡啶-3-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(3',5'-二氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3',5'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4'-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3',4'-二氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',6'-二氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4'-氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',4'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3',4'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(联苯-4-基)丙酸叔丁酯;
(S)-3-氨基-3-(5,6-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(2',5'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',6'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-乙基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4-氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3',4'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',3'-二氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4'-氟-3'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',3'-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)丙酸乙酯;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-氨基丙酸乙酯;
(S)-3-氨基-3-(2',4'-二氟-6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3-(1-乙基-1H-吲哚-6-基)苯基)丙酸乙酯;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-氨基丙酸乙酯;
(S)-3-氨基-3-(3',6-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-氨基丙酸乙酯;
(S)-3-氨基-3-(2',4'-二氟-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',6,6'-三甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',6,6'-三氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-氟-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3',5-二甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',4'-二氟-5-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4-氟-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-氟-3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2-氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(6-氟-2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',6'-二甲基联苯-4-基)丙酸乙酯;
(S)-3-氨基-3-(2'-甲基联苯-4-基)丙酸乙酯;和
(S)-3-氨基-3-(5-(三氟甲氧基)联苯-3-基)丙酸乙酯。
该程序也在50℃下进行以制备
(S)-3-氨基-3-(2',4',5-三氟联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4-甲氧基联苯-3-基)丙酸乙酯;和
(S)-3-氨基-3-(5-氟-2',6'-二甲基联苯-3-基)丙酸乙酯。
还对该程序进行修改,通过用活性炭预处理起始材料和乙酸的乙醇溶液。将混合物在40-50℃下搅拌30分钟至1小时,然后冷却,随后添加钯催化剂,将所述气氛与氢气交换,并如上文所述在室温下完成所述程序,以制备
(S)-3-氨基-3-(2',5'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(2',3'-二甲基联苯-3-基)丙酸乙酯;
和(S)-3-氨基-3-(3'-(三氟甲基)联苯-3-基)丙酸乙酯。
在用活性炭预处理后,还在50℃下进行氢化,以制备
(S)-3-氨基-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯;和
(S)-3-氨基-3-(2',4'-二氟-5-甲基联苯-3-基)丙酸乙酯;和
(S)-3-氨基-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯。
还可修改原始程序,以在通过过滤之后,浓缩粗制反应混合物的滤液,来分离作为乙酸盐的产物。该修改形式得到(S)-3-氨基-3-(5-氟-2',6'-二甲基联苯-3-基)丙酸乙酯乙酸盐;和(S)-3-氨基-3-(2',4'-二氟联苯-4-基)丙酸叔丁酯乙酸盐。
步骤9:在干燥氮气氛下,将1-5(121mg,0.67mmol)和1-8(800mg,3.86mmol)的DMF(1.3mL)悬浮液加热至70℃过夜,冷却至室温,然后用水稀释。将所得混合物用二氯甲烷萃取三次,并且将合并的有机层经MgSO4干燥并过滤。将滤液在减压下浓缩,所得残余物通过硅胶色谱(用己烷中的5%至75%乙酸乙酯进行梯度洗脱)纯化,得到(S)-3-(联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(1-9,120mg)。
对于该转化和下述修改形式,温度在50℃至90℃之间变化,结果没有显著差异。通过TLC监控反应的进展以确保完成,并且根据需要调整时间和温度。该程序还用于制备
(S)-3-(联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-10;
3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸乙酯1-11;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯1-12;
(S)-3-(2'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-13;
(S)-3-(6-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-14;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸乙酯1-15;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-16;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-17;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-18;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸乙酯1-19;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸乙酯1-20;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸乙酯1-21;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸乙酯1-22;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸乙酯1-23;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-24;
(S)-3-(3',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-25;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯1-26;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸乙酯1-28,
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-29;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-30;
(S)-3-(2',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-31;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-33;
(S)-3-(2',3'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-34;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸乙酯1-35;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-36;
(S)-3-(3'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-37;
(S)-3-(4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-38;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-39;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-40;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-41;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-42;
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-43;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-44;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-45;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸乙酯1-46;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-47;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯1-48;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-49;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸乙酯1-50;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-51;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-52;
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-53;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸乙酯1-54;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-55;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-56;
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-57;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-58;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-59;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-60;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯1-61;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯1-62;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸乙酯1-63;
(S)-3-(2'-乙基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-64;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-65;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-66;
(S)-3-(3',4'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-67;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-68;
(S)-3-(4'-氟-3'-甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-69;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸乙酯1-70;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-71;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸乙酯1-72;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯1-73;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-74;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-75;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-76;
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-77;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-78;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-79;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯1-80;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-81;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-82;
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-83;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-84;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸乙酯1-85;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-86;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-4-甲基-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸乙酯1-87;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-88;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-89;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-91;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸乙酯1-92;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-93;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-94;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-95;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-96;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-97;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-99;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯1-100;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸乙酯1-101;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-102;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-103;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸乙酯1-104;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-105;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-106;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-107;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-108;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-109;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-110;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-111;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸乙酯1-112;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-113;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯1-114;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-115;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-116;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸乙酯1-117;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸乙酯1-118;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-119;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸乙酯1-120;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(5-羟基-2-甲基-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸乙酯1-121;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-122;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-123;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-124;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯1-125;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-126;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-127;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-128;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-129;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸乙酯1-130;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-131;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-132;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-133;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-134;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯1-135;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-136;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-137;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-138;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-139;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-140;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯1-141;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-142;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸乙酯1-143;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-144;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-148;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-149;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-150;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-151;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-152;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-153;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸乙酯1-155;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯1-156;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯1-157;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯1-158;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-159;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-160;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-161;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-162;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-165;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-166;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-167;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基联苯-3-基)丙酸乙酯1-168;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯1-169;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯1-170;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯1-171;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-172;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸乙酯1-173;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯1-174;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-175;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-180;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-181;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸乙酯1-185;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-186;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸乙酯1-187;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸乙酯1-188;
(S)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸乙酯1-189;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸乙酯1-190;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-191;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-192;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-196;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸乙酯1-200;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸乙酯1-201;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸乙酯1-202;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸乙酯1-203;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯1-205;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯1-206;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-207;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-208;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-209;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸乙酯1-210;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-211;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸乙酯1-212;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸乙酯1-213;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-216;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸乙酯1-217;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-219;
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-220,
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-221
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-222,
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-223,
还通过添加碱来修改程序。该修改形式用于胺起始材料已作为盐酸盐或乙酸盐分离时的所有情况,但有时也用于游离碱性胺。碳酸氢钠用于制备:
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯1-163;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯1-164;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-176;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-177;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-178;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-179;
(S)-3-(2-氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-182;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-183;
和(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-184。
3-(3'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-198;
和3-(4'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-199。二异丙基乙胺用于制备(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-215;
N-甲基吗啉用于制备(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-90;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸乙酯1-98;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯1-145;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-146;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-147;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯1-154;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-193;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-194;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯1-195;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯1-204和
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸乙酯1-214;并且最后,三乙胺用于制备(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸乙酯1-27;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯1-32;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯1-195;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸乙酯1-197;和
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯1-218。
步骤10:在室温下,向1-9(120mg,0.266mmol)的THF(4mL)溶液中,添加氢氧化钠(2N,2mL)和甲醇(1mL)。将混合物搅拌2小时,并在旋转蒸发器上去除有机溶剂。将剩余的水性溶液用水稀释,并用HCl(2N)酸化。过滤所得悬浮液,用水洗涤。将固体在真空下干燥,得到(S)-3-(联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸(1-224,96mg)。
该程序还用于制备
(S)-3-(联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-225;
3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸1-226;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-227;
(S)-3-(2'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-228;
(S)-3-(6-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-229;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-230;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸1-231;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-232;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-233;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-234;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸1-235;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸1-236;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸1-237;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸1-238;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸1-239;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-240;
(S)-3-(3',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-241;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸1-242;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸1-243;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲基)联苯-3-基)丙酸1-244;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸1-245;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸1-246;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-247;
(S)-3-(2',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-248;
(S)-3-(2',3'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-249;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸1-250;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-251;
(S)-3-(3'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-252;
(S)-3-(4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-253;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸1-254;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-255;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-256;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-257;
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-258;
3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-259;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-260;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸1-261;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-262;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸1-263;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-264;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸1-265;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-266;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-267;
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-268;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸1-269;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-270;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-271;
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-272;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-273;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-274;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-275;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸1-276;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸1-277;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸1-278;
(S)-3-(2'-乙基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-279;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-280;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-281;
(S)-3-(3',4'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-282;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-283;
(S)-3-(4'-氟-3'-甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-284;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸1-285;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-286;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸1-287;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸1-288;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-289;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-290;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-291;
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-292;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-293;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-294;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸1-295;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-296;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸1-297;
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-298;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸1-299;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸1-300;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸1-301;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-4-甲基-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸1-302;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-303;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-304;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-305;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-306;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸1-307;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-308;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-309;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-310;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-311;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-312;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸1-313;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-314;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸1-315;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸1-316;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-317;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-318;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸1-319;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-320;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-321;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-322;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸1-323;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-324;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-325;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-326;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸1-327;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-328;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸1-329;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-330;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-331;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸1-332;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸1-333;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-334;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸1-335;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(5-羟基-2-甲基-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸1-336;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-337;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-338;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-339;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸1-340;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-341;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-342;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-343;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-344;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸1-345;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-346;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-347;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-348;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-349;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸1-350;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-351;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-352;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-353;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-354;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸1-355;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸1-356;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-357;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸1-358;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-359;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸1-360;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-361;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-362;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-363;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-364;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-365;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-366;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-367;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-368;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸1-369;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸1-370;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸1-371;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸1-372;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸1-373;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-374;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-375;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-376;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-377;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸1-378;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸1-379;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-380;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-381;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-382;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基联苯-3-基)丙酸1-383;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸1-384;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-385;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸1-386;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-387;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸1-388;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸1-389;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-390;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-391;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-392;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-393;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-394;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-395;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-396;
(S)-3-(2-氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-397;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-398;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-399;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸1-400;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-401;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸1-402;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸1-403;
(S)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸1-404;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸1-405;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-406;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-407;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-408;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-409;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-410;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸1-411;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸1-412;
3-(3'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-413;
3-(4'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-414;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸1-415;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸1-416;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸1-417;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸1-418;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸1-419;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸1-420;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸1-421;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸1-422;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸1-423;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-424;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸1-425;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-426;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸1-427;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸1-428;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸1-429;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-430;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸1-431;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸1-432;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-433;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸1-434,
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-435,
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸1-436。
在(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸的制备期间,使产物从乙酸乙酯中结晶。
步骤11:向1-224(96mg,0.228mmol)的不含抑制剂的四氢呋喃(2.5mL)溶液中,添加氢氧化钠水溶液(0.1000N,4.57mL,0.457mmol)。将混合物短暂加热至40℃以得到均匀混合物,并且通过旋转蒸发去除四氢呋喃。将混合物用去离子水稀释,然后在干冰/丙酮浴中冷冻并冻干,得到呈蓬松白色粉末的(S)-3-(联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠(1-437,115mg)。(MS[M+H+]+:计算值:422.17;测量值:422.09;IC50<20nM)。
该方法还用于制备:
(S)-3-(联苯-3-基)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-438(MS[M+H+]+:计算值:436.19;测量值:436.05;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸钠1-439(MS[M+H+]+:计算值:529.21;测量值:529.21);α4β1IC50=>200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-440(MS[M+H+]+:计算值:436.19;测量值:436.11;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-氟联苯-3-基)丙酸钠1-441(MS[M+H+]+:计算值:440.16;测量值:440.04;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟联苯-3-基)丙酸钠1-442(MS[M+H+]+:计算值:440.16;测量值:440.10;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-443(MS[M+H+]+:计算值:450.20;测量值:450.14;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸钠1-444(MS[M+H+]+:计算值:450.20;测量值:450.11;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-445(MS[M+H+]+:计算值:411.17;测量值:411.10;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-446(MS[M+H+]+:计算值:458.15;测量值:458.07;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-447(MS[M+H+]+:计算值:458.15;测量值:458.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸钠1-448(MS[M+H+]+:计算值:436.19;测量值:136.15;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸盐1-449(MS[M+H+]+:计算值:452.18;测量值:452.11;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸钠1-450(MS[M+H+]+:计算值:436.19;测量值:436.07;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸钠1-451(MS[M+H+]+:计算值:436.19;测量值:435.96;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-p1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸钠1-452(MS[M+H+]+:计算值:423.17;测量值:423.15;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-453(MS[M+H+]+:计算值:458.15;测量值:458.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3',5'-二甲基联苯-3-基)丙酸钠1-454(MS[M+H+]+:计算值:450.20;测量值:450.08;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸钠1-455;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲基)联苯-3-基)丙酸钠1-457(MS[M+H+]+:计算值:490.16;测量值:490.10;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸钠1-457(MS[M+H+]+:计算值:506.15;测量值:506.14;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-458(MS[M+H+]+:计算值:458.15;测量值:458.15;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5'-二甲基联苯-3-基)丙酸钠1-459(MS[M+H+]+:计算值:450.20;测量值:450.08;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸钠1-461(MS[M+H+]+:计算值:506.15;测量值:506.06;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',3'-二甲基联苯-3-基)丙酸钠1-462(MS[M+H+]+:计算值:450.20;测量值:450.10;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲基)联苯-3-基)丙酸钠1-461(MS[M+H+]+:计算值:490.16;测量值:490.08;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸钠1-463(MS[M+H+]+:计算值:439.16;测量值:438.98;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-464(MS[M+H+]+:计算值:458.15;测量值:458.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-氟联苯-3-基)丙酸钠1-465(MS[M+H+]+:计算值:440.16;测量值:440.05;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-氟联苯-3-基)丙酸钠1-466(MS[M+H+]+:计算值:440.16;测量值:440.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸钠1-467(MS[M+H+]+:计算值:506.15;测量值:505.97;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-468(MS[M+H+]+:计算值:482.19;测量值:481.99;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-469(MS[M+H+]+:计算值:482.19;测量值:482.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-3-基)丙酸钠1-470(MS[M+H+]+:计算值:450.20;测量值:449.97;α4β1IC50=<20nM:α4β7IC50=<200nM;
3-(4'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-471(MS[M+H+]+:计算值:456.13;测量值:455.91;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-472(MS[M+H+]+:计算值:456.13;测量值:455.95;α4β1IC50=<200nM:α4β7IC50=nd;
3-(2'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-473(MS[M+H+]+:计算值:456.13;测量值:455.93;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸钠1-474(MS[M+H+]+:计算值:490.16;测量值:489.96;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-475(MS[M+H+]+:计算值:482.19;测量值:481.95;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸钠1-476(MS[M+H+]+:计算值:453.18;测量值:452.96;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-477(MS[M+H+]+:计算值:482.19;测量值:481.96;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸钠1-478(MS[M+H+]+:计算值:424.16;测量值:423.92;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-479(MS[M+H+]+:计算值:482.19;测量值:481.95;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸钠1-482(MS[M+H+]+:计算值:412.15;测量值:411.90;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-483(MS[M+H+]+:计算值:439.20;测量值:438.95;α4β1IC50=<20nM:α4β7IC50=nd;
3-(3',5'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-486(MS[M+H+]+:计算值:490.09;测量值:489.87;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-487(MS[M+H+]+:计算值:458.15;测量值:458.02;α4β1IC50=<20nM:α4β7IC50=>200nM;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-488(MS[M+H+]+:计算值:444.14;测量值:443.94;α4β1IC50=<20nM:α4β7IC50=>200nM
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸钠1-489(MS[M+H+]+:计算值:466.20;测量值:465.97;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸钠1-490(MS[M+H+]+:计算值:466.20;测量值:465.96;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸钠1-491(MS[M+H+]+:计算值:520.17;测量值:519.91;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-乙基联苯-3-基)丙酸钠1-492(MS[M+H+]+:计算值:450.20;测量值:449.95;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟联苯-3-基)丙酸钠1-493(MS[M+H+]+:计算值:440.16;测量值:439.93;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-494(MS[M+H+]+:计算值:430.12;测量值:429.89;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3',4'-二甲基联苯-3-基)丙酸钠1-495(MS[M+H+]+:计算值:450.20;测量值:449.97;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-496(MS[M+H+]+:计算值:458.15;测量值:457.90;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-氟-3'-甲基联苯-3-基)丙酸钠1-497(MS[M+H+]+:计算值:454.18;测量值:453.91;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸钠1-498(MS[M+H+]+:计算值:411.17;测量值:410.87;α4β1IC50=>200nM:α4β7IC50=nd;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-499(MS[M+H+]+:计算值:456.13;测量值:455.89;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸钠1-500(MS[M+H+]+:计算值:436.19;测量值:435.94;α4β1IC50=>200nM:α4β7IC50=nd;
(S)-3-(3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-501(MS[M+H+]+:计算值:438.17;测量值:437.93;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-502(MS[M+H+]+:计算值:436.19;测量值:436.03;α4β1IC50=<20nM:α4β7IC50=<200nM;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-503(MS[M+H+]+:计算值:492.11;测量值:491.83;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-504(MS[M+H+]+:计算值:482.19;测量值:482.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-505(MS[M+H+]+:计算值:408.16;测量值:407.93;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-506(MS[M+H+]+:计算值:442.12;测量值:441.85;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-507(MS[M+H+]+:计算值:397.15;测量值:396.90;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(6-甲氧基吡啶-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-508(MS[M+H+]+:计算值:439.16;测量值:439.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-509(MS[M+H+]+:计算值:456.16;测量值:456.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸钠1-510(MS[M+H+]+:计算值:492.14;测量值:491.97;α4β1IC50=<20nM:α4β7IC50=nd;
3-(2',4'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-511(MS[M+H+]+:计算值:490.09;测量值:489.97;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸钠1-512(MS[M+H+]+:计算值:492.14;测量值:492.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸钠1-513(MS[M+H+]+:计算值:484.17;测量值:484.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸钠1-514(MS[M+H+]+:计算值:492.14;测量值:492.02;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-甲基-7-氧桥-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸钠1-515(MS[M+H+]+:计算值:500.11;测量值:499.95;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-516(MS[M+H+]+:计算值:452.15;测量值:452.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-517(MS[M+H+]+:计算值:466.16;测量值:466.02;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-518(MS[M+H+]+:计算值:448.16;测量值:448.05;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-519(MS[M+H+]+:计算值:474.15;测量值:474.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸钠1-520(MS[M+H+]+:计算值:428.13;测量值:427.92;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-521(MS[M+H+]+:计算值:475.20;测量值:475.10;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-522(MS[M+H+]+:计算值:398.15;测量值:398.02;α4β1IC50=<20nM:a4b7 IC50=nd;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-523(MS[M+H+]+:计算值:450.09;测量值:449.92;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-524(MS[M+H+]+:计算值:468.18;测量值:468.05;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸钠1-526(MS[M+H+]+:计算值:495.15;测量值:494.96;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-527(MS[M+H+]+:计算值:482.19;测量值:482.02;α4β1IC50=<20nM:α4β7IC50=>200nM;
(S)-3-(4-(3-甲氧基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-528(MS[M+H+]+:计算值:444.12;测量值:444.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-529(MS[M+H+]+:计算值:438.17;测量值:438.02;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-530(MS[M+H+]+:计算值:448.07;测量值:447.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-531(MS[M+H+]+:计算值:458.15;测量值:458.02;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸钠1-532(MS[M+H+]+:计算值:414.11;测量值:414.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-533(MS[M+H+]+:计算值:466.20;测量值:466.01;α4β1IC50=<20nM:α4β7IC50=<200nM;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2–二氢吡啶-3-基)脲基)丙酸钠1-534(MS[M+H+]+:计算值:472.13;测量值:472.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-535(MS[M+H+]+:计算值:522.15;测量值:521.95;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-536(MS[M+H+]+:计算值:522.15;测量值:521.98;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-537(MS[M+H+]+:计算值:476.08;测量值:475.94;α4β1IC50=<20nM:α4β7IC50=<200nM;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-538(MS[M+H+]+:计算值:448.07;测量值:447.92;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-539(MS[M+H+]+:计算值:398.15;测量值:398.07;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸钠1-540(MS[M+H+]+:计算值:428.13;测量值:427.96;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-541(MS[M+H+]+:计算值:458.15;测量值:457.96;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3'-甲氧基-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-542(MS[M+H+]+:计算值:452.18;测量值:452.02;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(2,6-二甲基苯基)噻吩-2-基)丙酸钠1-543(MS[M+H+]+:计算值:442.14;测量值:441.91;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-544(MS[M+H+]+:计算值:397.15;测量值:397.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'–三甲基联苯-3-基)丙酸钠1-545(MS[M+H+]+:计算值:450.20;测量值:450.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'–三氟联苯-3-基)丙酸钠1-546(MS[M+H+]+:计算值:462.13;测量值:462.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-547(MS[M+H+]+:计算值:456.16;测量值:456.04;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-548(MS[M+H+]+:计算值:412.16;测量值:411.98;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(2-甲基-5-氧桥-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸钠1-549(MS[M-H+]-:计算值:443.12;测量值:443.10;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-3-基)丙酸钠1-550(MS[M+H+]+:计算值:450.20;测量值:450.00;α4β1IC50=<20nM:α4β7IC50=<200nM;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-551(MS[M+H+]+:计算值:482.19;测量值:481.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-552(MS[M+H+]+:计算值:464.11;测量值:463.98;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸钠1-553(MS[M+H+]+:计算值:452.18;测量值:452.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-554(MS[M+H+]+:计算值:536.16;测量值:535.94;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-555(MS[M+H+]+:计算值:456.13;测量值:456.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-556(MS[M+H+]+:计算值:456.13;测量值:455.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(6-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-557(MS[M+H+]+:计算值:444.14;测量值:443.99;α4β1IC50=>200nM:α4β7IC50=nd;
(S)-3-(5-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-558(MS[M+H+]+:计算值:438.17;测量值:437.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-559(MS[M+H+]+:计算值:398.13;测量值:397.93;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-560(MS[M+H+]+:计算值:427.16;测量值:426.98;α4β1IC50=<20nM:α4β7IC50=>200nM;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-561(MS[M+H+]+:计算值:454.18;测量值:453.99;α4β1IC50=<20nM:α4β7IC50=<20nM;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-562(MS[M+H+]+:计算值:450.09;测量值:449.95;α4β1IC50=<20nM:α4β7IC50=>200nM;
(S)-3-(5-(3-甲氧基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-563(MS[M+H+]+:计算值:444.12;测量值:443.90;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-564(MS[M+H+]+:计算值:468.18;测量值:467.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-565(MS[M+H+]+:计算值:522.15;测量值:521.95;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-566(MS[M+H+]+:计算值:474.15;测量值:473.92;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-568(MS[M+H+]+:计算值:536.16;测量值:535.96;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸钠1-569(MS[M+H+]+:计算值:466.20;测量值:465.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-570(MS[M+H+]+:计算值:426.15;测量值:425.98;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸钠1-571(MS[M+H+]+:计算值:409.15;测量值:408.99;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-572(MS[M+H+]+:计算值:506.15;测量值:506.12;α4β1IC50=<20nM:α4β7IC50=>200nM;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸钠1-573(MS[M+H+]+:计算值:450.20;测量值:450.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-574(MS[M+H+]+:计算值:458.15;测量值:457.95;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-575(MS[M+H+]+:计算值:472.17;测量值:471.96;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-576(MS[M+H+]+:计算值:506.15;测量值:506.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-577(MS[M+H+]+:计算值:520.17;测量值:520.10;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟-2',6'-二甲基联苯-3-基)丙酸钠1-578(MS[M+H+]+:计算值:468.19;测量值:468.03;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-579(MS[M+H+]+:计算值:466.20;测量值:466.05;α4β1IC50=<20nM:α4β7IC50=<20nM;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸钠1-580(MS[M+H+]+:计算值:480.21;测量值:480.03;α4β1IC50=<20nM:α4β7IC50=<20nM;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-581(MS[M+H+]+:计算值:488.16;测量值:487.98;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3'-甲氧基-5-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-582(MS[M+H+]+:计算值:452.18;测量值:452.02;α4β1IC50=<20nM:α4β7IC50=<200nM;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠1-583(MS[M+H+]+:计算值:462.20;测量值:462.28;α4β1IC50=<20nM:α4β7IC50=<20nM;
(S)-3-(4'-甲基-2,3'-联噻吩-5-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-584(MS[M+H+]+:计算值:434.08;测量值:434.05;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-2,3'-联噻吩-5-基)丙酸钠1-585(MS[M+H+]+:计算值:448.10;测量值:448.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸钠1-586(MS[M+H+]+:计算值:466.20;测量值:466.39;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-587(MS[M+H+]+:计算值:442.14;测量值:442.09;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(2,6-二甲基苯基)噻吩-2-基)丙酸钠1-588(MS[M+H+]+:计算值:456.16;测量值:456.07;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-2',6'-二甲基联苯-3-基)丙酸钠1-589(MS[M+H+]+:计算值:468.19;测量值:468.32;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-590(MS[M+H+]+:计算值:454.18;测量值:454.32;α4β1IC50=<20nM:α4β7IC50=<20nM;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-593(MS[M+H+]+:计算值:456.16;测量值:456.29;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-594(MS[M+H+]+:计算值:510.13;测量值:510.27;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-595(MS[M+H+]+:计算值:524.14;测量值:524.27;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-596(MS[M+H+]+:计算值:438.17;测量值:438.27;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸钠1-597(MS[M+H+]+:计算值:464.22;测量值:464.33;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-598(MS[M+H+]+:计算值:422.17;测量值:422.27;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠1-599(MS[M+H+]+:计算值:436.19;测量值:436.27;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-600(MS[M+H+]+:计算值:454.18;测量值:454.09;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸钠1-601(MS[M+H+]+:计算值:498.09;测量值:498.02;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-602(MS[M+H+]+:计算值:466.20;测量值:466.33;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-3'-甲氧基联苯-3-基)丙酸钠1-603(MS[M+H+]+:计算值:470.17;测量值:470.32;α4β1IC50=<20nM:a4b7 IC50=nd;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-604(MS[M+H+]+:计算值:456.16;测量值:456.17;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-3'-甲氧基联苯-3-基)丙酸钠1-605(MS[M+H+]+:计算值:470.17;测量值:470.19;α4β1IC50=<20nM:α4β77IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-606(MS[M+H+]+:计算值:524.14;测量值:524.18;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-607(MS[M+H+]+:计算值:510.13;测量值:510.15;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-608(MS[M+H+]+:计算值:433.12;测量值:433.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)丙酸钠1-609(MS[M+H+]+:计算值:441.18;测量值:441.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-氟联苯-3-基)丙酸钠1-610(MS[M+H+]+:计算值:440.16;测量值:440.16;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟-2'-甲基联苯-3-基)丙酸钠1-611(MS[M+H+]+:计算值:454.18;测量值:454.16;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-612(MS[M+H+]+:计算值:440.16;测量值:440.14;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸钠1-613(MS[M+H+]+:计算值:414.11;测量值:414.07;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-614(MS[M+H+]+:计算值:450.09;测量值:450.06;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸钠1-615(MS[M+H+]+:计算值:492.14;测量值:492.09;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸钠1-616(MS[M+H+]+:计算值:422.17;测量值:422.14;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(5-甲氧基联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠1-617(MS[M+H+]+:计算值:464.18;测量值:464.16),
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸钠1-618(MS[M+H+]+:计算值:476.14;测量值:476.20),α4β1IC50=>200nM:α4β7IC50=nd;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-619(MS[M+H+]+:计算值:448.07;测量值:448.12),α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-620(MS[M+H+]+:计算值:432.10;测量值:432.06),α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-621(MS[M+H+]+:计算值:444.14;测量值:444.30;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-622(MS[M+H+]+:计算值:458.15;测量值:458.30;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-623(MS[M+H+]+:计算值:458.15;测量值:458.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸钠1-624(MS[M+H+]+:计算值:506.15;测量值:506.11;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸钠1-625;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3'-乙酰基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-626(MS[M+H+]+:计算值:464.18;测量值:463.99;α4β1IC50=<20nM:α4β7IC50=nd;
3-(4'-乙酰基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-627(MS[M+H+]+:计算值:464.18;测量值:463.97;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸钠1-628(MS[M+H+]+:计算值:428.13;测量值:427.92;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸钠1-631(MS[M+H+]+:计算值:520.17;测量值:520.40;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸钠1-632(MS[M+H+]+:计算值:476.14;测量值:476.25;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸钠1-633(MS[M+H+]+:计算值:462.13;测量值:462.29;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-634(MS[M+H+]+:计算值:522.15;测量值:522.30;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸钠1-635(MS[M+H+]+:计算值:536.16;测量值:536.34;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-636(MS[M+H+]+:计算值:436.19;测量值:436.17;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸钠1-637(MS[M+H+]+:计算值:436.19;测量值:436.09;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-4-基)丙酸钠1-638(MS[M+H+]+:计算值:450.20;测量值:450.15;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸钠1-639(MS[M+H+]+:计算值:409.15;测量值:409.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(6-甲氧基哒嗪-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-640(MS[M+H+]+:计算值:440.16;测量值:440.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸钠1-641(MS[M+H+]+:计算值:409.15;测量值:409.00;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-2',6'-二甲基联苯-3-基)丙酸钠1-642(MS[M+H+]+:计算值:468.19;测量值:468.11;α4β1IC50=<20nM:α4β7IC50=<20nM;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-643(MS[M+H+]+:计算值:422.17;测量值:421.95;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-646;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸钠1-647;
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-;
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-649。
在不影响结果的情况下,还使用乙腈或甲醇代替四氢呋喃来实现该转化。该程序还用于制备:
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-567(MS[M+H+]+:计算值:482.19;测量值:482.01;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸钠1-591(MS[M+H+]+:计算值:462.13;测量值:462.28;α4β1IC50=<20nM:α4β7IC50=nd;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸钠1-592(MS[M+H+]+:计算值:476.14;测量值:476.31;α4β1IC50=<20nM:α4β7IC50=nd。
该反应可在不借助于有机溶剂的情况下完成。将起始酸吸收于适当量的氢氧化钠中,并且搅拌直至溶解,必要时进行温和加热。将所得溶液冻干以得到(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸钠1-645(MS[M+H+]+:计算值:452.18;测量值:452.08;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸钠1-456(MS[M+H+]+:计算值:452.18;测量值:452.09;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸钠1-460(MS[M+H+]+:计算值:452.18;测量值:452.09;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-480(MS[M+H+]+:计算值:504.11;测量值:503.86;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3',4'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-481(MS[M+H+]+:计算值:490.09;测量值:489.95;α4β1IC50=<200nM:α4β7IC50=nd;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-484(MS[M+H+]+:计算值:474.12;测量值:473.90;α4β1IC50=<200nM:α4β7IC50=nd;
3-(2',3'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠1-485(MS[M+H+]+:计算值:490.09;测量值:489.91;α4β1IC50=<200nM:α4β7IC50=nd;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠1-629(MS[M+H+]+:计算值:470.15;测量值:470.02;α4β1IC50=<20nM:α4β7IC50=>200nM;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸钠1-630(MS[M+H+]+:计算值:415.11;测量值:414.96;α4β1IC50=<20nM:α4β7IC50=nd。
实施例2
3-氨基-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸乙酯(2-9)的合成
步骤1:将3-溴苯甲醛(50mL,0.43mol)、丙二酸(49.09g,0.47mol)和乙酸铵(49.73g,0.65mol)的无水乙醇(300mL)溶液回流过夜,然后冷却至室温。过滤悬浮液,用己烷洗涤。将固体在真空下干燥,得到呈白色固体的3-氨基-3-(3-溴苯基)丙酸(2-1,94.74g)。
该程序还用于制备3-氨基-3-(3-碘苯基)丙酸;
3-氨基-3-(6-氧代-1,6-二氢吡啶-3-基)丙酸;和
3-氨基-3-(3-溴-4-(2,2,2-三氟乙氧基)苯基)丙酸。
步骤2:向2-1(50g,0.21mol)的无水乙醇(400mL)混合物中,缓慢添加浓硫酸(12.8mL)。将混合物回流过夜,然后冷却至室温,并用饱和碳酸氢钠水溶液小心地淬灭。将混合物用水稀释,然后用乙酸乙酯萃取。用HCl水溶液(2N)将有机层萃取两次。将水性层用NaOH水溶液(2N)碱化,并用乙酸乙酯萃取三次。将这三个有机层合并,用盐水洗涤,经硫酸镁干燥,过滤并在减压下浓缩,得到3-氨基-3-(3-溴苯基)丙酸乙酯(2-2,25g)。
对该程序进行修改,使用亚硫酰氯代替硫酸。该修改形式用于制备3-氨基-3-(3-碘苯基)丙酸乙酯;
3-氨基-3-(6-氧代-1,6-二氢吡啶-3-基)丙酸乙酯;和
3-氨基-3-(3-溴-4-(2,2,2-三氟乙氧基)苯基)丙酸乙酯。
步骤3:在氮气下,向2-2(5.0g,18.4mmol)的二氯甲烷(50mL)溶液中添加三苯甲基溴(tritylbromide)(5.64g,17.5mmol)。将混合物冷却至0℃,并在15分钟的时程内,逐滴添加三乙胺(7.68mL,55.1mmol)。将混合物搅拌2小时,然后倾倒至饱和氯化铵水溶液中。用二氯甲烷将水性层萃取两次,合并的有机层用盐水洗涤,经硫酸镁干燥,过滤并在减压下浓缩,得到呈白色糊状物的3-(3-溴苯基)-3-(三苯甲基氨基)丙酸乙酯(2-3)。
该程序还用于制备3-(3-碘苯基)-3-(三苯甲基氨基)丙酸乙酯(3-1);
3-(6-氧代-1,6-二氢吡啶-3-基)-3-(三苯甲基氨基)丙酸乙酯(5-1),和
3-(3-溴-4-(2,2,2-三氟乙氧基)苯基)-3-(三苯甲基氨基)丙酸乙酯。
步骤4:在0℃,于氮气下向2-氯-3-硝基吡啶(5.00g,31.5mmol)的无水甲醇(20mL)悬浮液中,经30分钟逐滴添加甲醇钠的甲醇(25%,14.4mL,63.1mmol)溶液。将混合物升温至室温并搅拌3小时,然后倾倒至饱和氯化铵水溶液中。用乙酸乙酯将所得混合物萃取三次。合并的有机层经硫酸镁干燥,过滤并在减压下浓缩。将残余物置于四氢呋喃(7mL)和甲醇(7mL)中,并添加碳载钯(10%,催化量)。将混合物置于氢气氛下(在真空与来自气球的氢气之间切换数次)并且搅拌过夜。反应不完全,因此将反应混合物通过过滤,并将滤液用新鲜碳载钯处理并且如前所述置于氢气下。将混合物搅拌7小时,然后通过过滤并浓缩以得到2-甲氧基吡啶-3-胺(2-4,3.91g)。
步骤5:将2-4(500mg,4.03mmol)和盐酸水溶液(6M,2.28mL)的混合物短暂升温,得到均匀溶液,然后冷却至0℃。经5分钟,向所得混合物中逐滴添加亚硝酸钠(305mg,4.43nnol)的去离子水(0.5mL)溶液。将混合物搅拌20分钟并逐滴添加吗啉(0.356mL,4.43mmol),之后添加去离子水(0.5mL)。溶液通过添加氢氧化钠水溶液(1N),调节至pH 7,然后将混合物搅拌1小时。将所得悬浮液过滤,得到呈锈色固体的(E)-4-((2-甲氧基吡啶-3-基)二氮烯基)吗啉(2-5,517mg)。
步骤6:在0℃,于氮气下向2-5(300mg,1.35mmol)的二噁烷(1mL)溶液中逐滴添加四氟硼酸(40%于水中,0.64mL,4.1mmol)。将混合物升温至室温,并添加二乙酸钯(30mg,0.14mmol)和苯基硼酸(329mg,2.70mmol)。将混合物在氮气下搅拌4小时,然后用乙酸乙酯稀释并通过过滤。浓缩滤液,残余物通过硅胶柱层析(用己烷、之后己烷中的5%乙酸乙酯洗脱)纯化,得到呈黄色油状物的2-甲氧基-3-苯基吡啶(2-6,81mg)。
步骤7:向2-6(800mg,4.32mmol)的冰乙酸(20mL)溶液中添加碘化钾(2.15g,13.0mmol)。将混合物加热至回流持续6小时,然后冷却至室温并浓缩。将残余物置于氯仿中并用饱和碳酸氢钠水溶液和盐水洗涤。有机层经硫酸镁干燥,过滤并在减压下浓缩,得到呈黄色粉末的3-苯基吡啶-2(1H)-酮(2-7,350mg)。
该程序还用于制备6-氧代-1,6-二氢吡啶-3-甲醛(来自6-甲氧基-3-吡啶甲醛)。
步骤8:向装有2-3(750mg,1.45mmol)、2-7(373mg,2.19mmol)、碘化铜(I)(38mg,0.29mmol)和碳酸钾(302mg,2.19mmol)的烧瓶中,添加N,N-二甲基甲酰胺(2mL),并将反应物加热至回流,持续6小时。将反应物冷却至室温,用饱和氯化铵稀释并用乙酸乙酯萃取三次。合并的有机层用盐水洗涤,经硫酸镁干燥,过滤并在减压下浓缩。残余物通过硅胶色谱(用己烷、然后己烷中的增加至20%的10%乙酸乙酯洗脱)纯化,得到3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)-3-(三苯基氨基)丙酸乙酯(2-8,220mg)。
步骤9:在室温下,向2-8(202mg,0.334mmol)的丙酮(2mL)溶液中添加盐酸水溶液(2N,2mL)。将混合物搅拌4小时,用氯仿稀释,并用盐酸水溶液萃取三次。通过添加固体碳酸钾,将合并的水性层调节至pH 8,并且用乙酸乙酯萃取三次。将有机层合并且在减压下浓缩,得到3-氨基-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸乙酯(2-9,0.237mmol)。该材料直接用于下一步骤中。
该程序还用于制备3-(3-(1H-吡咯-1-基)苯基)-3-氨基丙酸乙酯;
3-氨基-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸乙酯;
和3-氨基-3-(5'-氯-2',4'-二氟联苯-3-基)丙酸乙酯。
对该程序进行修改,使用乙腈代替丙酮,以制备3-氨基-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸乙酯。对该修改形式的实验程序(workup)进行改变,浓缩粗制混合物,并用醚洗涤固体残余物,以通过过滤来分离作为盐酸盐的产物,得到
3-(3'-乙酰基联苯-3-基)-3-氨基丙酸乙酯盐酸盐;和
3-(4'-乙酰基联苯-3-基)-3-氨基丙酸乙酯盐酸盐。
实施例3
3-(3-(1H-吡咯-1-基)苯基)-3-(三苯甲基氨基)丙酸乙酯(3-2)的合成
步骤1:在氩气氛下,向装有碳酸钾(259mg,1.87mmol)和碘化铜(I)(1.6mg,0.008mmol)的烧瓶中,添加3-1(500mg,0.891mmol,通过实施例2的步骤1至3制备)的二噁烷(0.9mL)溶液、吡咯(0.074mL,1.07mmol)和(1R,2R)-(-)-N,N’-二甲基-1,2-环己二胺(0.0107mL,0.0891mmol)。将混合物加热至110℃过夜,然后冷却至室温,用乙酸乙酯稀释,并用水和盐水洗涤。有机层经硫酸镁干燥,过滤并在减压下浓缩。残余物通过硅胶色谱(用己烷中的10%乙酸乙酯洗脱)纯化,得到3-(3-(1H-吡咯-1-基)苯基)-3-(三苯基氨基)丙酸乙酯(3-2,250mg)。
该程序还用于制备(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(苄基((R)-1-苯基乙基)氨基)丙酸乙酯;和
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(苄基((R)-1-苯基乙基)氨基)丙酸乙酯。修改该程序,使用磷酸钾代替碳酸钾,来制备(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(苄基((R)-1-苯基乙基)氨基)丙酸乙酯。
实施例4
(E)-3-(3-溴-4-甲基苯基)丙烯酸乙酯(4-1)的合成
步骤1:向冷却至0℃的膦酰基乙酸三乙酯(3.59g,16.0mmol)的四氢呋喃(5mL)溶液中,逐渐添加氢化钠(60%的矿物油分散液,0.69g,17.3mmol)。将所得混合物升温至室温并搅拌15分钟。向该混合物中,通过注射器添加3-溴-4-甲基苯甲醛(2.65g,13.3mmol)的四氢呋喃(5mL)溶液。将混合物搅拌1小时,用盐酸水溶液(2N)小心地淬灭,并用乙酸乙酯萃取。有机层干燥,过滤并浓缩,得到(E)-3-(3-溴-4-甲基苯基)丙烯酸乙酯(4-1,3.58g)。
该程序还用于制备(E)-3-(3-溴-4-甲氧基苯基)丙烯酸乙酯;
(E)-3-(5,6-二甲氧基联苯-3-基)丙烯酸乙酯;
(E)-3-(5-溴-2-氟苯基)丙烯酸乙酯;
(E)-3-(2-甲基联苯-3-基)丙烯酸乙酯;
(E)-3-(3-碘苯基)丙烯酸乙酯;
(E)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)丙烯酸乙酯;
(E)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙烯酸乙酯;
(E)-3-(5-溴-2-甲氧基苯基)丙烯酸乙酯;
(E)-3-(3-碘-4-(三氟甲氧基)苯基)丙烯酸乙酯;
(E)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙烯酸乙酯;
(E)-3-(2-氟-3-碘苯基)丙烯酸乙酯;
和(E)-3-(3-溴-5-(三氟甲氧基)苯基)丙烯酸乙酯。
实施例5
3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)-3-(三苯甲基氨基)丙酸乙酯(5-2)的合
成
步骤1:在室温下,向5-1(150mg,0.33mmol)(依照实施例2的步骤7,然后步骤1至3,由6-甲氧基-3-吡啶甲醛制备)和苯基硼酸(80mg,0.66mmol)的二氯甲烷(1.3mL)溶液中,依序添加分子筛(0.6g)、吡啶(0.5mL)和乙酸铜(II)(12mg,0.066mmol)。在搅拌过夜的同时,将空气从填充有氯化钙的干燥管轻轻抽过,穿过所得混合物。将所得混合物用氢氧化铵稀释,并用二氯甲烷萃取三次。将有机层合并,干燥,过滤并在减压下浓缩,得到呈白色泡沫的3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)-3-(三苯甲基氨基)丙酸乙酯(5-2,151mg)。该材料在不经进一步纯化的情况下即可使用。
实施例6
(S)-3-氨基-3-(5-苯基呋喃-2-基)丙酸乙酯(6-3)的合成
步骤1:在-78℃,于氮气下,向(+)-(1S)-薄荷基(R)-对甲苯亚磺酸酯(500mg,1.70mmol)的四氢呋喃(8mL)溶液中,通过注射器添加六甲基二硅氮烷锂(1.0M于四氢呋喃中,2.22mL,2.22mmol)。将混合物搅拌8小时,然后通过注射器添加5-苯基-2-糠醛(322mg,1.87mmol)的四氢呋喃(5mL)溶液。将混合物在-78℃下搅拌3小时,然后用水和醚稀释。用乙酸乙酯将水性层萃取两次,并且将合并的有机层用盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶柱色谱(用己烷中的5%乙酸乙酯洗脱)纯化,得到呈油状物的(R,E)-4-甲基-N-((5-苯基呋喃-2-基)亚甲基)苯亚磺酰胺(6-1,292mg)。
该程序还用于制备(R,E)-4-甲基-N-((1-苯基-1H-吡咯-2-基)亚甲基)苯亚磺酰胺;
(R,E)-4-甲基-N-((4-苯基噻吩-2-基)亚甲基)苯亚磺酰胺;
(R,E)-4-甲基-N-((5-苯基噻吩-2-基)亚甲基)苯亚磺酰胺;
(R,E)-N-((4-(2,4-二氟苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-N-((4-(3-甲氧基苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-N-((4-(3-氯苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-N-((3'-氯-6-甲氧基联苯-3-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-4-甲基-N-(3-(吡嗪-2-基)亚苄基)苯亚磺酰胺;
(R,E)-N-(3-(6-甲氧基吡啶-2-基)亚苄基)-4-甲基苯亚磺酰胺;
(R,E)-N-((4-(2,6-二甲基苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-4-甲基-N-(3-(1-(三异丙基硅基)-1H-吡咯-3-基)亚苄基)苯磺酰胺;
(R,E)-4-甲基-N-(3-(1-甲基-1H-吡唑-4-基)亚苄基)苯亚磺酰胺;
(R,E)-N-((3'-氯-6-甲基联苯-3-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-4-甲基-N-(3-(噻唑-2-基)亚苄基)苯亚磺酰胺;
(R,E)-N-(3-(3,5-二甲基异噁唑-4-基)亚苄基)-4-甲基苯亚磺酰胺(19-1);
(R,E)-4-甲基-N-((4'-甲基-2,3'-联噻吩-5-基)亚甲基)苯亚磺酰胺;
(R,E)-N-((5-(2,6-二甲基苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-4-甲基-N-((5-(3-(三氟甲氧基)苯基)噻吩-2-基)亚甲基)苯亚磺酰胺;
(R,E)-N-((5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-N-((5-(2,5-二氟苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;
(R,E)-4-甲基-N-((6-(三氟甲氧基)联苯-3-基)亚甲基)苯磺酰胺;
(R,E)-N-((5-(3-氯苯基)噻吩-2-基)亚甲基)-4-甲基苯磺酰胺;和
(R,E)-N-((5-(3-氟苯基)噻吩-2-基)亚甲基)-4-甲基苯亚磺酰胺。
步骤2:在-78℃,于氮气下,向乙酸乙酯(0.154mL,1.58mmol)的四氢呋喃(3mL)溶液中,通过注射器添加六甲基二硅氮烷钠(1.0M于四氢呋喃中,1.58mL,1.58mmol)。将所得混合物搅拌30分钟,然后添加6-1(292mg,1.05mmol)的四氢呋喃(4mL)溶液。将混合物在-78℃下搅拌4小时,然后用饱和氯化铵水溶液淬灭。将混合物升温至室温并用乙酸乙酯萃取。有机层经硫酸镁干燥,过滤并浓缩。残余物通过硅胶柱色谱(用己烷中的30%至50%乙酸乙酯洗脱)纯化,得到(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(5-苯基呋喃-2-基)丙酸乙酯(6-2,270mg)。
该程序还用于制备(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(1-苯基-1H-吡咯-2-基)丙酸乙酯;
(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(4-苯基噻吩-2-基)丙酸乙酯;
(S)-3-((R)-5-甲基苯基亚磺酰氨基)-3-(4-苯基噻吩-2-基)丙酸乙酯;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(4-(3-甲氧基苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(3-(吡嗪-2-基)苯基)丙酸乙酯;
(S)-3-(3-(6-甲氧基吡啶-2-基)苯基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(3-(1-(三异丙基硅基)-1H-吡咯-3-基)苯基)丙酸乙酯;
(S)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(3-(噻唑-2-基)苯基)丙酸乙酯;
(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸乙酯;和
(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸乙酯。该程序经修改,以使用醚作为与四氢呋喃的共溶剂。该修改形式用于制备(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(4'-甲基-2,3'-联噻吩-5-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯;和
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯。
步骤3:向6-2(200mg,0.50mmol)的乙醇溶液中,添加三氟乙酸(0.077mL,1.0mmol)。将混合物搅拌2小时,用饱和碳酸氢钠水溶液稀释,并用乙酸乙酯萃取。有机层用盐水洗涤,经硫酸镁干燥,过滤并浓缩,以得到呈黄色油状物的(S)-3-氨基-3-(5-苯基呋喃-2-基)丙酸乙酯(6-3,110mg)。
该程序还用于制备
(S)-3-氨基-3-(1-苯基-1H-吡咯-2-基)丙酸乙酯;
(S)-3-氨基-3-(4-苯基噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(5-苯基噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(3-(吡嗪-2-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(3-(6-甲氧基吡啶-2-基)苯基)丙酸乙酯;
和(S)-3-氨基-3-(3-(噻唑-2-基)苯基)丙酸乙酯。
通过使用2N盐酸代替三氟乙酸来改变该程序。该修改形式用于制备(S)-3-(3-(1H-吡咯-3-基)苯基)-3-氨基丙酸乙酯(来自(S)-3-((R)-4-甲基苯基亚磺酰氨基)-3-(3-(1-(三异丙基硅基)-1H-吡咯-3-基)苯基)丙酸乙酯,也去除三异丙基硅基团),
(S)-3-氨基-3-(4-(2,4-二氟苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(4-(3-氯苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(3'-氯-6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(4-(2,6-二甲基苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(3'-氯-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3-(呋喃-3-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(3-(3,5-二甲基异噁唑-4-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯;
(S)-3-氨基-3-(5-(2,6-二甲基苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(5-(2,5-二氟苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(5-(3-氯苯基)噻吩-2-基)丙酸乙酯;
和(S)-3-氨基-3-(5-(3-氟苯基)噻吩-2-基)丙酸乙酯。
在另一修改形式中,使用二噁烷中的4M氯化氢代替三氟乙酸。该修改形式用于制备(S)-3-氨基-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(5-(2,4-二氟苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯;
(S)-3-氨基-3-(6-苯基吡啶-2-基)丙酸乙酯;
(S)-3-氨基-3-(3-(噻吩-2-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(2',6'-二氯联苯-3-基)丙酸乙酯;
(S)-3-氨基-3-(3-(5-氯噻吩-2-基)苯基)丙酸乙酯;
(S)-3-氨基-3-(3-(4-甲基噻吩-3-基)苯基)丙酸乙酯;
和(S)-3-氨基-3-(3'-氯联苯-3-基)丙酸乙酯。
当通过该修改形式制备(S)-3-氨基-3-(5-苯基吡啶-3-基)丙酸乙酯二盐酸盐时,粗制反应混合物经浓缩,得到盐酸盐。
实施例7
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧
代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(7-5)的合成
步骤1:向7-1(13.1g,30.29mmol,根据实施例1的步骤5和步骤6,由3-硝基肉桂酸制备)的乙醇(136mL)溶液中,添加锌粉(11.88g,181.7mmol)和盐酸水溶液(136mL)。将所得混合物在室温下搅拌2小时,调节至pH 4,并通过过滤。滤液经浓缩,得到呈固体的(S)-3-(3-氨基苯基)-3-(苄基((R)-1-苯基乙基)氨基)丙酸乙酯(7-2,10.6g)。
步骤2:在氮气下,向7-2(1.00g,2.28mmol)的乙醇(9mL)溶液中,添加碳载钯(10%,500mg)。将所述气氛与氢气交换(在真空与来自气球的氢气之间切换数次),并且将混合物搅拌1小时,然后通过过滤并浓缩。将残余物置于醚中并用盐酸水溶液(1N)萃取三次。将合并的水性层用饱和碳酸氢钠水溶液碱化,然后用乙酸乙酯萃取三次。将合并的有机层用盐水洗涤,干燥,过滤并浓缩,得到(S)-3-氨基-3-(3-氨基苯基)丙酸乙酯(7-3,352mg)。
步骤3:将1-4(100mg,0.52mmol)和7-3(161mg,0.77mmol)的N,N-二甲基甲酰胺(2.5mL)混合物加热至60℃并保持6小时,然后冷却至室温。将混合物用乙酸乙酯稀释,用盐酸水溶液(2N)、水和盐水洗涤。将有机层经硫酸镁干燥,过滤并浓缩。残余物通过硅胶柱色谱(用氯仿中的10~20%甲醇洗脱)纯化,得到(S)-3-(3-氨基苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(7-4,166mg)。
该程序还用于制备(S)-3-(3-氨基苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(13-1,来自7-3和5-甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮)。
步骤4:向7-4(91mg,0.23mmol)的冰乙酸(1mL)混合物中,添加2,5-己二酮(0.040mL,0.34mmol),将混合物加热至85℃并保持1小时。将混合物用饱和碳酸氢钠水溶液稀释,并用氯仿萃取三次。将合并的有机层干燥,过滤并浓缩,得到(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(7-5,71mg)。该材料不纯化即使用。
实施例8
5,6-二甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮(8-2)的合成
步骤1:在室温,于氩气下,向4-羟基-6-甲基-3-硝基吡啶酮(998mg,5.87mmol)的N,N-二甲基甲酰胺溶液中,分三份添加氢化钠(60%于矿物油中的分散液,517mg,12.9mmol)。将所得混合物搅拌1小时,并通过注射器添加碘甲烷(0.44mL,7.04mmol)。将混合物搅拌过夜,在此期间已形成固体。将混合物倾倒至己烷中的50%乙酸乙酯中,用乙酸乙酯洗涤反应烧瓶。将所得悬浮液搅拌30分钟,然后过滤,用己烷中的50%乙酸乙酯洗涤。将固体滤饼空气干燥15分钟,然后溶解于水(40mL)中,并用盐酸水溶液(2N,10mL)酸化。将所得混合物搅拌30分钟,在此期间已形成黄色固体。将混合物过滤,用水洗涤,并将固体在真空下干燥过夜,得到呈黄色粉末的4-羟基-1,6-二甲基-3-硝基吡啶-2(1H)-酮(8-1,865mg)。
该程序还用于制备4-羟基-1-甲基-3-硝基吡啶-2(1H)-酮和4-氯-5-甲氧基-2-甲基哒嗪-3(2H)-酮(29-2,来自29-1)。
在另一反应中,对实验程序进行修改,用2N盐酸稀释粗制反应混合物,并用二氯甲烷萃取数次。将有机层干燥,过滤并浓缩。将残余物置于醚中以得到悬浮液,将其过滤,得到呈固体的1-乙基-4-羟基-3-硝基吡啶-2(1H)-酮。
步骤2:在室温,于氩气下,向8-1(860mg,4.67mmol)的N,N-二甲基甲酰胺(15.6mL)溶液中,添加锌粉(1.374g,21.0mmol)和盐酸三甲胺(3.536g,25.7mmol)。将混合物加热至60℃并保持3小时,然后冷却至室温,并且添加一份1,1’-羰基二咪唑(2.27g,14.0mmol)(气体逸出)。将混合物在氩气下加热至80℃并保持2小时,然后热过滤以去除未反应的锌,用N,N-二甲基甲酰胺洗涤。滤液在减压下浓缩,并将残余物置于盐酸水溶液(1N,50mL)中。将烧瓶剧烈涡旋5分钟,然后过滤所得悬浮液,用水洗涤。将固体在真空下干燥,得到呈奶油色粉末的5,6-二甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮(8-2,637mg)。
该程序还用于制备5-甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮。
对该程序进行修改,使用二噁烷中的4M氯化氢代替盐酸三甲胺,以制备5-乙基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮和噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮。
实施例9
4-羟基-1-甲基-6,7-二氢-1H-环戊并[b]吡啶-2(5H)-酮(9-3)的合成
步骤1:在密封管中,将2-氧代环戊并烷羧酸乙酯(5.0mL,33.7mmol)和分子筛的甲胺(2M于四氢呋喃中,17.0mL,34mmol)混合物加热至100℃并保持过夜。将所得混合物冷却至室温,用乙酸乙酯稀释,并通过用乙酸乙酯洗涤的过滤。浓缩滤液,得到呈黄色固体的2-(甲基氨基)环戊-1-烯羧酸乙酯(9-1,5.35g)。
步骤2:在0℃,于氮气下,向9-1(5.35g,31.6mmol)的四氢呋喃(63mL)溶液中,分批添加氢化钠(60%于矿物油中的分散液,1.39g,34.8mmol)。将所得混合物搅拌15分钟,然后逐滴添加乙酰氯(3.2mL,45.0mmol)。将反应物搅拌15分钟,然后从冰浴中移出并再搅拌2小时。将混合物用饱和氯化铵水溶液稀释,并用乙酸乙酯萃取三次。将合并的有机层经硫酸镁干燥,过滤并浓缩,得到呈深黄色油状物的2-(N-甲基乙酰氨基)环戊-1-烯羧酸乙酯(9-2,6.04g)。该材料含有矿物油和其它微量杂质,但未经纯化即使用。
该反应还可使用DMF作为溶剂来进行。该修改形式用于制备3-(N-甲基乙酰氨基)噻吩-2-羧酸甲酯和2-(N-甲基乙酰氨基)烟酸甲酯。
步骤3:在0℃,于氮气下,向9-2(6.04g,来自前一步骤的粗制材料)的四氢呋喃(36mL)溶液中,通过注射器缓慢添加六甲基二硅氮烷锂(1.0M于四氢呋喃中,72.0mL,72.0mmol)。将反应物搅拌15分钟,然后从冰浴中移出,并搅拌4小时。通过添加冰乙酸(4.1mL)淬灭反应,然后浓缩。将残余物置于氯仿中的30%甲醇中,并通过过滤。滤液经浓缩,残余物通过硅胶色谱(用氯仿中的10%甲醇洗脱)进行纯化。将含有产物的级分置于氯仿中,得到悬浮液,将其过滤。将固体在真空下干燥,得到4-羟基-1-甲基-6,7-二氢-1H-环戊并[b]吡啶-2(5H)-酮(9-3,2.107g)。
该程序还用于制备4-羟基-1-甲基-6,7-二氢-1H-环戊并[b]吡啶-2(5H)-酮;
4-羟基-1-甲基-1,8-萘啶-2(1H)-酮;和
7-羟基-4-甲基噻吩并[3,2-b]吡啶-5(4H)-酮。
实施例10
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸乙
酯(10-4)的合成
步骤1:向装有硫酸水溶液(14%,260mL)的烧瓶中,添加3-溴-2-甲基苯胺(5.00mL,40.6mmol)。将混合物回流,并在1小时的时程内逐滴添加亚硝酸钠(3.08g,44.6mmol)的水(溶解所需的最小量)溶液。将混合物再回流30分钟,冷却至室温,并用氯仿萃取三次。将合并的氯仿层用氢氧化钠水溶液(1M)萃取三次。将水性层用浓盐酸酸化并用氯仿萃取三次。将这三份氯仿萃取物合并,经硫酸镁干燥,过滤并浓缩,得到呈棕色固体的3-溴-2-甲基苯酚(10-1,5.63g)。
该程序还用于制备3-溴-4-甲基苯酚。
步骤2:在室温下,将氢氧化铯水合物(6.57g,39.1mmol)和分子筛(15.06g)于N,N-二甲基甲酰胺(75mL)中的混合物搅拌15分钟后,添加10-1(5.63g,30.1mmol)。将混合物搅拌30分钟,并添加碘甲烷(2.44mL,39.1mmol)。将反应物搅拌4小时,然后用乙酸乙酯稀释并通过过滤。滤液经水稀释,并用氢氧化钠水溶液(1N)将水性层调节至pH 9。将有机层用盐水洗涤,经硫酸镁干燥,过滤并浓缩。将残余物置于己烷(250mL)中的5%乙酸乙酯中,并通过短硅胶塞过滤。滤液经浓缩,得到呈黄色液体的1-溴-3-甲氧基-2-甲基苯(10-2,4.57g)。该程序还用于制备2-溴-4-甲氧基-1-甲基苯。
反应还可在密封管中回流时,使用碳酸钾代替碳酸铯来进行。该变型用于制备3-溴-4-(2,2,2-三氟乙氧基)苯甲醛(来自2,2,2-三氟乙基碘)。
步骤3:在-78℃,于氮气下,向10-2(1.00g,4.97mmol)和硼酸三异丙酯(1.72mL,6.46mmol)于甲苯(8mL)和四氢呋喃(2mL)以及四甲基乙二胺(0.99mL,6.46mmol)中的混合物中,在1小时的时程内通过注射器逐滴添加丁基锂(2.5M于己烷中,2.58mL,6.46mmol)。将反应物搅拌1小时,升温至-20℃,用盐酸水溶液(2N,20mL)淬灭,升温至室温并且搅拌45分钟。将所得混合物用乙酸乙酯稀释,并将有机层用盐水洗涤,经硫酸镁干燥并过滤。浓缩滤液,将残余物置于己烷中并且将所得悬浮液过滤。在静置过夜后,更多固体从滤液中沉淀出来,通过过滤收集。将合并的固体在真空下干燥,得到3-甲氧基-2-甲基苯基硼酸(10-3,517mg)。
该程序还用于制备5-甲氧基-2-甲基苯基硼酸。
步骤4:向装有10-3(500mg,3.01mmol)、氟化钾(350mg,6.03mmol)、乙酸钯(II)(34mg,0.15mmol)和2-(二环己基膦基)联苯(106mg,.301mmol)的螺旋帽厚壁管中,添加1-6(993mg,2.01mmol)的二噁烷(3mL)溶液。将混合物置于氮气下,密封并加热至65℃,保持16小时。将混合物冷却至室温,用乙酸乙酯稀释,通过过滤并浓缩。残余物通过硅胶色谱(用己烷中的5%乙酸乙酯洗脱)纯化,得到(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯(10-4,891mg)。
该程序还用于制备(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3'-氯联苯-3-基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',4'-二氟联苯-4-基)丙酸叔丁酯;
(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2'-乙基联苯-3-基)丙酸乙酯(来自26-2和1-溴-2-乙基苯)。
实施例11
1-苯基-1H-吡咯-2-甲醛(11-1)的合成
步骤1:在0℃,于氮气下,合并氧氯化磷(1.30mL,14.0mmol)和N,N-二甲基甲酰胺(1.08mL,14.0mmol),升温至室温并搅拌15分钟。向所得混合物中,通过注射器逐滴添加1-苯基吡咯(2.00g,14.0mmol)的N,N-二甲基甲酰胺(1mL)溶液。将反应物加热至50℃并保持3小时,冷却至室温,用饱和碳酸氢盐水溶液稀释,并搅拌10分钟。将混合物用乙酸乙酯萃取,并且将有机层经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱(用己烷中的10%乙酸乙酯洗脱)纯化,得到1-苯基-1H-吡咯烷-2-甲醛(11-1,581mg)。
实施例12
(S)-3-(3-溴苯基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯(12-2)
步骤1:在室温,于氮气下向3-溴苯甲醛(0.33mL,2.72mmol)和(R)-(+)-2-甲基-2-丙烷亚磺酰胺(300mg,2.49mmol)的二氯甲烷(5mL)溶液中,添加硫酸铜(II)(788mg,4.94mmol)。将混合物搅拌过夜,通过过滤并浓缩。残余物通过硅胶色谱纯化,得到呈淡黄色油状物的(R,E)-N-(3-溴亚苄基)-2-甲基丙烷-2-亚磺酰胺(12-1,561mg)。
该材料还用于制备(R,E)-2-甲基-N-(3-(噻吩-2-基)亚苄基)丙烷-2-亚磺酰胺;
(R,E)-N-((2',6'-二氯联苯-3-基)亚甲基)-2-甲基丙烷-2-亚磺酰胺;
(R,E)-N-(3-(5-氯噻吩-2-基)亚苄基)-2-甲基丙烷-2-亚磺酰胺;
(R,E)-2-甲基-N-(3-(4-甲基噻吩-3-基)亚苄基)丙烷-2-亚磺酰胺;
(R,E)-N-(3-(6-甲氧基哒嗪-3-基)亚苄基)-2-甲基丙烷-2-亚磺酰胺;
(R,E)-N-(3-(呋喃-3-基)亚苄基)-2-甲基丙烷-2-亚磺酰胺;
(R,E)-N-((5-(2,4-二氟苯基)噻吩-2-基)亚甲基)-2-甲基丙烷-2-亚磺酰胺;和
(R,E)-N-((5-(3-甲氧基苯基)噻吩-2-基)亚甲基)-2-甲基丙烷-2-亚磺酰胺。
步骤2:在0℃,于氮气下向二异丙胺(0.612mL,4.37mmol)的四氢呋喃(10mL)溶液中,通过注射器添加正丁基锂(2.5M于己烷中,1.75mL,4.38mmol)。将所得混合物搅拌30分钟,冷却至-78℃,并逐滴添加乙酸乙酯(0.406mL,4.16mmol)。将反应物搅拌30分钟,添加三异丙氧基氯化钛(IV)(1.0M于己烷中,8.73mL,8.73mmol),将混合物再搅拌30分钟。向所得混合物中添加12-1(600mg,2.08mmol)的四氢呋喃(8mL)中溶液。将反应物在-78℃下搅拌3小时,添加饱和氯化铵水溶液(10mL)并将混合物升温至室温。倾析有机层并保存。将混合物的剩余部分用乙酸乙酯和水稀释,并搅拌20分钟。分离各相,并用乙酸乙酯将水性层萃取三次。将所有有机相合并,用盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱纯化,得到呈透明油状物的(S)-3-(3-溴苯基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯(12-2,600mg)。
该反应还用于制备(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(3-(噻吩-2-基)苯基)丙酸乙酯;
(S)-3-(2',6'-二氯联苯-3-基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯;
(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸乙酯;
(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(3-(呋喃-3-基)苯基)丙酸乙酯;
(S)-3-(5-溴吡啶-3-基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯(20-2);和
(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(6-苯基吡啶-2-基)丙酸乙酯。
实施例13
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-
3-基)脲基)丙酸乙酯(13-2)的合成
步骤1:向13-1(181mg,0.484mmol,根据实施例7的步骤3中所述的程序,由7-3和5-甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮制备)的四氢呋喃(1.7mL)溶液中,添加冰乙酸(2.2mL)和2,5-二甲氧基四氢呋喃(0.100mL,0.774mmol)。将混合物加热至75℃并过夜,冷却至室温,用水稀释,通过小心添加固体碳酸氢钠加进行碱化,并用氯仿萃取三次。将合并的有机层经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱(用乙酸乙酯洗脱)纯化,得到(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯(13-2,87.5mg)。
实施例14
3-(噻吩-2-基)苯甲醛(14-1)的合成
步骤1:在室温,于氮气下,向3-溴苯甲醛二乙缩醛(1.495g,5.77mmol)和双(三苯基膦)二氯化钯(II)(206mg,0.29mmol)于二甲氧基乙烷(30mL)中的混合物中,添加2-噻吩硼酸(1.189g,9.29mmol)和碳酸氢钠水溶液(1M,29mL)。将混合物加热至回流并过夜,冷却至室温,并用乙酸乙酯稀释。将有机层用水和盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱纯化,得到2-(3-(二乙氧基甲基)苯基)噻吩和14-1的混合物。将该材料置于1:1甲醇:水(30mL)中,并添加浓硫酸(1mL)。将混合物加热至回流并保持2小时,冷却至室温并浓缩。将残余物置于乙酸乙酯中,用饱和碳酸氢钠水溶液、水和盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱(用己烷中的10%乙酸乙酯洗脱)纯化,得到呈黄色油状物的3-(噻吩-2-基)苯甲醛(14-1,661mg)。
在该程序的修改形式中,第一步骤中的粗制反应混合物用2N盐酸酸化,以水解缩醛。然后,在水解完成后,采用第二步骤的实验程序,得到3-(5-氯噻吩-2-基)苯甲醛。
实施例15
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-
基)苯基)丙酸钠(15-2)的合成
步骤1:向15-1(30.4mg,0.0695mmol,根据实施例1的步骤9中所述的程序,由(S)-3-氨基-3-(3-(吡嗪-2-基)苯基)丙酸乙酯和5-甲基噁唑并[4,5-c]吡啶-2,4(3H,5H)-二酮制备)的乙腈(0.25mL)溶液中,添加氢氧化钠水溶液(0.1004N,0.69mL,0.0693mmol)。将混合物搅拌过夜,并添加额外的氢氧化钠水溶液(0.1004N,0.69mL,0.0693mmol)。将混合物在室温下搅拌3小时,然后在35℃下搅拌3小时。将所得混合物用乙醚萃取,分离水性层,冷冻并冻干,得到呈灰白色固体的(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸钠(15-2,30.3mg,MS[M+H+]+:计算值:410.15;测量值:410.02;α4β1IC50=<20nM:α4β7IC50=nd。
该程序还用于制备(S)-3-(3-(6-甲氧基吡啶-2-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠(MS[M+H+]+:计算值:439.16;测量值:439.00;α4β1IC50=<20nM:α4β7IC50=nd。
实施例16
4-碘-1-甲基-1H-吡唑(16-1)的合成
步骤1:在0℃,于氮气下,向4-碘吡唑(675mg,3.48mmol)于N,N-二甲基甲酰胺(13mL)中的混合物中,添加氢化钠(60%于矿物油中的分散液,167mg,4.18mmol)。将所得混合物搅拌30分钟,并添加碘甲烷(0.217mL,3.48mmol)。将所得混合物升温至室温,并搅拌过夜。通过小心添加盐酸水溶液(2N)将混合物淬灭,然后用碳酸氢钠水溶液碱化,并用氯仿萃取三次。将有机层合并,经硫酸镁干燥,过滤并浓缩,得到4-碘-1-甲基-1H-吡唑(16-1)。该材料含有矿物油和其它杂质,但未经纯化即使用。
该程序还用于制备6-溴-1-乙基-1H-吲哚;
3-(甲基氨基)噻吩-2-羧酸甲酯(来自3-氨基噻吩-2-羧酸甲酯);和
2-(甲基氨基)烟酸甲酯(来自2-氨基烟酸甲酯)。
实施例17
(E)-3-(3-溴-5-甲氧基苯基)丙烯酸乙酯(17-1)的合成
步骤1:在室温,于氮气下,向3,5-二溴苯甲醚(1.01g,3.79mmol)的乙腈(20mL)溶液中,依序添加乙酸钯(II)(42mg,0.19mmol)、三(邻甲苯基)膦(116mg,0.38mmol)、丙烯酸乙酯(0.36mL,3.38mmol)和三乙胺(2.10ml,15.1mmol)。将混合物加热至回流4小时,冷却至室温,用乙酸乙酯稀释,并用水和盐水洗涤。将有机层经硫酸镁干燥,过滤并浓缩。通过硅胶色谱(用己烷中的5%乙酸乙酯洗脱)纯化残余物。将含有产物的级分合并,浓缩,并将残余物再次色谱分离(用己烷中的3%增加至5%的乙酸乙酯洗脱),得到呈黄色油状物的(E)-3-(3-溴-5-甲氧基苯基)丙烯酸乙酯(17-1,354mg)。
该程序还用于制备(E)-3-(3-溴-5-甲基苯基)丙烯酸乙酯。
在仅存在一个溴的情况下,可使用过量的丙烯酸酯(1.25当量)。该变型用于制备(E)-3-(2',4',5-三氟联苯-3-基)丙烯酸乙酯;
(E)-3-(5-氟-3'-甲氧基联苯-3-基)丙烯酸乙酯;
和(E)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)丙烯酸乙酯。
实施例18
7-羟基-2,3-二氢吲嗪-5(1H)-酮(18-3)的合成
步骤1:在室温,于氮气下,在2小时的时程内向装有硫酸二甲酯(8.90mL,139mmol)的烧瓶中,缓慢添加2-吡咯烷酮(7.20mL,94mmol)。将所得混合物加热至60℃并过夜,然后冷却至室温,并倾倒至冰水中的碳酸钠中。用含少量乙酸乙酯的乙醚将混合物萃取两次,并且用二氯甲烷萃取两次。将醚萃取物干燥,过滤并浓缩,得到5-甲氧基-3,4-二氢-2H-吡咯(18-1,7.8g)。将二氯甲烷萃取物单独干燥,过滤并浓缩,得到额外的18-1(2.87g)。来自二氯甲烷萃取物的材料含有比来自醚萃取物的材料少的杂质,并且未经纯化即使用。
步骤2:在室温下,向装有18-1(2.87g,28.9mmol)的烧瓶中,添加1,3-丙酮二羧酸二乙酯(7.90mL,43.4mmol)和三乙胺(0.45mL,3.2mmol)。将混合物在室温下搅拌过夜,然后加热至35℃并保持3天。将混合物冷却至室温并用醚稀释。过滤所得悬浮液,用醚洗涤。额外的固体从通过过滤收集的滤液中沉淀出来。将合并的固体在真空下干燥,得到呈白色固体的7-羟基-5-氧代-1,2,3,5-四氢吲嗪-8-羧酸乙酯(18-2,2.52g)。
步骤3:将18-2(1.00g,4.5mmol)的浓盐酸(15mL)溶液加热至回流过夜,然后浓缩至干燥,得到7-羟基-2,3-二氢吲嗪-5(1H)-酮(18-3,700mg)。该材料不纯化即使用。
实施例19
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-((R)-4-甲基苯基亚磺酰氨基)丙
酸乙酯(19-2)的合成
步骤1:在室温,于氮气下,向锌粉(300mg,4.65mmol)于四氢呋喃中的混合物中,添加催化量的1,2-二溴乙烷,并将混合物加热至回流持续10分钟。向该回流的混合物中,通过注射器逐滴添加19-1(630mg,1.86mmol,根据实施例6步骤1中所述的程序,由3-(3,5-二甲基异噁唑-4-基)苯甲醛制备)和溴乙酸乙酯(810mg,4.84mmol)于四氢呋喃(6mL)中的溶液。将混合物回流2小时,冷却至室温,用己烷中的25%乙酸乙酯稀释,并用饱和氯化铵水溶液和盐水洗涤。将有机层经硫酸钠干燥并过滤。将滤液通过硅胶塞,用己烷中的25%乙酸乙酯、然后33%乙酸乙酯且最后50%乙酸乙酯的洗涤,得到呈透明玻璃状的(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-((R)-4-甲基苯基亚磺酰氨基)丙酸乙酯(19-2,360mg)。
该程序还用于制备(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸乙酯;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-((R)-1,1-二甲基乙基亚磺酰氨基)丙酸乙酯;
(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯;和
(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(5-(三氟甲基)联苯-3-基)丙酸乙酯。
实施例20
(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(5-苯基吡啶-3-基)丙酸乙酯(20-
3)的合成
步骤1:在室温,于氮气下,向5-溴烟碱醛(500mg,2.69mmol)的四氢呋喃(10mL)溶液中,添加(R)-(+)-2-甲基-2-丙烷亚磺酰胺(358mg,2.95mmol)和乙氧化钛(IV)(1.11mL,5.38mmol)。将所得混合物搅拌过夜,用乙酸乙酯和盐水稀释,再搅拌20分钟,并通过过滤。从滤液中分离有机层,经硫酸镁干燥,过滤并浓缩,得到呈黄色固体的(R,E)-N-((5-溴吡啶-3-基)亚甲基)-2-甲基丙烷-2-亚磺酰胺(20-1,771mg)。
该程序还用于制备(R,E)-2-甲基-N-((6-苯基吡啶-2-基)亚甲基)丙烷-2-亚磺酰胺;和
(R,E)-2-甲基-N-((5-(三氟甲基)联苯-3-基)亚甲基)丙烷-2-亚磺酰胺。
步骤2:在氮气下,向装有20-2(250mg,0.66mmol,根据实施例12步骤2中所述的程序,使用20-1制备)、苯基硼酸(121mg,0.99mmol)、氟化钾(193mg,2.19mmol)、三(二亚苄基丙酮)二钯(0)(9mg,0.01mmol)和四氟硼酸三叔丁基鏻(6mg,0.02mmol)的带螺旋帽厚壁管中,添加四氢呋喃(2mL)。将管密封,加热至60℃过夜,然后冷却至室温。将所得混合物用乙酸乙酯稀释,并通过过滤,用乙酸乙酯洗涤。浓缩滤液并通过硅胶柱色谱(用二氯甲烷中的10%甲醇洗脱)纯化残余物,得到呈白色固体的(S)-3-((R)-1,1-二甲基乙基亚磺酰氨基)-3-(5-苯基吡啶-3-基)丙酸乙酯(20-3,227mg)。
对该程序进行修改,使用在二噁烷而非THF中的碳酸铯而非氟化钾,来制备(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',3'-二甲基联苯-3-基)丙酸乙酯;和(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(2',5'-二甲基联苯-3-基)丙酸乙酯。
实施例21
6-苯基吡啶甲醛(21-2)的合成
步骤1:在室温,于氮气下,向2,6-二溴吡啶(3.50g,14.8mmol)和苯基硼酸(1.80g,14.8mmol)于N,N-二甲基甲酰胺(20mL)中的混合物中,添加磷酸钾(7.80g,36.7mmol)的水(14mL)溶液和双(三苯基膦)二氯化钯(II)(518mg,0.74mmol)。将混合物脱氧(在真空与氮气之间切换5次),并加热至80℃过夜。将混合物冷却,用乙酸乙酯稀释,并用水和盐水洗涤。将有机层干燥,过滤并浓缩。残余物通过硅胶柱层析(用己烷中的5%乙酸乙酯洗脱)纯化,得到含有2-溴-6-苯基吡啶(21-1,2.70g)的混合物,该混合物不经进一步纯化即使用。
该程序还用于制备:
3-溴-5-氟-3'-甲氧基联苯(来自1,3-二溴-5-氟苯);
3-溴-5-氟-3'-(三氟甲氧基)联苯;和
3'-溴-2,4,5'-三氟联苯。
步骤2:在氮气下,向冷却至-78℃的21-1(2.70g,来自前一步骤的混合物)的四氢呋喃(50mL)溶液中,逐滴添加正丁基锂(2.5M于己烷中,5.8mL,14.5mmol)。将混合物搅拌45分钟,然后添加N,N-二甲基甲酰胺(1.80mL,23mmol)。将混合物在-78℃下搅拌1小时,升温至室温,用水淬灭,并用乙酸乙酯萃取。将有机层用水洗涤三次,用盐水洗涤一次,经硫酸钠干燥,过滤并浓缩。残余物通过硅胶柱色谱(用己烷中的2.5%、之后5%乙酸乙酯洗脱)纯化,得到呈黄色油状物的6-苯基吡啶甲醛(21-2,1.24g)。
实施例22
(S)-3-(联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲
基)丙酸(22-3)的合成
步骤1:在氮气下,向4-溴肉桂酸(51.1g,225mmol)于二氯甲烷(750mL)中的混合物中,添加亚硫酰氯(33mL,450mmol)。将混合物加热至回流过夜,冷却至室温并浓缩。将残余物置于甲苯(600mL)中,并添加叔丁醇(110mL,1.15mol)和碳酸钠(29g,270mmol)。将混合物加热至回流并保持8小时,冷却至室温并浓缩。将残余物置于乙酸乙酯中,并用水和盐水洗涤。将有机层经硫酸镁干燥,过滤并浓缩,得到(E)-3-(4-溴苯基)丙烯酸叔丁酯(22-1,42.6g)。
步骤2:将22-2(259mg,0.542mmol,根据实施例1的步骤6-9中所述的程序,在4个步骤中由22-1制备)于二噁烷(8M,7mL,56mmol)中的氯化氢溶液,在室温下搅拌4小时。将混合物用氢氧化钠水溶液稀释,并用氯仿萃取两次。将水性层用浓盐酸酸化,并用乙酸乙酯萃取两次。将乙酸乙酯层合并,用盐水洗涤,经硫酸镁干燥,过滤并浓缩,得到呈白色固体的(S)-3-(联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸(22-3,161mg)。
该程序还用于制备(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸(来自(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯)。
实施例23
(E)-3-(3-溴-5-氟苯基)丙烯酸乙酯(23-1)的合成
步骤1:在室温,在氩气下,向N,N-二甲基氨基吡啶(211mg,1.73mmol)的N,N-二甲基甲酰胺(40mL)溶液中,添加丙二酸氢乙酯(3.43g,26.0mmol)。在氩气下,将所得混合物连同N,N-二甲基甲酰胺(3mL)冲洗物,一起添加至装有3-溴-5-氟苯甲醛(3.52g,17.3mmol)的烧瓶中。向所得混合物中,添加哌啶(0.17mL,1.7mmol)。将混合物加热至55℃过夜,冷却至室温,并用己烷中的20%乙酸乙酯和水中稀释。有机层用饱和碳酸氢钠水溶液、饱和氯化铵水溶液、水(两次)和盐水洗涤。将所得有机层经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱(SNAP 100KP-Sil柱)纯化,得到呈白色固体的(E)-3-(3-溴-5-氟苯基)丙烯酸乙酯(23-1,3.51g)。
实施例24
3-碘-4-(三氟甲氧基)苯甲醛(24-1)的合成
步骤1:在0℃,向4-(三氟甲氧基)苯甲醛(5.00g,26.3mmol)于三氟甲磺酸(11.6mL,132mmol)中的混合物中,添加N-碘琥珀酰亚胺(5.92g,26.3mmol)。将混合物升温至室温,搅拌过夜,并用水和乙酸乙酯稀释。将有机层用水和盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱(用己烷中的5%乙酸乙酯洗脱)纯化,得到3-碘-4-(三氟甲氧基)苯甲醛(24-1,3.42g)。
实施例25
5-(三氟甲基)联苯-3-甲醛(25-7)的合成
步骤1:向3-硝基-5-三氟甲基苯甲酸(5.00g,21.3mmol)的甲醇(75mL)溶液中,添加碳载钯金属(10%,1.0g)。用氢气替代所述气氛(在真空与来自气球的氢气之间切换数次),并将反应物搅拌6小时。将混合物通过过滤,并将滤液在减压下浓缩,得到呈淡黄色固体的3-氨基-5-(三氟甲基)苯甲酸(25-1,4.36g)。
步骤2:在0℃,向25-1(4.36g,21.3mmol)于水中的悬浮液,添加浓硫酸(10.6mL,191mmol)。搅拌混合物直至固体已完全溶解,并逐滴添加亚硝酸钠(1.47g,21.3mmol)的水(40mL)溶液。将混合物在0℃下搅拌15分钟,然后再回流15分钟。将混合物冷却至室温,并用乙醚萃取三次。将有机层合并,用盐水洗涤,经硫酸镁干燥,过滤并浓缩,得到呈黄色固体的3-羟基-5-(三氟甲基)苯甲酸(25-2,4.06g)。
步骤3:向25-2(2.90g,14.1mmol)的无水乙醇溶液中,添加浓硫酸(0.04mL,催化)。将所得混合物加热至回流并保持3天,冷却至室温,浓缩至约10mL,并用乙酸乙酯稀释。将混合物用水和盐水洗涤,经硫酸镁干燥,过滤并浓缩,得到呈橙色固体的3-羟基-5-(三氟甲基)苯甲酸乙酯(25-3,3.16g)。
步骤4:在0℃,于氮气下,向25-3(2.90g,12.4mmol)和吡啶(1.20mL,15.0mmol)于二氯甲烷(24mL)中的溶液中,通过注射器逐滴添加三氟甲磺酸酐(2.29mL,13.6mmol)。将混合物在0℃下搅拌1小时,然后在室温下搅拌30分钟。将混合物用二氯甲烷稀释并用盐酸(0.5N)和水洗涤。将两次水性洗涤物合并,用二氯甲烷萃取。将有机层合并,经硫酸镁干燥并浓缩。将残余物通过短硅胶垫过滤,用己烷中的15%乙酸乙酯洗涤。浓缩滤液,得到呈黄色油状物的3-(三氟甲基)-5-(((三氟甲基)磺酰基)氧基)苯甲酸乙酯(25-4,3.65g)。
步骤5:在氮气下,向装有苯基硼酸(1.16g,9.50mmol)、氟化钾(1.52g,26.1mmol)、乙酸钯(35mg,0.16mmol)和三环己基膦四氟硼酸盐(61mg,0.17mmol)的压力容器中,添加四氢呋喃(12mL)和25-4(2.90g,7.92mmol)。将容器密封并加热至45℃过夜,冷却至室温,用醚稀释,并通过过滤。浓缩滤液,并通过硅胶色谱(用增加至己烷中的5%醚的己烷洗脱)纯化残余物,得到呈白色固体的5-(三氟甲基)联苯-3-羧酸乙酯(25-5,2.40g)。
步骤6:在0℃,于氮气下,向25-5(2.40g,8.15mmol)的四氢呋喃(16mL)溶液中,逐滴添加氢化铝锂(1.0M于四氢呋喃中,16.3mL,16.3mmol)。将混合物逐渐升温至室温并过夜,然后小心地倾倒至冰冷的硫酸水溶液(10%)中。将所得混合物用乙酸乙酯萃取三次,并且将合并的有机层用盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱(用己烷中的15%乙酸乙酯洗脱)纯化,得到呈白色固体的(5-(三氟甲基)联苯-3-基)甲醇(25-6,1.74g)。
步骤7:在0℃,于氮气下,向25-6(1.70g,6.74mmol)的二氯甲烷(12mL)溶液中,添加三氯异氰脲酸(1.72g,7.41mmol)和2,2,6,6-四甲基哌啶1-氧基(TEMPO,20mg,0.13mmol)。将混合物升温至室温,搅拌30分钟,然后用二氯甲烷稀释并通过过滤。滤液用饱和碳酸氢钠水溶液、盐酸水溶液(1N)和盐水洗涤。将有机层经硫酸镁干燥,过滤并浓缩,得到呈黄色油状物的5-(三氟甲基)联苯-3-甲醛(25-7,1.49g)。
实施例26
(S)-3-氨基-3-(3-(吡啶-2-基)苯基)丙酸乙酯(26-4)的合成
步骤1:在室温,于氮气下,将Pd(CH3CN)2Cl2(39mg,0.15mmol)和DPPF(84mg,0.15mmol)于DMF(5mL)中的混合物搅拌30分钟。向所得混合物中,添加1-6(2.50g,5.05mmol)的DMF(15mL)溶液、双(频那醇基)二硼(bis(pinacolato)diboron)(1.41g,5.56mmol)和乙酸钾(1.49g,15.2mmol)。在氮气下,将所得混合物加热至80℃过夜,然后冷却至室温,并用乙酸乙酯稀释。将混合物用饱和氯化铵水溶液和盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶色谱纯化,得到(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)苯基)丙酸乙酯(26-1,2.42g)。
步骤2:向26-1(1.00g,1.84mmol)的丙酮(50mL)溶液中,添加高碘酸钠(789mg,3.69mmol)、乙酸铵(284mg,3.69mmol)和水(50mL)。将所得混合物在室温下搅拌2天,然后通过旋转蒸发去除丙酮。将水性混合物用氯仿萃取三次,并且将合并的有机层用盐水洗涤,经硫酸镁干燥,过滤并浓缩,得到呈棕色泡沫的3-((S)-1-(苄基((R)-1-苯基乙基)氨基)-3-乙氧基-3-氧代丙基)苯基硼酸(26-2,689mg)。
步骤3:在室温,向已用氩气脱氧(在真空与氩气之间切换数次)的甲苯(2mL)和碳酸钠水溶液(2M,0.93mL,1.86mmol)的混合物中,添加26-2(400mg,0.927mmol)、2-溴吡啶(0.132mL,1.39mmol)和Pd(PPh3)4(107mg,0.093mmol)。在氩气下,将混合物加热至回流并保持18小时,冷却至室温,并用乙酸乙酯稀释。将混合物用盐水洗涤,经硫酸镁干燥,过滤并浓缩,得到呈透明油状物的(S)-3-(苄基((R)-1-苯基乙基)氨基)-3-(3-(吡啶-2-基)苯基)丙酸乙酯(26-3,239mg)。
该程序还用于制备3-(6-甲氧基哒嗪-3-基)苯甲醛(来自3-甲酰基苯基硼酸和3-氯-6-甲氧基哒嗪)。
步骤4:向26-3(239mg,0.514mmol)的乙醇溶液中,添加Pd(OH)2(20%于碳上,293mg,0.417mmol)、甲酸铵(105mg,1.67mmol)和冰乙酸(0.064mL,1.1mmol)。将混合物加热至回流并保持2.3小时,冷却至室温,用乙酸乙酯稀释,并通过过滤。将滤液用饱和碳酸氢钠水溶液和盐水洗涤,经硫酸镁干燥,过滤并浓缩。残余物通过硅胶柱色谱纯化,得到呈透明油状物的(S)-3-氨基-3-(3-(吡啶-2-基)苯基)丙酸乙酯(26-4,115mg)。
实施例27
3-溴-2-甲基苯甲醛(27-2)的合成
步骤1:向硼氢化钠(0.630g,16.7mmol)于THF(82mL)中的悬浮液中,添加3-溴-2-甲基苯甲酸(3.00g,14.0mmol)。搅拌混合物,直至气体逸出停止,然后分小份添加碘(1.77g,6.98mmol)。将混合物在室温下搅拌2小时,然后通过缓慢添加HCl水溶液(2N)小心地淬灭反应。将所得混合物用水稀释,并用醚萃取。将有机层用NaOH水溶液(2N)洗涤三次,用盐水洗涤一次,经硫酸镁干燥,过滤并浓缩,得到呈白色固体的(3-溴-2-甲基苯基)甲醇(27-1,2.79g)。
步骤2:在氮气下,向冷却至-78℃的二甲亚砜(2.99mL,41.8mmol)的二氯甲烷(55mL)溶液中,缓慢添加草酰氯(2.0M于二氯甲烷中,10.4mL,20.8mmol)。将混合物在-78℃下搅拌30分钟,然后通过套管逐滴添加27-1(2.79g,13.9mmol)的二氯甲烷(15mL)溶液。将混合物搅拌1小时,缓慢添加三乙胺(5.8mL,41.8mmol),并且使反应物升温至室温。混合物用饱和碳酸氢钠水溶液、水和盐水洗涤。将有机层经硫酸镁干燥,过滤并浓缩,得到3-溴-2-甲基苯甲醛(27-2,2.76g)。
实施例28
3-(1-乙基-1H-吲哚-6-基)苯甲醛(28-3)的合成
步骤1:在0℃,于氮气下,向28-1(依照实施例1步骤7的程序,由6-溴-1-乙基-1H-吲哚和3-乙氧基羰基苯基硼酸制备,330mg,1.12mmol)的THF溶液中,通过注射器添加氢化铝锂(1.0M于THF中,1.23mL,1.23mmol)。将混合物升温至室温,并搅拌3.5小时。通过向反应物中添加冰来淬灭混合物,将所得混合物经硫酸钠干燥并过滤。浓缩滤液,得到呈浅黄色固体的(3-(1-乙基-1H-吲哚-6-基)苯基)甲醇(28-2,0.30g)。
步骤2:在室温,于氮气下,向28-2(0.30g,1.19mmol)的二氯甲烷(40mL)溶液中,添加活化二氧化锰(85%,1.46g,14.3mmol)。将混合物在室温下搅拌过夜,通过过滤,并浓缩,得到呈黄棕色油状物的3-(1-乙基-1H-吲哚-6-基)苯甲醛(28-3,0.29g)。
实施例29
5-羟基-2-甲基哒嗪-3(2H)-酮(29-4)的合成
步骤1:在室温,向4,5-二氯-2-羟基吡嗪(5.00g,30.3mmol)于甲醇(90mL)中的悬浮液中,添加甲醇钠(30%于甲醇中,32.8mL,182mmol)。将混合物加热至回流并保持2天,然后浓缩至干燥。将残余物溶解于水中,并用冰乙酸酸化。通过过滤收集形成的白色沉淀物,用水洗涤。将固体在真空下干燥,得到4-氯-5-甲氧基哒嗪-3(2H)-酮(29-1,2.99g)。
该程序还用于,在回流甲醇中使用碳酸钾代替氢氧化钠,由3,6-二氯哒嗪来制备3-氯-6-甲氧基哒嗪。
步骤2:在氮气下,向加热至80℃的29-2(依照实施例8步骤1的程序,由29-1制备,2.18g,12.5mmol)于氢氧化钠水溶液(90mL)中的悬浮液中,添加钯(10%于碳上,9.0g,8.45mmol)。用氢气替代所述气氛(在真空与来自气球的氢气之间切换数次),并将混合物在80℃下搅拌3.5小时。将混合物通过过滤,用热水洗涤。将滤液冷却至室温,再次通过过滤,然后浓缩至大约20mL,并用乙酸乙酯萃取。将有机层用盐水洗涤,经硫酸钠干燥,过滤并浓缩,得到呈白色固体的5-甲氧基-2-甲基哒嗪-3(2H)-酮(29-3,0.46g)。
步骤3:向29-3(0.46g,3.29mmol)的冰乙酸(11mL)溶液中,添加浓氢溴酸(48%,11mL)。将混合物加热至回流过夜,然后冷却至室温,用水稀释,并用固体碳酸氢钠(逐份添加)碱化。用乙酸乙酯萃取所得混合物。将水性层用HCl水溶液(2N)酸化,并浓缩。将残余物悬浮于热乙酸乙酯中,并过滤。将固体再悬浮于热甲醇中,并过滤。将两种滤液经硫酸钠干燥,减小体积,然后吸附至硅胶上。将吸附的材料置于硅胶柱上,并用二氯甲烷中的10%甲醇洗脱,得到呈白色固体的5-羟基-2-甲基哒嗪-3(2H)-酮(29-4,264mg)。
本发明非常适于获得所提到的目的和优势,以及其中固有的那些目的和优势。此外,除非专利权人另外明确且清楚地定义,否则权利要求书中的术语具有它们清楚、通用的含义。
Claims (5)
1.一种化合物,所述化合物为:
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(2'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(6-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸乙酯;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸乙酯;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸乙酯,
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',3'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸乙酯;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸乙酯;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸乙酯;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸乙酯;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2'-乙基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',4'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4'-氟-3'-甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸乙酯;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸乙酯;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-4-甲基-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸乙酯;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸乙酯;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸乙酯;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸乙酯;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(5-羟基-2-甲基-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸乙酯;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸乙酯;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸乙酯;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸乙酯;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸乙酯;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸乙酯;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸乙酯;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2-氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸乙酯;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸乙酯;
(S)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸乙酯;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
3-(3'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(4'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸乙酯;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸乙酯;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸乙酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸乙酯;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸叔丁酯;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸乙酯;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸乙酯;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯,
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯,
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸乙酯
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(2-氧代-3-苯基吡啶-1(2H)-基)苯基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸;
(S)-3-(2'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(6-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸;
(S)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',5'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',3'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(4'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(2'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(2',3'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(3',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸;
3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸;
(S)-3-(2'-乙基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3',4'-二甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4'-氟-3'-甲基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(1-苯基-1H-吡咯-2-基)丙酸;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸;
3-(2',4'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-4-甲基-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(3-甲氧基苯基)噻吩-2-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-羟基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)丙酸;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸;
(S)-3-(4-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(5-羟基-2-甲基-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3'-氯联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-羟基-6-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-甲氧基苯基)噻吩-2-基)丙酸;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸1;
(S)-3-(4-氟联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-[2,3'-联噻吩]-5-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)丙酸;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2-氟联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸;
(S)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)-3-(5-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸;
3-(3'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
3-(4'-乙酰基联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-羟基-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基哒嗪-3-基)苯基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸;
(S)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸,
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸,
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸,
(S)-3-(联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(联苯-3-基)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-氟联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟联苯-3-基)丙酸钠;
(S)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸钠;
3-(3-(1H-吡咯-1-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',5'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-3-基)苯基)丙酸钠;
(S)-3-(3',5'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3',5'-二甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲氧基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲基)联苯-3-基)丙酸钠;
(S)-3-(3',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5'-二甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',3'-二甲基联苯-3-基)丙酸钠;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氧代-1-苯基-1,6-二氢吡啶-3-基)丙酸钠;
(S)-3-(2',6'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-氟联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-氟联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(2',4'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3',4'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-3-基)丙酸钠;
3-(4'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(3'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(2'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲基)联苯-3-基)丙酸钠;
(S)-3-(5,6-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6-甲氧基吡啶-3-基)苯基)丙酸钠;
(S)-3-(2',5'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(嘧啶-5-基)苯基)丙酸钠;
(S)-3-(2',6'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(3',4'-二氯联苯-3-基)-3-(3-(1-乙基-5-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(3',4'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基呋喃-2-基)丙酸钠;
(S)-3-(3-(2,5-二甲基-1H-吡咯-1-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(3'-氯-4'-氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(2',3'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(3',5'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-2'-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5'-甲氧基-2'-甲基联苯-3-基)丙酸钠;
3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(2,2,2-三氟乙氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-乙基联苯-3-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟联苯-3-基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3',4'-二甲基联苯-3-基)丙酸钠;
(S)-3-(2',3'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-氟-3'-甲基联苯-3-基)丙酸钠;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(5'-氯-2',4'-二氟联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',3'-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1H-吡咯-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(6-甲氧基吡啶-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2'-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-(三氟甲氧基)联苯-3-基)丙酸钠;
3-(2',4'-二氯联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-2,5,6,7-四氢-1H-环戊并[b]吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(4-甲基-7-氧桥-5-氧代-4,5-二氢噻吩并[3,2-b]吡啶-6-基)脲基)丙酸钠;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(苯并[d][1,3]二氧代-5-基)苯基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1H-吲唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟-6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸钠;
(S)-3-(3-(1-乙基-1H-吲哚-6-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1H-吡唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(2',5'-二氯联苯-3-基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢-1,8-萘啶-3-基)脲基)丙酸钠;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(4-(3-甲氧基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(4-(3-氯苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(1-乙基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻吩-2-基)苯基)丙酸钠;
(S)-3-(6-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3'-氯-6-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2–二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(6-甲氧基-4'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',6'-二氯联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(5-氯噻吩-2-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(4-甲基噻吩-3-基)苯基)丙酸钠;
(S)-3-(2',4'-二氟-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3'-甲氧基-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-(2,6-二甲基苯基)噻吩-2-基)丙酸钠;
(S)-3-(3-(1H-吡咯-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6,6'-三氟联苯-3-基)丙酸钠;
(S)-3-(6-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-1H-吡唑-4-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(2-甲基-5-氧桥-3-氧代-2,3-二氢哒嗪-4-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-3-基)丙酸钠;
(S)-3-(3',6-二甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(4-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3'-氯-6-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3'-氯联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(呋喃-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(6-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-(2,4-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-(3-甲氧基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3',5-二甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-甲基联苯-3-基)丙酸钠;
(S)-3-(4-氟联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-苯基吡啶-2-基)丙酸钠;
(S)-3-(5-甲基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸钠;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟-5-甲基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-甲基-3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟-2',6'-二甲基联苯-3-基)丙酸钠;
(S)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-甲氧基-2',6'-二甲基联苯-3-基)丙酸钠;
(S)-3-(2',4'-二氟-5-甲氧基联苯-3-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3'-甲氧基-5-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',6'-二甲基联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠;
(S)-3-(4'-甲基-2,3'-联噻吩-5-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲基-2,3'-联噻吩-5-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-5-甲基联苯-3-基)丙酸钠;
(S)-3-(5-(2,6-二甲基苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(2,6-二甲基苯基)噻吩-2-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-2',6'-二甲基联苯-3-基)丙酸钠;
(S)-3-(4-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4,4'-三氟联苯-3-基)丙酸钠;
(S)-3-(4-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(4-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',5,6'-三甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-3-基)丙酸钠;
(S)-3-(5-氟-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(3-(三氟甲氧基)苯基)噻吩-2-基)丙酸钠;
(S)-3-(4-甲氧基-2',6'-二甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-氟-3'-甲氧基联苯-3-基)丙酸钠;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-氟-3'-甲氧基联苯-3-基)-3-(3-(4-羟基-1,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-3'-三氟甲氧基联苯-3-基)丙酸钠;
(S)-3-(5-氟-3'-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-(3,5-二甲基异噁唑-4-基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(3,5-二甲基异噁唑-4-基)苯基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2-氟联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-氟-2'-甲基联苯-3-基)丙酸钠;
(S)-3-(6-氟-2'-甲基联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸钠;
(S)-3-(5-(2,5-二氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸钠;
(S)-3-(5-甲氧基联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-(三氟甲基)联苯-3-基)丙酸钠;
(S)-3-(5-(3-氯苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(5-(3-氟苯基)噻吩-2-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(2',4'-二氟联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基-6-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(6-(三氟甲氧基)联苯-3-基)丙酸钠;
3-(3'-乙酰基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
3-(4'-乙酰基联苯-3-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4-苯基噻吩-2-基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基噻吩-2-基)丙酸钠;
(S)-3-(2',4'-二氟联苯-3-基)-3-(3-(7-氧桥-5-氧代-1,2,3,5-四氢吲嗪-6-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(噻唑-2-基)苯基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟甲基-3'-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',4',5-三氟联苯-3-基)丙酸钠;
(S)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3'-甲氧基-6-(三氟甲氧基)联苯-3-基)丙酸钠;
(S)-3-(2',6'-二甲基联苯-4-基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2'-甲基联苯-4-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(2',6'-二甲基联苯-4-基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡啶-2-基)苯基)丙酸钠;
(S)-3-(3-(6-甲氧基哒嗪-3-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-苯基吡啶-3-基)丙酸钠;
(S)-3-(3-(1,6-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(5-氟-2',6'-二甲基联苯-3-基)丙酸钠;
(S)-3-(联苯-4-基)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(6'-甲氧基吡啶-2-基)苯基)丙酸钠;
(S)-3-(3-(1,5-二甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(4'-甲氧基联苯-3-基)丙酸钠;
(S)-3-(3-(1H-咪唑-1-基)苯基)-3-(3-(1-甲基-4-氧桥-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠;
(S)-3-(3-(4-羟基-1-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)-3-(3-(吡嗪-2-基)苯基)丙酸钠,
3-(3-溴苯基)-3-(3-(4-羟基-1,5-二甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠,或
3-(3-溴苯基)-3-(3-(1-乙基-4-羟基-5-甲基-2-氧代-1,2-二氢吡啶-3-基)脲基)丙酸钠。
2.根据权利要求1所述的化合物,其中所述化合物具有(S)-构型。
3.一种药物组合物,包含:至少一种根据权利要求1所述的化合物;和一种或多种药学上可接受的载体。
4.根据权利要求3所述的药物组合物在制备用于治疗造血干细胞移植疗法期间或用于治疗镰状细胞病、干眼病、动脉粥样硬化、类风湿性关节炎、哮喘、变态反应、多发性硬化、狼疮、炎性肠病、移植排斥、接触性超敏反应、中风、肺动脉高压、糖尿病或癌症的药物中的用途。
5.根据权利要求1所述的化合物在制备用于治疗癌症的药物中的用途,所述治疗通过使癌细胞与所述药物接触以抑制α4β1整合素在其中结合来进行。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/497,414 US10875875B2 (en) | 2017-04-26 | 2017-04-26 | Propionic acid derivatives and methods of use thereof |
PCT/US2018/039289 WO2018201167A2 (en) | 2017-04-26 | 2018-06-25 | Propionic acid derivatives and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110914242A CN110914242A (zh) | 2020-03-24 |
CN110914242B true CN110914242B (zh) | 2023-07-25 |
Family
ID=63916437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880042454.1A Active CN110914242B (zh) | 2017-04-26 | 2018-06-25 | 丙酸衍生物及其使用方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US10875875B2 (zh) |
EP (1) | EP3615514B1 (zh) |
CN (1) | CN110914242B (zh) |
AU (1) | AU2018256931B2 (zh) |
CA (1) | CA3061362A1 (zh) |
DK (1) | DK3615514T3 (zh) |
WO (1) | WO2018201167A2 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240015737A (ko) | 2018-10-30 | 2024-02-05 | 길리애드 사이언시즈, 인코포레이티드 | 알파4베타7 인테그린 억제제로서의 퀴놀린 유도체 |
WO2020092394A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
AU2019373245C1 (en) | 2018-10-30 | 2022-10-27 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4β7 integrin |
CA3115820A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Compounds for inhibition of .alpha.4.beta.7 integrin |
US11578069B2 (en) | 2019-08-14 | 2023-02-14 | Gilead Sciences, Inc. | Compounds for inhibition of α4 β7 integrin |
JP7437495B2 (ja) * | 2019-10-16 | 2024-02-22 | モーフィック セラピューティック,インコーポレイテッド | ヒトインテグリンα4β7の阻害 |
WO2023166067A1 (en) | 2022-03-02 | 2023-09-07 | Syngenta Crop Protection Ag | Microbiocidal pyridazinone amide derivatives |
WO2024132895A1 (en) | 2022-12-19 | 2024-06-27 | Syngenta Crop Protection Ag | Microbiocidal dihydrooxadiazinyl pyridazinone compounds |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000067746A1 (en) * | 1999-05-07 | 2000-11-16 | Texas Biotechnology Corporation | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
WO2000068188A1 (en) * | 1999-05-07 | 2000-11-16 | Texas Biotechnology Corporation | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
US6262084B1 (en) * | 1998-04-16 | 2001-07-17 | Texas Biotechnology Corporation | Compounds that inhibit the binding of integrins to their receptors |
CN1412181A (zh) * | 2001-10-09 | 2003-04-23 | 得克萨斯生物技术公司 | 抑制整联蛋白与其受体结合的羧酸衍生物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US781203A (en) | 1904-06-30 | 1905-01-31 | Henry J Heider | Draft-equalizer. |
ZW6189A1 (en) | 1988-05-09 | 1990-05-09 | Smithkline Beckman Corp | Anti-aggregatory peptides |
NZ235563A (en) | 1989-10-13 | 1993-04-28 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical composition |
US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
WO1995015973A1 (en) | 1993-12-06 | 1995-06-15 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
EP0917462B1 (en) | 1996-07-25 | 2006-09-13 | Biogen Idec MA Inc. | Cell adhesion inhibitors |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6723711B2 (en) | 1999-05-07 | 2004-04-20 | Texas Biotechnology Corporation | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
US6972296B2 (en) * | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
US7501538B2 (en) | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
-
2017
- 2017-04-26 US US15/497,414 patent/US10875875B2/en active Active
-
2018
- 2018-06-25 WO PCT/US2018/039289 patent/WO2018201167A2/en unknown
- 2018-06-25 CN CN201880042454.1A patent/CN110914242B/zh active Active
- 2018-06-25 CA CA3061362A patent/CA3061362A1/en active Pending
- 2018-06-25 DK DK18791126.8T patent/DK3615514T3/da active
- 2018-06-25 AU AU2018256931A patent/AU2018256931B2/en active Active
- 2018-06-25 EP EP18791126.8A patent/EP3615514B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262084B1 (en) * | 1998-04-16 | 2001-07-17 | Texas Biotechnology Corporation | Compounds that inhibit the binding of integrins to their receptors |
WO2000067746A1 (en) * | 1999-05-07 | 2000-11-16 | Texas Biotechnology Corporation | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
WO2000068188A1 (en) * | 1999-05-07 | 2000-11-16 | Texas Biotechnology Corporation | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
CN1412181A (zh) * | 2001-10-09 | 2003-04-23 | 得克萨斯生物技术公司 | 抑制整联蛋白与其受体结合的羧酸衍生物 |
Also Published As
Publication number | Publication date |
---|---|
EP3615514A2 (en) | 2020-03-04 |
AU2018256931A1 (en) | 2019-12-19 |
DK3615514T3 (da) | 2024-02-19 |
WO2018201167A3 (en) | 2018-12-20 |
CA3061362A1 (en) | 2018-11-01 |
AU2018256931B2 (en) | 2022-06-30 |
CN110914242A (zh) | 2020-03-24 |
EP3615514B1 (en) | 2023-11-22 |
WO2018201167A2 (en) | 2018-11-01 |
EP3615514A4 (en) | 2020-09-30 |
US20180312523A1 (en) | 2018-11-01 |
US10875875B2 (en) | 2020-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110914242B (zh) | 丙酸衍生物及其使用方法 | |
CA2979391C (en) | Alpha-cinnamide compounds and compositions as hdac8 inhibitors | |
CA3016182C (en) | Substituted indole mcl-1 inhibitors | |
TWI360539B (en) | 3-carbamoyl-2-pyridone derivatives | |
JP4629666B2 (ja) | mtp阻害剤としてのチアゾリルピペリジン誘導体 | |
CA2752269C (en) | Novel triazine derivative and pharmaceutical composition comprising the same | |
AU2014326596B2 (en) | Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway | |
JP7508584B2 (ja) | PI3Kα阻害剤およびそれらの使用 | |
AU2006322094A1 (en) | Bicyclic compounds with kinase inhibitory activity | |
AU2022279504A1 (en) | Substituted 4-Phenyl Pyridine Compounds As Non-Systemic TGR5 Agonists | |
CA3229539A1 (en) | Inhibitors of nlrp3 | |
TW201016702A (en) | Novel pyrrolinone derivative and pharmaceutical composition comprising the same | |
WO2010007756A1 (ja) | Ttk阻害作用を有するピリジン誘導体 | |
PT1249233E (pt) | Antagonistas de y5 de npy | |
AU736414B2 (en) | Novel carboxylic acid derivatives, their preparation and use as mixed eta/etb receptor antagonists | |
IL280719B1 (en) | Transglutaminase 2 (tg2) inhibitors | |
AU2013366898A1 (en) | Halogen-substituted heterocyclic compound | |
CA3114883A1 (en) | Matriptase 2 inhibitors and uses thereof | |
NZ319595A (en) | Amino acid derivatives as endothelin antagonists | |
IL300976A (en) | Quinoline compounds as CGAS antagonists | |
US20190233380A1 (en) | Fluoroalkylating agent | |
NZ502319A (en) | 3-Beta-amino and beta-azidocarboxylic acid derivates useful as endothelin receptor antagonists | |
JP3143571B2 (ja) | ピロロピリダジン誘導体 | |
AU2021368444B2 (en) | Amide derivative having antiviral activity | |
AU2021368444A9 (en) | Amide derivative having antiviral activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |